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CHAPTER 1 
INTRODUCTION AND OBJECTIVES 
 
 
1.1. INTRODUCTION AND OBJECTIVES 
 
Hot-melt extrusion is defined as the process of pumping raw materials with one or two 
rotating screw(s) through a die into a product of uniform shape under controlled conditions, 
such as temperature, feed rate and pressure [1]. At the end of the eighteenth century, the 
extrusion technique was originally invented for the manufacturing of lead pipes. Today, it is 
widely applied in the plastic, rubber and food industry. In pharmaceutical manufacturing, the 
technique is used to produce molecular dispersions of active pharmaceutical ingredients 
(APIs) in various polymer and/or lipid matrices. The hot-melt extrusion process has proven to 
be a viable method for the production of granules, pellets, tablets, suppositories, implants, 
stents, transdermal systems, transmucosal systems and ophthalmic inserts [2], thereby 
enhancing the dissolution rate and bioavailability of poorly soluble drugs, enabling 
controlled or modified release of the drug, masking the bitter taste of several active 
pharmaceutical ingredients and allowing the formulation of various thin films. 
 
One of the advantages of the hot-melt extrusion technique, compared to the more 
conventional pharmaceutical manufacturing processes, is its ability to be operated in a 
continuous mode [3, 4]. The benefits of continuous manufacturing compared to batch 
production are numerous [5-7]: no scale-up issues resulting in a shorter development time; 
possible automation of the production line; reduction of production costs; faster product 
release; less product variability and improved product quality. In contrast with the food and 
chemical industry where continuous production processes are well established, the 
pharmaceutical manufacturing industry currently primarily relies on batch wise production 
[5], where product quality is assessed subsequent to each processing step using off-line, 
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time-consuming analytical techniques on randomly collected samples to evaluate the end or 
intermediate product quality. 
 
Pharmaceutical production must be carried out in accordance with the Good Manufacturing 
Practice (GMP) guidelines, which ensure that products should be consistently produced and 
controlled to the quality standards appropriate to their intended use and as required by the 
Marketing Authorization, Clinical Trial Authorization or product specification [8]. Recently, 
the regulatory authorities began to encourage the transition from batch production to 
continuous processing. The application of traditional off-line quality control methods would 
annul the benefits inherent in continuous manufacturing, and therefore real-time, in-process 
measurements of (intermediate) product quality are essential to sustain a continuous 
production process. The Process Analytical Technology (PAT) guideline, proposed by the 
Food and Drug Administration (FDA), presents a framework for the continuous monitoring 
and control of pharmaceutical production processes [9]. Continuous manufacturing requires 
a PAT monitoring and control strategy, to allow production according to the Quality by 
Design (QbD) approach [10]. The ultimate purpose of PAT is to develop manufacturing 
processes that can compensate for the variability in raw materials and in equipment, to 
guarantee a consistent end-product quality, as required by the GMP guidelines. Therefore, 
information on the critical quality attributes is gathered in real-time, to allow process 
adjustments. PAT ensures that all sources of variability affecting a process are identified, 
explained and managed. 
 
Despite the increasing popularity of hot-melt extrusion as a pharmaceutical production 
process, quality control is still performed off-line, and the process is more or less controlled 
using standard, univariate process monitoring sensors such as temperature and pressure 
probes. The data generated by these sensors does not suffice to assess the critical quality 
attributes of the extrudates, and cannot ensure the development of an end product with 
predefined and consistent quality characteristics. This thesis examines the application of 
spectroscopic tools as process analytical techniques for the monitoring of critical quality 
attributes such as API concentration, solid state and occurrence of polymer-drug interactions 
during hot-melt extrusion, for the visualization of material behaviour in the process 
environment and to improve the overall process understanding. 
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In Chapter 2, a general overview of the principles of hot-melt extrusion, its advantages and 
shortcomings for pharmaceutical production and an overview of the extrusion equipment 
are provided. Chapter 3 summarizes the concept of PAT, and discusses the various process 
analytical tools available for observation of critical process and product parameters which 
are currently being applied in pharmaceutical hot-melt extrusion and in polymer extrusion. 
 
Chapters 4 to 9 provide the results from the conducted experimental work. In Chapter 4, the 
feasibility of Raman spectroscopy as a process analytical tool for in-line monitoring and 
prediction of the API concentration and for monitoring of the physicochemical state of the 
extrudates and possible interactions between polymers and drugs during hot-melt extrusion 
was assessed. Raman spectra were collected in the extrusion die. A predictive PLS model was 
developed for the in-line determination of the API concentration, and the manifestation of 
peak broadening and shifts in the in-line collected Raman spectra was correlated to 
differences in solid state and interactions between the API and the polymer during hot-melt 
extrusion. Once the suitability of Raman spectroscopy to monitor and predict the API 
concentration during hot-melt extrusion was verified, an improved API calibration model 
was developed and a thorough validation method for drug quantification based on Raman 
spectra collected in the extrusion die was applied (Chapter 5). The validation of the 
developed method was based on the calculation of the accuracy profile, which allowed the 
determination of the proportion of future measurements that will be found within preset 
acceptance limits (a preset percentage of the relative bias, here set at 10%). Finally, the 
uncertainty of the method was determined, and the robustness of the predictive model was 
assessed via a design of experiments, where possible small fluctuations in process settings 
were simulated. 
 
In Chapter 6, the influence of variations in drug concentration, barrel temperature and 
screw speed on the polymer-drug solid state and interactions throughout the entire 
extrusion barrel was examined. A Raman probe was implemented in each section of the 
extrusion barrel, to visualize and enhance the understanding of material behaviour during 
hot-melt extrusion. 
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The aim of the experiments performed in Chapter 7, was to create a method for the real-
time classification of extrudates according to their solid state, based on Raman spectroscopic 
measurements collected in the extrusion die of a 12 mm twin-screw extruder. The influence 
of variations in drug concentration, changes in barrel temperature and three different screw 
configurations on the physicochemical state of the extrudates was assessed. Soft 
independent modelling of class analogy was performed to develop a classification model 
which allowed distinction between glassy solid solutions and crystalline dispersions of a 
poorly soluble API in a polymer. Additionally, the effects on the Raman measurements of the 
applied drug concentration, processing temperature and feeder performance, all resulting in 
fluctuations in die pressure, were evaluated. 
 
In Chapter 8, the suitability of NIR spectroscopy for the in-line determination of the drug 
concentration, the polymer-drug solid state and molecular interactions was evaluated by 
implementing an NIR probe in the extrusion die. A PLS model was developed for in-line API 
concentration monitoring. The relationship between peak broadening, peak shifts, and 
variations in physicochemical state of the extrudates was studied. The manifestation of new 
peaks in the NIR spectra was used to determine the type of interactions occurring between 
the selected polymer and API. 
 
The aim of Chapter 9 was to evaluate the suitability of ultrasonic techniques as process 
analytical tools for the in-line monitoring of the API concentration. A PLS model for API 
quantification was developed based on the monitoring of torque, die pressure, ultrasonic 
transit time and peak height of the ultrasound signal. 
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CHAPTER 2 
HOT-MELT EXTRUSION AS A 
PHARMACEUTICAL PRODUCTION PROCESS 
 
 
2.1. HOT-MELT EXTRUSION 
 
HME is one of the most widely used processing techniques in the plastic and rubber 
manufacturing industry and is extensively applied in the food processing industry. It is 
defined as the process of pumping raw materials with a rotating screw through a die into a 
product of uniform shape under controlled conditions, such as temperature, feed rate and 
pressure [1, 2]. HME has potential to be applied in continuous manufacturing for a wide 
variety of dosage forms and formulations, such as granules, pellets, tablets, capsules, 
implants, suppositories, stents, transdermal and transmucosal systems and ophthalmic 
inserts [3, 4]. In hot-melt extruded drug delivery systems, active pharmaceutical ingredients 
(APIs) are embedded in a carrier, containing meltable materials and additional excipients. 
These materials can be polymeric materials or thermodeformable waxes [5]. 
 
HME offers several advantages compared to conventional pharmaceutical production 
processes [1, 3, 4, 6, 7] of solid dosage forms for certain formulations. Formulations 
produced with HME often exhibit an enhanced bioavailability of poorly soluble drugs, due to 
dispersion of the API at molecular level in the final dosage forms [8-10]. The molten 
polymers can function as thermal binders and act as drug depots or drug release retardants, 
hence allowing sustained, modified and targeted release. HME also allows masking of the 
bitter taste of an API [11-13]. An improved content uniformity is obtained by the intense 
agitation and distributive and dispersive mixing generated by the rotating screw and its 
selected configuration, resulting in the de-aggregation of suspended particles in the molten 
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polymer. The process is anhydrous, avoiding potential water-mediated drug degradation. 
Exclusion of solvents in the production process decreases the number of processing steps 
and eliminates the need for time-consuming drying steps. The extrudates can be cut into 
tablets, hence eliminating tabletting issues caused by poor compressibility of the 
formulation. An additional significant advantage is that HME is a continuous process. The 
advantages of continuous production over traditional batch processes are numerous [14-16]: 
less scale-up issues resulting in a shorter development time, possible automation of the 
production line, reduction of production costs and waste, a reduced time-to-market, less 
product variability and improved product quality. 
 
During extrusion, all components in the formulation must be thermally stable at the selected 
processing temperatures, which could limit the extrusion of thermosensitive APIs and 
carriers. However, the residence time in a twin-screw extruder is relatively short, and the 
temperature of each barrel segment can be controlled accurately. Downstream feeding of 
thermolabile APIs (behind the kneading zone) can avoid degradation of these compounds 
due to high temperatures caused by the shear forces generated by the rotating screw and its 
screw design that are needed to melt the polymers. Hence, the exposure of the API to high 
temperatures is reduced to a minimum. Another drawback of HME is related to the high 
energy input from the shear forces in the extrusion barrel, leading to higher, uncontrolled 
and unknown product temperatures, which could induce drug or polymer degradation, 
having a significant impact on the product quality. This obstacle can be overcome by 
adjusting the process parameters as well as the screw and die design [2]. 
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2.2. PROCESS AND EQUIPMENT 
 
The equipment for HME comprises an extruder, downstream auxiliary equipment and 
monitoring tools used for performance and product quality evaluation. The extruder itself 
(Figure 2.1) consists of a feeding hopper, a temperature controlled barrel with one or two 
screws, a screw-driving unit, a die to shape the final product and a heating/cooling device [2, 
5]. A powder blend, typically containing the API, thermoplastic polymers or waxes as a 
matrix carrier and other functional excipients (e.g. plasticizers, release modifying agents, 
superdisintegrants, thickening agents, antioxidants, thermal lubricants, bulking agents and 
miscellaneous additives [1, 2]), is fed through the feed hopper into the barrel. This barrel 
usually contains different zones, each with a specific set barrel temperature. The rotating 
screws within the barrel transport the powder blend towards the extrusion die. The powder 
blend will melt primarily due to the heat generated by friction as the material is sheared 
between the rotating screw(s) and the barrel wall, and additional heat is conducted from the 
barrel [6]. This melt is then pumped through the die located at the end of the extrusion 
barrel, and subjected to further downstream processing equipment. 
 
The screw design has a significant influence on the efficiency of the HME process and on the 
quality of the end product. Screw geometry directly affects the throughput, melting rate, 
mixing, product temperature and homogeneity of the melt. Different screw configurations 
allow downstream transport of the material in the barrel towards the extrusion die, 
conveying, melting, mixing, venting or devolatilization, and pumping and compression of the 
molten powder blend. Several types of screw elements are required to perform these tasks. 
Conveying elements provide transport of the melt, either forward or backward. Different 
mixing elements can also be included in the screw design. Their function, distributive or 
dispersive mixing, is related to their geometry. Furthermore, they also play a key role in 
transforming the API from its crystalline to its amorphous form [17]. A detailed overview of 
all possible screw elements can be found in the literature [8, 18, 19]. 
 
In pharmaceutical HME, twin-screw extrusion is preferred over single-screw extrusion. In 
twin-screw extrusion, the screws can rotate in the opposite direction (counter-rotating) or in 
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the same direction (co-rotating), whichever is most favourable. Counter-rotating designs are 
used when regions with very high shear are required. These extruder types allow potential 
air entrapment, high pressure generation and low maximum screw speeds and output [1]. 
Co-rotating screws are often fully intermeshing, indicating that as the screws rotate, the 
element on one screw wipes the element on the neighbouring screw, causing material to 
transfer between both screws [6]. They can be operated at high screw speeds and deliver 
high outputs, and offer better mixing and conveying of the melt. Other benefits related to 
co-rotating screws are a shorter residence time, less tendency to overheat the materials, and 
an easier material feed [6, 20]. 
 
 
 
Figure 2.1. Hot-melt extrusion equipment and process settings and parameters traditionally monitored during 
pharmaceutical HME.(1. Feeding system 2. Feeding hopper 3. Temperature controlled barrel with 1 or 2 screws 
4. Die 5. Heating and cooling device 6. Screw-driving unit). 
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Several downstream processing devices are available for further cooling, cutting and shaping 
of the hot-melt extruded strands. Cooling of the extrudates can be accomplished with air, 
nitrogen, in water or simply at room temperature on conveyor belts or rolls. Film extrusion 
on chilled rolls or calenders has been applied for the manufacturing of films for oral 
administration [21-27] and transdermal drug delivery [28, 29]. Calendering allows 
continuous shaping of the melt and solidification into tablet- or capsule-like forms [30]. 
Injection moulding is a downstream process step where the melt is injected into a closed 
mould under high pressure and temperature conditions after leaving the extrusion die. An 
overview of the applications of injection moulding for drug delivery is presented in [31]. 
Another possibility of shaping the extruded strands is by cutting them into small pellets using 
pelletizers [32-34]. 
 
Nowadays, extruders are equipped with standard (univariate) process monitoring sensors. 
These traditional monitoring options provide information on barrel and die temperatures, 
feed rate or throughput, screw speed, torque and drive amperage, melt pressure, melt 
temperature and possibly melt viscosity [1, 35] (Figure 2.1). Classical process control based 
on measurements of these conventional parameters is in many cases not sufficient to 
account for process-induced variations in material properties, to guarantee stable processing 
and to monitor and predict the quality attributes of the extrudates. 
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CHAPTER 3 
PROCESS MONITORING AND VISUALIZATION 
SOLUTIONS FOR HOT-MELT EXTRUSION 
 
 
3.1. INTRODUCTION 
 
Process analytical tools for pharmaceutical HME are required for two purposes: (i) improving 
the understanding of pharmaceutical HME by monitoring and visualizing material behaviour 
during processing (an enhanced understanding of the process and the material behaviour 
allows optimization of formulations, process settings such as screw configuration etc.); and 
(ii) monitoring and analyzing critical product and process parameters for process control, 
allowing to maintain a desired process state and guaranteeing the quality of the end 
product. 
 
The implementation of suitable process analytical tools in HME will enable the “Quality by 
design” (QbD) approach introduced by the Food and Drug Administration (FDA). The Process 
Analytical Technology (PAT) concept encourages continuous monitoring and control of 
pharmaceutical production processes based on timely measurements of critical quality and 
performance attributes of raw and in-process materials and processes [1]. A thorough 
knowledge of product performance over a range of material attributes, manufacturing 
process options and process parameters is requested in the ICH Q8 guideline [2], and this 
understanding can be gained by the application of PAT. Continuous manufacturing cannot 
rely on the currently applied quality control methods for intermediate or end products which 
are mainly based on time-consuming and off-line analytical techniques, and annul the 
advantages of continuous pharmaceutical production. In-process monitoring, analysis and 
control of the critical process and product parameters are essential to constantly ensure 
end-product quality during continuous manufacturing. Continuous manufacturing processes, 
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like HME, are made for continuous process control [3]. They adapt easily to QbD and Design 
of Experiments (DOE) investigations can be performed by changing process parameters 
within one experimental run. By implementing process analyzers or PAT tools, real-time 
information on physical or chemical material properties is obtained, which can be utilized in 
process control systems to steer the process towards a desired state, to allow real-time 
release or for scale-up of the production process. The implementation of PAT strategies in 
HME is valuable both in commercial manufacturing and in the development scale. 
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3.2. PROCESS ANALYTICAL TECHNOLOGY 
 
Conventional pharmaceutical manufacturing is generally accomplished using batch 
processing followed by time-consuming, expensive and inefficient off-line laboratory testing 
on randomly collected samples to evaluate the end product quality. The processes 
themselves are not fully understood and are often inefficient black-boxes. Therefore, the 
FDA has introduced the concept of PAT [1]. 
 
PAT is defined as “a system for designing, analyzing and controlling manufacturing through 
timely measurements (i.e. during processing) of critical quality and performance attributes 
of raw and in- process materials and processes, with the goal of ensuring final product 
quality” [1]. The objective of PAT is to improve process understanding and to control the 
manufacturing process, and thus to design and develop well understood processes that will 
compensate for the variability in raw materials and in equipment, thereby consistently 
ensuring a predefined quality at the end of the manufacturing process. Quality should not be 
tested into products, it should be built-in, to improve the efficiency of the process, and 
reduce risks to quality and regulatory concerns. When implementing this QbD paradigm in 
pharmaceutical manufacturing, PAT strategies are used to reduce identified manufacturing 
risks associated with product quality. An appropriate combination of several PAT tools 
provides relevant information concerning the critical sources of variability during 
manufacturing, allowing real-time, continuous analysis of manufacturing processes and 
enabling process control and optimization. In the PAT framework, these tools are 
categorized as followed [1]: 
 
- Multivariate tools for design, data acquisition and analysis 
 
There are many development strategies that can be used to identify optimal formulations 
and processes. These tools enable the identification and evaluation of product and process 
variables that may be critical to product quality and performance. Additionally, they allow 
the identification of potential failure modes and mechanisms and the quantification of their 
effects on product quality. 
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- Process analyzers 
 
Process analysis has advanced significantly during the past several decades, from the 
univariate process measurements (e.g. pressure, temperature, and pH) to analyzers 
measuring biological, chemical and physical attributes of the materials being processed. The 
process analyzers applied in hot-melt extrusion should be non-destructive, non-invasive, fast 
and should require no sample pretreatment. Various measurement setups are possible 
(Figure 3.1): When the sample is isolated from the process stream and analyzed in close 
proximity to the process, measurements are performed at-line. At-line monitoring differs 
from off-line analysis in the reduced time between sampling and analysis results, but still 
maintains a delay in quality control. On-line measurements involve the diversion of a small 
part of the product from the process stream which is then presented continuously to an 
analyzer. The sample is returned to the process stream after analysis. In-line techniques are 
located directly in the process stream, providing information without removing samples 
from the process stream. 
 
 
Figure 3.1. At-line, on-line and in-line measurement positions for the monitoring of hot-melt extrusion 
processes. 
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- Process control tools 
 
The application of process monitoring and control strategies enables monitoring of the state 
of a process and actively manipulating it to maintain a desired state. Consequently, final 
product quality can be guaranteed, end product characteristics can be predicted and real-
time release can be ensured, hence avoiding batch losses. 
 
- Continuous improvement and knowledge management tools. 
 
Over the life cycle of a product, continuous data collection and analysis are essential to 
improve understanding of the process and product, and to justify proposals for post-
approval changes. 
 
An overview of the applied process analytical tools for pharmaceutical HME discussed in this 
chapter can be found in Table 3.1, together with their purpose, interfacing possibilities, 
challenges and disadvantages encountered during implementation. Table 3.2 provides an 
overview of the reviewed HME process analytical tools used in polymer extrusion with 
relevant potential for monitoring and control of pharmaceutical HME. Their purpose, 
possible benefits and shortcomings for pharmaceutical HME and interface positions are also 
listed in Table 3.2. The reported possible drawbacks of each technique applied in 
pharmaceutical extrusion and polymer extrusion should be taken into account when 
considering application of these tools for analysis, understanding and control of 
pharmaceutical HME processes. 
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3.3. PROCESS ANALYTICAL TECHNIQUES APPLIED FOR PHARMACEUTICAL 
HOT-MELT EXTRUSION 
 
3.3.1. NIR spectroscopy 
 
Tumuluri et al. [4] applied NIR spectroscopy to predict the clotrimazole quantity in hot-melt 
extruded polyethylene oxide (PEO) films via a developed partial least squares (PLS) model. A 
fibre-optic NIR reflectance probe was fixed above the extruded films, behind the extrusion 
die. Vector normalization of the spectra was performed to reduce the variations in intensity 
caused by path length variation. Extrusion was performed on a single-screw extruder. The 
calibration model, containing 9 different PEO films with varying clotrimazole content, 
regressing the on-line collected NIR spectra versus the actual clotrimazole content as 
determined with high-performance liquid chromatography (HPLC), yielded a root mean 
square error of cross validation (RMSECV) of 0.298% (w/w). Four validation samples were 
predicted within a margin of error of less than 3.5% (w/w). It was shown that the model was 
more accurate for predictions at higher concentrations.  
 
Saerens et al. [5] implemented a diffuse reflectance NIR probe in the extrusion die of a co-
rotating twin-screw extruder (screw diameter = 16 mm) (Figure 3.2) to monitor and predict 
drug content and to evaluate the physicochemical state of the extrudates before exiting the 
die. A PLS model was built, regressing the in-line NIR spectra collected during extrusion of 
physical mixtures containing 20, 30 and 40% (w/w) metoprolol tartrate (MPT) in Kollidon® SR 
(BASF, Ludwigshafen, Germany) versus the known MPT concentrations. The model was 
validated with new extrusion experiments, resulting in a root mean square error of 
prediction (RMSEP) of 1.54% (w/w).  
 
Furthermore, a physical mixture with a drug load of 40% MPT (w/w) in Kollidon® SR was 
extruded at 135°C and at 105°C. The in-line NIR spectra were compared to the NIR spectrum 
of the physical mixture. The spectra of both extrudates still contained the MPT peaks, 
though broader, indicating that not all MPT remained in its crystalline form. This broadening 
of spectral bands was slightly more pronounced at 135°C than at 105°C. Peak shifts 
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throughout the entire spectrum were also visible, expressing the extent of molecular 
interactions between polymer and drug. At 105°C, these shifts were smaller, suggesting 
stronger interactions between Kollidon® SR and MPT at 135°C. Furthermore, the polymer-
drug interactions were confirmed by the manifestation of a new peak, attributed to 
hydrogen bonded hydroxyl groups. At 135°C, this peak was more intense than at 105°C. 
Saerens et al. hence demonstrated that NIR spectroscopy can be used in-line during HME to 
monitor the drug concentration and solid state and hydrogen bonds formed during 
extrusion. The authors chose a formulation with Kollidon® SR as matrix since this 
formulation does not produce a transparent extrudate, which could cause detection 
problems when using reflectance NIR spectroscopy. 
 
 
Figure 3.2. Implementation of NIR (left) and Raman (right) spectroscopic probes via fibre optic cables in the 
extrusion die [5, 11]. 
 
Smith-Goettler et al. [6] used NIR spectroscopy for real-time predictions of the API loading 
and surfactant loading (% w/w). Two transmission NIR probes were mounted in a die 
adapter on a twin-screw extruder with a screw diameter of 27 mm. The first probe is used to 
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send the light through the melt, and on the opposite side of the melt channel, a second 
probe captures this signal and sends it to the detector. 20 calibration mixtures for the 
development of a PLS model and six independent validation mixtures with varying API (0-
30.1% w/w) and surfactant (4.8-27.0% w/w) concentrations were extruded with an output 
varied from 20 kg/h to 35 kg/h. Bands specific for the amorphous API were found in the 
spectra of the extrudates, indicating that changes in the solid state of the API had occurred. 
The API loading prediction model yielded an RMSEP of 0.3% w/w. The surfactant loading 
prediction model yielded an RMSEP of 0.6% w/w. These predictions were then used for fault 
detection, isolation of suspect material and real-time troubleshooting during HME using the 
SIPAT software package (Siemens nv/sa, Brussels, Belgium). When a drift in the API loading, 
due to a change in API lots with different bulk densities, was detected, the molten extrudate 
stream was diverted to waste. Process parameters regarding the material feeders were 
investigated, and the material continued to be diverted to waste until the feeder reached 
steady state. In this research, NIR spectroscopy was hence applied for quantitative 
monitoring and control of the extrusion process. 
 
McKelvey et al. [7] illustrated the use of transmission NIR spectroscopy to study the impact 
of process design and scale up on residence time distributions (RTDs) and on composition 
disturbances caused by feeding issues. RTD measurements as a function of screw speed and 
feed rate were performed on a co-rotating twin-screw extruder with a screw diameter of 16 
mm, by adding a single drop of blue food colouring to the extruder feed inlet and measuring 
the optical response at the die adapter. This RTD fingerprint was used to assess the ability to 
scale from the 16 mm to a 27 mm co-rotating twin-screw extruder, using the ratio of free 
volumes in the extruders (3.63) to adjust the feed rate from 2.75 kg/h to 10 kg/h. In the 27 
mm extruder, each component of the mixture (compound ‘C’, a surfactant and polyvinyl 
pyrrolidone-polyvinyl acetate copolymer) was fed individually, and NIR spectroscopy was 
used to monitor the composition of this melt during extrusion. A die block adapter was 
designed to accommodate the transmission optical probes. A predictive model based on 
feeder input parameters was used to determine the melt composition and was compared to 
the real-time concentration measurements with NIR spectroscopy. This model can be used 
to control the feeding system and to isolate bad product. The transmission NIR spectroscopic 
tool presented here was successful in measuring RTDs and formulation composition at the 
CHAPTER 3 – PROCESS MONITORING AND VISUALIZATION SOLUTIONS FOR HOT-MELT EXTRUSION 
33 
 
extrusion die, providing possibilities for scale-up of the process and optimization with limited 
amounts of material and time. 
 
Troup et al. [8] described the development and implementation of an in-line transmission 
NIR measurement system allowing the determination of the composition of a multi-
component melt stream at the exit of a twin-screw extruder. NIR measurements were 
performed in a custom built die adapter on a 27 mm twin-screw extruder. Two loss-in-
weight mass feeders were used to feed the polymer and drug separately into the extruder. A 
liquid surfactant was fed into the process using a gear pump. Data from the mass feeders 
and liquid addition system were also logged. Using a PLS model, NIR spectroscopy allowed 
the simultaneous prediction of the concentration of all three components in the extrudate. 
The used spectral range was the 1600 – 1800 nm region since all three components have 
chemical groups with strong absorbance in this region, and since this range is robust to 
moisture variability. In routine manufacturing, the NIR system demonstrated to be able to 
detect process upsets and to continuously ensure product uniformity over the entire 
manufacturing run. 
 
A different application of pharmaceutical HME is the production of cocrystals. Kelly et al. [9] 
used NIR spectroscopy to monitor the formation of ibuprofen and nicotinamide cocrystals 
during extrusion based solvent free continuous cocrystallization. The cocrystallization of 
ibuprofen and nicotinamide in a 1:1 molar ratio was carried out in a co-rotating twin-screw 
extruder with a screw diameter of 16 mm. A high temperature NIR reflectance probe with a 
sapphire window was fitted into a threaded port at the end of the extruder barrel. Off-line 
NIR spectra were taken at several points along the extruder screws to examine the dynamics 
of the cocrystal formation. The formation of cocrystals occurred mainly in the latter stages of 
the extruder screw, suggesting that cocrystal formation is highly dependent on the length of 
the screws, residence time and shear caused by the mixing elements across the length of the 
screw. The effects of three different screw configurations with different mixing intensities 
(low, medium and high) dependent on the number and angle of mixing elements, the set 
temperature profiles and the screw speeds were evaluated. NIR spectra from cocrystals 
showed significant differences to those from the physical mixture. Once ibuprofen and 
nicotinamide are bonded together, the vibrations are modified and the peaks shift, giving 
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rise to the appearance of new peaks in the NIR spectrum. The high mixing intensity screw 
configuration (the screw design comprising the most mixing elements at an angle of 90°) 
resulted in the most significant spectral changes compared to the spectrum of the physical 
mixture. Increasing the set temperature at a screw speed of 30 rpm induced similar spectral 
changes as increasing the mixing intensity of the screw configuration. Relatively small 
spectral changes were observed when varying the screw speed (20, 30 and 40 rpm) at 90°C 
using the high intensity screw configuration. A PLS model, regressing the in-line NIR spectra 
against cocrystal purity as determined from X-ray diffraction (XRD), was developed using a 
dataset including only the spectra obtained at a set temperature of 90°C with medium and 
high screw intensity configurations, since temperature is a well known factor influencing the 
NIR spectral signals. It was expected that calibrations over multiple temperature 
configurations would not give accurate results. A correlation coefficient of 0.999 for 
measured and predicted purity was obtained. 
 
NIR spectroscopy has demonstrated to be a versatile process analysis tool for 
pharmaceutical HME to monitor several critical product characteristics such as quantitative 
formulation composition, solid state, polymer-drug interactions and the formation of 
cocrystals (Table 3.1). Besides the application for monitoring purposes, it was also applied to 
control API levels adequately. NIR spectroscopy can be applied in both reflectance and 
transmission mode, depending on the type of formulation used. For transparent 
formulations, the transmission mode is favoured, since spectra collected in reflection mode 
contain more noise. Interpretation of the collected NIR spectra can be a challenging task 
since they contain broad, overlapping overtones and combination bands. However, with the 
proper chemometric techniques, the relevant information can be extracted from NIR 
spectra. 
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Table 3.1. Process analytical tools applied in pharmaceutical hot-melt extrusion 
 
Process analytical 
tool 
Interface In-line or on-
line 
application [1] 
Purpose Reported challenges/disadvantages/shortcomings References 
Near infrared (NIR) 
spectroscopy: 
reflection 
  
  
die in-line monitoring of drug 
concentration 
not possible to monitor a transparent formulation (low 
signal/noise ratio) 
[5] 
post die on-line monitoring of drug 
concentration 
variations in path length cause variations in signal intensity, 
normalization is required 
[4] 
die in-line monitoring of 
cocrystal production 
temperature influence on NIR measurements: the correlation 
improved when temperature variation was excluded from the 
dataset 
[9] 
die in-line monitoring of solid 
state and polymer-
drug interactions 
not possible to monitor a transparent formulation (low 
signal/noise ratio) [5] 
[5, 12] 
NIR spectroscopy: 
transmission 
  
  
die in-line monitoring of drug 
concentration 
- [6-8] 
die in-line monitoring of 
surfactant 
concentration 
- [6-8] 
die in-line monitoring of 
residence time 
distribution (RTD) 
- [7] 
die in-line identification of 
feeding disturbances 
- [6-8] 
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Table 3.1. Process analytical tools applied in pharmaceutical hot-melt extrusion (continued) 
 
Process analytical 
tool 
Interface In-line or on-
line 
application [1] 
Purpose Reported challenges/disadvantages/shortcomings References 
Raman 
spectroscopy 
  
  
  
die in-line monitoring of drug 
concentration 
difficulties with collecting spectra from a non-transparent melt 
[5], resulting in a high background signal 
[11] 
post die on-line monitoring of drug 
concentration 
film undulation caused differences in path length resulting in 
variations in signal intensity, normalization is required 
[10] 
die in-line monitoring of solid 
state and polymer-
drug interactions 
difficulties with collecting spectra from a non-transparent melt 
[5], resulting in a high background signal 
[11, 12]  
die in-line monitoring of 
complex formation 
by an acid-base 
reaction 
- [14] 
barrel 
segments 
in-line monitoring of solid 
state and polymer-
drug interactions 
sapphire probe window provides peaks in Raman spectrum 
when window is not completely covered by sample 
[13] 
Motor load motor in-line monitoring of 
surfactant 
concentration 
- [15] 
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3.3.2. Raman spectroscopy 
 
Tumuluri et al. [10] used Raman spectroscopy to quantify the drug load in hot-melt extruded 
films and to evaluate the physical state of the APIs in the formulations. A fibre optic Raman 
probe was used for on-line analysis and clamped above the film in a 90° angle behind the 
extrusion die. Clotrimazole and ketoprofen were used as model APIs and extruded in PEO 
films on a single-screw extruder. Two PLS models were developed regressing the on-line 
collected Raman spectra against the known concentration of each API. For both PLS models, 
normalization to a peak for PEO was performed to allow quantification. A challenge was the 
undulation of the film, resulting in different path lengths between the extruded film and the 
Raman probe. This was corrected by using the ratio of the active band to the polymer band. 
 
Saerens et al. [11] used a Raman probe implemented in the extrusion die of a co-rotating 
twin-screw extruder (screw diameter = 16 mm) (Figure 3.2) to monitor and predict the drug 
content and to evaluate the physicochemical state of the extrudates before exiting the die. A 
PLS model was built, regressing in-line Raman spectra collected during extrusion of physical 
mixtures containing 10, 20, 30 and 40% (w/w) MPT in Eudragit® RL PO (Evonik, Darmstadt, 
Germany) versus the known MPT concentrations. The model was validated with 
independent test extrusion runs, and resulted in an RMSEP of 0.59% (w/w). Furthermore, 
two physical mixtures containing 10% (mixture A) and 40% (mixture B) MPT (w/w) in 
Eudragit® RS PO (Evonik, Darmstadt, Germany) were extruded at temperatures of 140°C and 
105°C, respectively. The in-line Raman spectra were compared to the Raman spectrum of 
the physical mixtures. In both extrudates, peak shifts occurred, indicating interactions 
through hydrogen bonds between polymer and drug. The shifts were larger in the extrudates 
of mixture A, indicating stronger interactions. Evidence was found for the formation of 
hydrogen bonds between the hydroxyl and/or amino groups from MPT and the carbonyl 
groups belonging to the polymer. The MPT peaks in the extrudates of mixture B are still well 
defined, sharp peaks, whereas for mixture A, they have broadened extensively, showing the 
presence of amorphous MPT. Raman spectroscopy allowed differentiation between solid 
states of the drug and formulation, and was able to accurately predict drug concentration 
during HME. 
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Almeida et al. [12] extruded physical mixtures containing MPT and ethylene vinylacetate 
(EVA) (50:50) on a co-rotating twin-screw extruder (16 mm). Diffuse reflectance NIR 
spectroscopy and Raman spectroscopy were implemented in the die to evaluate the material 
behaviour at a molecular level in-line as a function of the process settings (temperature: 90, 
110 and 140°C; screw speed: 90 and 110 rpm). Principal component analysis (PCA) was 
performed on all in-line collected Raman spectra. The first principal component (PC) 
captured 60% of the spectral variation, induced by differences in polymer/drug solid state 
caused by the variation in applied extrusion temperatures. An increased process 
temperature induced a loss in drug crystallinity. Extrusion of the physical mixtures at 90°C 
and 110°C provided Raman spectra characterized by sharp MPT bands, indicating that (the 
majority of) the MPT was crystalline. When the extrusion temperature was increased to 
140°C, broadening of the MPT peaks in the spectrum confirmed the melting of the drug. 
Evidence for interactions (hydrogen bonds) between the drug and polymer, induced by a 
higher processing temperature, was found. Increasing the screw speed did not result in peak 
shifts in the Raman spectrum. Besides Raman spectroscopy, diffuse reflectance NIR 
spectroscopy was also applied for the in-line monitoring of the extrusion process. PCA of the 
NIR data led to similar conclusions as the Raman spectra. NIR spectroscopy confirmed the 
formation of hydrogen bonds by the manifestation of an extra peak at 6500cm-1, attributed 
to the first overtone of the hydrogen bonded hydroxyl group. NIR and Raman spectroscopy 
hence provided complementary information concerning the manifestation of hydrogen 
bonds between polymer and drug in this formulation. 
 
Only one application of spectroscopic in-barrel monitoring has been illustrated [13]. To 
improve the understanding of material behaviour in the barrel, a Raman probe was 
implemented in each section of the barrel. MPT concentration (10 and 40% w/w in Eudragit® 
RS PO), extrusion temperature (100, 120 and 140°C) and screw speed (80 and 160 rpm) were 
varied to examine their influence on polymer/drug solid state throughout the entire barrel. 
When extruding the formulation with 40% (w/w) MPT, broadening of MPT peaks indicated 
melting of MPT between sections 2 and 3, caused by the first kneading zone (Figure 3.3). 
Decreasing the concentration to 10% w/w showed an additional spectral difference (i.e., 
peak shifts indicating interactions between MPT and carrier) between sections 5 and 6, due 
to formation of a solid solution. At a 10% (w/w) MPT load, increasing the extrusion 
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temperature did not influence the solid state or the barrel section where the final solid state 
is obtained. At a drug load of 40% (w/w), the solid state of the end product was reached 
further down the barrel when extrusion was performed at a lower barrel temperature. 
Doubling the screw speed when processing a 10% MPT formulation (w/w) did not affect the 
product solid state. In contrast, for a 40% (w/w) drug load, the section where the final 
product solid state was obtained, was situated earlier in the barrel when applying a higher 
screw speed. To conclude, the Raman spectra provided real-time information about 
polymer/drug behaviour throughout the entire extrusion barrel, facilitating process 
visualisation and understanding. Twin-screw extrusion is a starve-fed process where most 
screw elements are not completely filled with material. This presents a challenge in 
positioning the Raman probe, since the distance between probe and measured material 
varies throughout processing. This variation in distance creates an undesired source of 
spectral variability which needs to be filtered out. 
 
 
Figure 3.3. Detail of the Raman spectra collected in barrel sections 2 and 3 during extrusion of mixtures with 
40% MPT (w/w) with all screw speed settings at a) 100°C and b) 140°C [13]. 
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Kindermann et al. [14] used Raman spectroscopy for the monitoring of the formation of 
polyelectrolyte complexes composed of poorly water-soluble acid drugs (naproxen and 
furosemide) and basic polymethacrylates (Eudragit® E PO) by an acid base-reaction during 
HME. Physical mixtures of naproxen and Eudragit® E PO were pre-blended in a mixer and 
subsequently hot-melt extruded with a co-rotating twin-screw extruder (screw diameter = 
27 mm). A Raman spectrometer was equipped with an extruder-compatible probe. The 
authors do not mention the exact location of implementation of the probe. Raman 
spectroscopy was used to characterize the drug-polyelectrolyte interaction. The Raman band 
representing the symmetric stretch vibration of the carbonyl group of naproxen was found 
in the pure naproxen and in the physical mixture, but disappeared in the spectra of the 
extrudates, confirming the acid-base-reaction and complex formation in the melt. 
 
Similar to NIR spectroscopy, Raman spectroscopy can be used as a process analytical tool to 
monitor component concentrations, solid state and intermolecular interactions that might 
occur during extrusion (Table 3.1). Both techniques are complementary, and depending on 
the formulation used for extrusion, one technique will be more suitable than the other. 
Raman spectra are influenced by fluorescence and colour in the formulation, which might 
cause difficulties due to a high background signal. These can however be (partly) overcome 
by changing the type of laser.  
 
3.3.3. Monitoring of torque and power consumption 
 
Schilling et al. [15] determined the influence of the plasticizer citric acid on the processability 
of Eudragit® RS PO during single-screw extrusion. The process parameters screw speed and 
motor load were monitored as a function of citric acid (CA) content and the preset 
temperature in the die. The quotient of the maximum applicable screw speed divided by the 
measured load at a given temperature was calculated for each CA level. This quotient was 
then interpreted as an index of processability of the formulation at the preset die 
temperature. Improved processability due to plasticization was reflected by high quotients 
at lower temperatures. Improved processability of a powder blend by plasticization of the 
polymer yielded a higher screw speed and a lower motor load at a predefined temperature. 
A temperature of 140°C was needed to extrude the pure polymer with a screw speed of 20 
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rpm, while blends containing citric acid monohydrate (CA MH) could be processed at 
temperatures from 110°C to 130°C. The screw speed/motor load quotient significantly 
increased when the CA MH concentration was increased from 0 to 10, 15, 20 and 25% (w/w). 
This indicated a decrease in melt viscosity and enabled extrusion at lower temperatures. The 
absence of a statistically significant difference between 25 and 30% (w/w) CA MH suggested 
that the plasticizing effect plateaued at this concentration, coinciding with the solubility limit 
of CA MH in Eudragit® RS PO. Finally, it was found that CA MH facilitated the extrusion 
process more efficiently than its anhydrous form. 
 
Torque can be easily measured during HME and is correlated with several important product 
parameters that cannot straightforwardly be monitored during extrusion, such as the 
rheological behaviour of the material, plasticizing effects of components in the melt, 
grinding processes during extrusion and the velocity of material through the extruder. This 
parameter can easily be monitored during HME without the requirement of barrel and/or 
die modifications, and without the need for additional sensors. 
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3.4. MONITORING OF POLYMER MELT EXTRUSION 
 
The polymer processing industry has developed and applied numerous process analytical 
tools to improve HME process understanding, monitoring and control, to enhance product 
quality and to allow real-time fault detection. In addition to the use of conventional 
monitoring techniques and spectroscopic techniques such as NIR and Raman spectroscopy, 
the literature describes applications of ultrasonic techniques, rheological techniques, 
advanced temperature sensors, dielectric sensors, nuclear magnetic resonance (NMR) 
spectroscopy, fluorescence spectroscopy, ultraviolet-visible (UV-VIS) spectroscopy and 
terahertz (THz) spectroscopy. The following section provides an overview of process 
monitoring techniques that have been applied in polymer extrusion which could be relevant 
for pharmaceutical HME process monitoring and control. A summarized overview can be 
found in Table 3.2, together with the analysis possibilities of each technique, the position in 
the extruder where the technique should be/can be implemented for its purpose and 
possible challenges, disadvantages and shortcomings of the analytical technique. 
 
3.4.1. Spectroscopic techniques 
 
3.4.1.1. NIR spectroscopy 
 
Hansen and Vedula [16] used in-line NIR spectroscopy to monitor the comonomer (vinyl 
acetate (VA)) concentration in a system of EVA copolymers simultaneously with the polymer 
melt flow index (MI) for this system. In NIR absorption spectra, variations in chemical 
composition are dominant effects, whereas the rheological flow effects cause only subtle 
variations in the NIR spectra. The anisotropic nature of flow depends on the molecular 
orientation and the orientation distribution of flowing polymer melt, which are related to 
molecular weight, chain length, entanglement and branching of the polymer chain. 
Differences in molecular orientation and orientation distribution affect the NIR absorbance 
spectra and induce spectral shifts, hence providing information about physical properties 
that directly correlate with molecular weight parameters such as MI. For EVA random 
copolymers, these rheological properties are not related to the comonomer ratio for VA 
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concentrations lower than 30%. This indicates that primary effects (composition of the melt) 
and secondary effects (MI) on the absorbance spectrum are independent. Dual transmission 
fibre optic probes were mounted in a flow cell attached to a single-screw extruder. The 
authors developed two PLS models, a first one containing three principal components which 
is used for MI predictions, and a second PLS model with only one principal component for VA 
concentration measurements. The standard error of prediction (SEP) values for the two 
models were 0.46 for MI (ln MI (g/10 min)) predictions and 0.62 wt% for VA predictions. 
These models were then applied for in-line monitoring of MI and VA concentration. All 
predicted values for both responses were found between the actual laboratory value ± SEP, 
indicating that NIR spectroscopic measurements can predict the VA content and the MI of 
the melt during extrusion. 
 
In a second study [17], Vedula and Hansen developed a PLS-1 model to predict the complex 
viscosity (ln (│η* (ω)│)) and the VA monomer content of molten EVA copolymers. Dual 
transmission fibre optic probes were mounted in a flow cell attached to a single-screw 
extruder. The PLS-1 model, where the NIR spectra were regressed versus the complex 
viscosities measured with a dynamic stress rheometer at different frequencies, comprised 
four components. The first PC (explained 31.5% of the variation related to the rheological 
response) accounted for the spectral variation caused by varying VA content, and a second 
(63.4%) PC described the spectral variation caused by the rheological response. The standard 
error of calibration (SEC) and SEP values were 0.38 and 0.8 respectively. Most new predicted 
measurements are found within the detection limits for predictions as determined by the 
SEP values. A limitation for this type of measurements is the melt temperature, which has a 
large effect on rheological properties. These experiments were all performed at the same 
temperature, assuring only a small variance in melt temperature in the flow cell (1-3°C). A 
further improvement of the calibration models from both studies might be achieved by 
including temperature as an independent variable in the X matrix. 
 
Nagata et al. [18] developed an in-line density sensor using NIR spectroscopy. The 
transmission NIR spectra of molten polyethylene (PE) in flow were collected using a fibre-
optic device attached to a single-screw extruder. The PE density depends on the number of 
polymer chain branches and their length. The degree of branching could be estimated by 
CHAPTER 3 – PROCESS MONITORING AND VISUALIZATION SOLUTIONS FOR HOT-MELT EXTRUSION 
44 
 
measuring the composition ratio of the methyl group (-CH3, at the ends of branches and 
main chains) to the methylene (-CH2-, in polymer chains) group. In attempts to correlate the 
density with the NIR spectra, the correlation coefficient R² between polymer densities and 
scaled absorbances of 14 polymer grades was calculated, and the highest R² (0.9853) was 
found at 1170 nm. Using this model, it was hence possible to monitor the PE density in-line 
in the extrusion die. 
 
Witschnigg et al. [19] developed an NIR method where the results of on-line extensional 
rheometry (on-line measurements of drawing force performed by on-line Rheotens 
equipment), Young’s modulus (calculated out of tensile tests) and interlayer distance 
(determined by small angle X-ray scattering) are correlated with in-line collected NIR 
spectra. A mixture of 90% polypropylene (PP), 5% organoclay and 5% compatibilizer (w/w) 
was extruded in a co-rotating twin-screw extruder, which had a bypass system to create a 
melt string for on-line Rheotens measurements. The NIR probe was implemented in front of 
the extrusion die. Two different screw geometries (1 and 2) were applied during 
experiments. Screw geometry 1 contained three kneading zones, whereas only 1 kneading 
zone was present in geometry 2. For geometry 1, a PLS model with 5 components regressing 
the NIR spectra versus the Young's modulus was developed resulting in an RMSECV of 30 
MPa. For geometry 2, a four component PLS model was built resulting in an RMSECV of 94 
MPa. For the correlation with drawing force, 2 component PLS models were developed 
resulting in an RMSECV of 2.64 mN for geometry 1 and an RMSECV of 1.98 mN for geometry 
2. Concerning the correlation of NIR spectra with the interlayer distance, a PLS model with 1 
component and an RMSECV of 0.013 nm was developed for geometry 1 and for geometry 2, 
a PLS model with 2 components resulted in an RMSECV of 0.019 nm. The measurements 
were not performed at different aggregate states (melt state vs. semicrystalline solid state), 
since this creates differences in NIR spectra that would affect the chemometric models. 
Variations in NIR spectra caused by changing the physicochemical state of the extrudates 
might interfere with the variations attributed to Young’s modulus, drawing force and 
interlayer distance. Nevertheless, the authors demonstrated that NIR spectra can be used 
with sufficient precision for in-line quality monitoring. However, in this publication it is not 
mentioned how changes in Young’s modulus, interlayer distance and drawing force affect 
the in-line collected NIR spectra. 
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In pharmaceutical HME, NIR spectroscopy is mainly applied to monitor the concentration of 
melt components, and in some cases to determine the solid state and occurring 
intermolecular interactions within the melt. In polymer extrusion applications however, NIR 
spectra showed to correlate well with Young’s modulus, interlayer distance, drawing force, 
melt flow index, complex viscosity and density. 
 
3.4.1.2. UV-VIS spectroscopy 
 
Wang et al. [20] applied the UV-VIS spectroscopy technique to monitor the process induced 
degradation of poly-L-lactic acid (PLLA) during extrusion. Extrusion was performed on a co-
rotating twin-screw extruder, equipped with a special measurement slit die that contained 
the UV-VIS transmission probes. The influence of the processing parameters barrel 
temperature, screw speed and throughput on the degradation of PLLA was investigated. 
Samples were also collected for off-line analysis (molar mass, melt viscosity and in vitro 
biodegradation). The residence time distribution was determined by adding a red coloured 
pellet to the feeding during stationary state. A reference spectrum was taken, and 
subtracted from all the UV-VIS spectra collected during experiments. These difference 
spectra (ΔA) exhibited a maximum at 310 nm for all processing conditions, indicating the 
wavelength range of the most significant spectral changes due to degradation. ΔA increased 
with increasing processing temperature and screw speed as well as with decreasing 
throughput. This means that an increase in ΔA is accompanied by decrease in average molar 
mass and an increase in specific mechanical energy. UV-VIS absorption of the melt can be 
used to get an estimate of the molar mass of the extrudates of dry PLLA, regardless of 
variations in extrusion parameters. To evaluate the effects of processing parameters on the 
biodegradation rate of the extrudates, an in vitro biodegradation experiment at elevated 
temperature was performed for selected extrudates. Higher in vitro weight loss was related 
to higher UV-VIS absorption of the extruded materials, which is correlated with lower molar 
mass of the extruded materials. The authors demonstrated that UV-VIS is very sensitive to 
colour changes of the PLLA melt, and a clear correlation between increasing absorption and 
a decrease in molar mass of the extrudates was found, which can be used as a measure of 
polymer degradation. 
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Table 3.2. Process analytical tools applied in polymer extrusion 
 
Process analytical 
tool 
Interface In-line or on-line 
application [1] 
Purpose Reported challenges/disadvantages/shortcomings References 
Near infrared (NIR) 
spectroscopy: 
transmission  
  
  
die in-line monomer 
concentration 
- [16] 
die in-line complex viscosity - [17] 
die in-line density by 
monitoring 
polymer chain 
branches 
- [18] 
NIR spectroscopy: 
reflection  
die in-line drawing force and 
Young's modulus 
Different aggregate states will affect the chemometric 
models negatively. 
[19] 
Ultraviolet/visible 
(UV-VIS) 
spectroscopy: 
transmission 
die in-line polymer 
degradation 
The low count rate of the UV-VIS diode array detector leads 
to a large error, since this area is the wavelength range 
where the absorption of the optical fibres connecting the 
probe with the spectrometer becomes dominant. 
[20] 
UV-VIS spectroscopy: 
reflectance 
die in-line residence time 
distribution (RTD) 
- [21] 
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Table 3.2. Process analytical tools applied in polymer extrusion (continued) 
Fluorescence 
spectroscopy 
  
  
die in-line melt 
temperature 
measurements, 
temperature 
gradient 
measurements 
- Can only be used in development phase with inert fluorescent dyes. 
- Effect of pressure on calibration curve must be considered, accurate 
temperature measurements require simultaneous acquisition of pressure 
(temperature results need to be compensated). 
- Only a small sample volume is allowed (specific probe and lens design). 
- Radial measurements need to be possible (specific probe and lens design). 
- Selection of fluorescent dyes: dyes need to be stable at high temperatures, 
spectra should show significant changes with varying temperature, dyes 
should be soluble in polymer resin and should be chemically inert. 
- Effect of shear on temperature measurements: sensor needs to be located 
beyond the end of screw (low shear rate flow region). 
[22, 23, 25] 
die in-line RTD Global RTD measurements in single-screw extrusion are delicate, as the tracer 
must be incorporated at the feed opening under very specific conditions (to 
avoid material accumulation, starve feed conditions and the distribution of the 
dye in different screw turns, a minimal concentration though easily detectable 
should be used) [25]. 
[25-27] 
barrel in-line RTD - [25] 
mixing 
zone 
in-line melt 
temperature 
measurements, 
temperature 
gradient 
measurements 
- Calibration should involve pressure data. 
- Temperature spikes in data are associated with shear heating, these spikes 
need to be filtered out to calculate average temperatures. 
[25] 
kneading 
block 
in-line RTD Video images revealed that, in contrast with the kneading block, the conveying 
elements upstream of the kneading block were only partially filled, causing 
unstable and weak signals. Therefore, measurements were performed 
exclusively on the kneading block. 
[25] 
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Table 3.2. Process analytical tools applied in polymer extrusion (continued) 
Terahertz 
spectroscopy 
die in-line refractive index 
measurements related 
to additive compound 
content 
- Complexity of the system, high costs, very sensitive to vibration → a new, 
partially fibre coupled terahertz spectrometer was developed. 
- Die adaptations were required: silica plates that can withstand pressures only 
up to 26 bar and temperatures only up to 260°C. 
- The recording time needs to be reduced: only the amplitude value at a fixed 
time position is used as an indicator. 
- The pressure and temperature of the melt need to be observed in order to 
correct the experimental data. 
[28] 
Dielectric 
spectroscopy 
  
  
die in-line comonomer 
concentration, 
sidechain composition 
At higher temperatures, the analysis becomes more difficult since ions, permanent 
dipoles and induced dipoles may all have a significant influence at an elevated 
temperature. 
[29] 
die in-line filler concentrations Measuring cells are not sensitive for the melt in the centre of the ring, cells should 
therefore be as narrow as possible. 
[30] 
die in-line melt viscosity The sensor utilizes a fringe field to monitor the polymer melt, so the field of the 
measurement is limited to the depth of penetration of the fringe field. Therefore, 
the dielectric parameters are measured at the surface of the melt stream. 
[51] 
Optical probes 
  
  
die in-line particle size and 
concentration of 
dispersed phase 
- [31] 
die in-line melting behaviour - [34] 
mixing 
zone 
in-line RTD Dependent on the optical characteristics of the extruded polymer and tracer, the 
optical probe measured the RTD of either the entire channel volume or that of a 
surface layer of the volume. 
[36] 
Nuclear magnetic 
resonance (NMR) 
spectroscopy 
die on-line temperature, 
composition, 
homogeneity 
- Increasing temperature decreases the magnetic field strength. 
- Ferromagnetic materials in the extruder might deform the static field. 
- Low sensitivity, but this can be overcome by increasing the experiment time for 
signal accumulation. 
[35] 
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Table 3.2. Process analytical tools applied in polymer extrusion (continued) 
Ultrasonic 
techniques: 
longitudinal 
waves 
  
  
  
melting, 
mixing, 
pumping 
zones 
- barrel integrity at melting, 
mixing and pumping zones, 
screw and barrel wear 
- [41] 
melting, 
mixing, 
pumping 
zones 
in-line RTD - [36] 
die in-line RTD - [36, 37] 
barrel in-line melting phenomena 
dependent on screw 
configurations 
The channel should be completely filled at measurement position: 
adaptations in screw configuration/probe location are required. 
[38] 
Ultrasonic 
techniques: 
shear waves 
die in-line melt density - Assumption: a change in melt density will be directly manifested by a 
change in extrudate density (accurate for most polymer extrusion 
applications). 
- The accuracy of the measurements is highly dependent on the 
condition of the ultrasound transducer and stability of the process: 
constant cooling of the transducer was necessary. 
- It is essential to keep the melt temperature and pressure within a 
narrow range during extrusion: a change in either will affect the 
acoustic properties of the melt and will interfere with the accuracy of 
the intended measurements: normalisation procedures should be 
applied. 
[39] 
Ultrasonic 
techniques: 
undefined 
wave type 
die in-line melt density - [51] 
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Table 3.2. Process analytical tools applied in polymer extrusion (continued) 
Rheological 
techniques: 
         
Stress and shear 
rate sensor 
die in-line melt viscosity as a function of 
shear rate 
- [42] 
Capillary 
rheometer 
barrel on-line torque, shear stress, shear 
rate, melt flow index, linear 
viscoelastic behaviour 
Large deformations and relatively high shear rates 
associated with the flow in a capillary rheometer may 
affect the morphology of the material and consequently 
its rheological response. 
[43] 
Oscillatory 
rheometer 
barrel on-line linear visco-elastic behaviour - [43] 
Rotational 
rheometer 
barrel on-line morphology development, 
reaction kinetics, linear 
viscoelastic behaviour 
- [44] 
barrel on-line storage and loss modulus of 
polymer melts 
- [45] 
Extensional 
rheometer 
die on-line melt strength - [47] 
Slit die die in-line thermal degradation of 
polymer 
- [46] 
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Table 3.2. Process analytical tools applied in polymer extrusion (continued) 
Perturbation method barrel sections in-line melting behaviour 
of polymer blends 
- [48] 
Temperature measurements:          
Thermocouple die in-line melt temperature - Slow response time. 
- Measurements are highly dominated by barrel/die wall 
metal temperature. 
[49] 
Infrared (IR) sensor die in-line melt temperature - Temperature information is limited to a small volume of 
the melt flow. 
- IR measurements may be affected by polymer type and 
sensor calibration accuracy. 
[49] 
Thermocouple mesh (TCM) die in-line melt temperature - Melt flow may be slightly disturbed by the TCM. 
- TCM measurements are slightly influenced by shear 
heating depending on the size of the mesh wires and 
junctions. 
- Mesh wires may be damaged under poor melting 
conditions (e.g. highly viscous or un-melted materials). 
[49] 
Monitoring of motor current motor in-line friction, torque, 
identification of 
conveying issues 
Since the screw load torque signal is dominated by the solids 
conveying torque, it is not sensitive enough to identify 
unstable melting issues. 
[50] 
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Gilmor et al. [21] developed an in-line colour monitoring system: the colour of the melt 
during changeover from one pigmented PE to another was continuously measured directly in 
an extruder using a fibre-optic assisted charge coupled device spectrometer. The fibre-optic 
reflection probe was inserted into the die of a single-screw extruder. Residence time 
distributions were calculated from the in-line reflectance data, without requiring knowledge 
of the absolute concentration values in the melt. 
 
UV-VIS spectroscopy is a process analytical technique that can be applied in pharmaceutical 
HME to monitor residence time distributions of the melt, to detect polymer and/or drug 
degradation, to detect impurities in the melt and to quantitatively analyse the melt 
compounds. It is a simple, straightforward technique, which can be implemented through 
the use of fibre optic cables. The most important advantage of UV-VIS spectroscopy 
compared to NIR and Raman spectroscopy is its much lower detection limit. UV-VIS spectral 
bands are highly overlapping, therefore chemometric analysis and proper pre-processing of 
the obtained spectra is required.  
 
3.4.1.3. Fluorescence spectroscopy 
 
Migler and Bur [22] incorporated bis(-pyrene) propane (BPP), a temperature-sensitive 
fluorescent dye in the polymer resin at dopant levels. By monitoring relevant spectral 
features of this dye, its temperature can be measured. And through a focusing technique 
(confocal fluorescent optics), the temperature can be measured as a function of distance 
into the resin. Temperature profiles were measured in a circular die at the exit of a twin-
screw extruder. These measurements are based on the dependence of Ie/Im (e = eximer, m = 
monomer) with temperature for BPP in polyethylene. In a succeeding study, Bur et al. [23] 
added different temperature sensitive fluorescent dyes to the polymer melt during single-
screw extrusion processing to overcome the inadequacies of thermocouple and infrared 
radiometer transducers. The fluorescence spectrum, collected in a slit die rheometer 
attached to the extruder, reflects the resin temperature in its neighbourhood. The 
temperature measurement is based on the calibration curve where the ratio I464/I473 is 
plotted versus temperature for atmospheric pressure. A pressure compensation factor was 
added later on. Additionally, Bur et al. [24] relocated the fluorescent confocal sensor and 
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positioned it over the top of the mixing section of a 63.5 mm diameter single-screw extruder 
to monitor the temperature gradient in the channel, as a function of screw speed, screw 
design and melt flow rate. Temperatures were found to be lowest in the centre of the 
channel and increased at the barrel wall and at the root of the screw for the conventional 
screw with only transporting elements. As expected, the channel temperatures increased 
with increasing screw speed. For the mixing screw, the temperature was lowest at the barrel 
wall and highest at the root of the screw. In summary, this sensor is capable of measuring 
melt temperatures and temperature gradients within the melt. 
 
Carneiro et al. [25] determined the RTD along a kneading block via in-line monitoring of the 
light emission of a fluorescent tracer (perylene) in a slit die attached to a single-screw 
extruder and at several locations along a co-rotating twin-screw extruder. RTD 
measurements are often used to monitor and control process attributes such as consistency, 
extent of polymer degradation and degree of mixing. Three devices were developed to 
accommodate the probe: a slit die for single-screw extrusion, a sampling device with rotating 
valve for partial measurements within twin-screw extrusion which can be inserted between 
any 2 consecutive barrel sections and a transparent barrel modified to accommodate the 
probe (Figure 3.4). First, the probe position (horizontal or vertical) and the influence of screw 
speed were evaluated on a single-screw extruder. The authors found that increasing screw 
speed reduced the RTD and by changing the probe position, different fractions of the melt 
stream are monitored. Secondly, concentration versus time curves were generated to 
characterize the RTD at several locations along the barrel of a twin-screw extruder, and 
direct comparison with off-line data using a silica tracer produced good results. Finally, 
experiments were performed on a co-rotating twin-screw extruder with a transparent barrel 
to visualize the flow within a mixing block with staggered kneading disks. Video images 
revealed that, in contrast with the kneading block, the conveying elements upstream of the 
kneading block were only partially filled, causing unstable and weak signals. Therefore, 
measurements were performed exclusively on the kneading block. The determination of 
partial RTD is particularly relevant in compounding operations, or when processing thermally 
sensitive materials, since it provides information that can be used to optimize the operating 
window or to improve the screw configuration. In this work, an in-line technique, based on 
the light emission of a perylene fluorescent tracer, was developed for the measurement of 
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RTD along the extruder axis. In-line readings were compared with off-line measurements, 
and a good agreement was found. Two other examples of RTD monitoring with fluorescence 
spectroscopy are presented by Barnes et al. [26] and Fang et al. [27].  
 
 
Figure 3.4. Solutions to accommodate the optical probe: (a) slit die used for measurements in a single-screw 
extruder; (b) modified sampling device for partial measurements in a twin-screw extruder; (c) device for partial 
measurement along a transparent barrel [25]. 
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Fluorescence spectroscopy has been mainly applied to monitor residence times via the use 
of fluorescent tracers in the melt. The RTD of a formulation provides information on the 
mixing history of the melt. A lower RTD indicates a decrease in degree of mixing in the 
extrusion barrel. In addition, fluorescent tracers allow more accurate melt temperature 
measurements. These applications might be of interest in pharmaceutical HME, especially 
for monitoring of extrusion processes during formulation development. The addition of 
fluorescent tracers will provide insight in residence times and temperature gradients 
throughout the melt, and the exposure time of an API to high temperatures can be 
estimated. This will enhance the understanding of material behaviour within the barrel, and 
will allow the optimization of screw designs. 
 
3.4.1.4. Terahertz (THz) spectroscopy 
 
Krumbholz et al. [28] demonstrated the potential of an in-line monitoring method using a 
fibre-coupled THz spectrometer, to study the influence of temperature and pressure on 
molten PP. Measurements were performed in a custom-made die at the end of a planetary 
gear extruder. The temperature and pressure of a PP melt were varied independently. No 
influence of melt pressure on the terahertz parameters (absorption coefficient and refractive 
index) was found. Also, no effect on the absorption coefficient was obtained when changing 
the melt temperature. However, when the temperature was increased, the refractive index 
decreased. The refractive index of a melt can be calculated from the time delay of the THz 
pulse propagating through the melt. It is directly related to the additive content of a 
compound. When extruding polymer-filler compounds, a linear relation between the 
refractive index of the compound and its volumetric additive content was established. 
Though a THz spectrometer is a very complex and expensive system, these first 
measurements with a newly developed probe supply promising results for refractive index 
measurements. The refractive index of a melt depends on the melt composition, but is also 
related to the melt density, allowing the monitoring of melt density as well. 
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3.4.1.5. Dielectric spectroscopy 
 
Perusich and McBrearty [29] applied dielectric spectroscopy to make composition 
measurements of the comonomer concentration along polymer chains. Dielectric 
spectroscopy imposes an electric field across the flowing polymer and measures the 
resultant alternating current produced from the movement and energy associated with 
dipole orientation and ionic conduction. These measurements are related to the physical 
and chemical structure of the polymer. The dielectric permittivity or capacitance was found 
to be proportional to the polymer sidechain composition. A short sidechain required a high 
measurement frequency (short relaxation time), whereas a longer sidechain, needed a much 
lower frequency (longer relaxation time) to orient the sidechain to a measurable extent. Two 
types of extruders were used. First, a 22 mm single-screw extruder where the sensor 
assembly was positioned at the exit of a static mixer section downstream from the screw. 
And second, a twin-screw extruder without static mixer, and with the sensor positioned 
downstream from the screw directly upstream from the die. The melt composition of a 
variety of polymer melt systems was measured with an in-line dielectric sensor. In-line 
measurements were performed on Elvax® (DuPont, Wilmington, Delaware, USA), an EVA 
copolymer. Once the polymer reached the die, the measured capacitance increased 
dramatically, and after 10 min a plateau was achieved. The absolute plateau value was a 
direct function of the applied frequency. The measured capacitance was found to be 
proportional to the VA content of Elvax®. Bur et al. [78] used the same setup on a twin-screw 
extruder to perform permittivity and conductivity measurements of resin melts to quantify 
filler concentrations. Sensitivity to polymer/filler composition can arise because of 
permittivity contrast between polymer and filler or because of changes in conductivity 
caused by variations in filler concentration. The authors found that the interelectrode 
separation distance was crucial for the measurement quality. By increasing the separation, 
the fringe field will extend beyond the surface, and the capacitance of the cell will decrease 
and affect the sensitivity of the measurements. 
 
Dielectric measurements are used to analyze the physical/chemical structure of organic 
materials through the measurement of their dielectric properties. Since the dielectric loss 
factor is affected by dipolar alignment and by ionic mobility, it provides information on 
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changes in viscosity in a material. Thus, in addition to the monitoring of comonomer content 
and filler concentrations, dielectric spectroscopy could also be applied to perform 
rheological measurements in the melt [30]. For example, wall slip may be preceded by 
extensional stress, orienting the material and producing anisotropic dielectric properties. 
Migration of polymer additives at high shear stress can be detected as well. These 
measurements can easily be performed in-line, and therefore present an interesting addition 
to the existing analytical techniques applied in pharmaceutical HME. 
 
3.4.1.6. Optical detectors 
 
Pinheiro et al. [31] measured the morphology of immiscible blends containing PP and 
polyamide 6 (PA 6) in a co-rotating twin-screw extruder. The disperse phase particle size and 
concentration were determined in-line with an optical device developed by Mélo and 
Canevarolo [32, 33], placed at a slit die with transparent windows at the extruder exit. A 
polychromatic, visible light source illuminates the entire surface of the glass window and a 
photocell. The detector’s signal depends on the volume concentration and size of the 
disperse phase. The normalized detector’s signal follows a linear correlation with particle 
concentration of four calibration standards (Al2O3 0.5 and 2.0 µm and TiO2 0.5 and 2.0 µm). 
Mixtures of Al2O3 with different particle sizes (0.5 and 2.0 µm) at different ratios showed 
that the signal increases linearly with an increase in the concentration of 0.5 µm. The 
detector captures the average value of a set of particles once the signal is linear with the 
weight average particle size. The signal also increased with increasing PA 6 content (disperse 
phase) because of the higher light scattering. The results showed that this detector is an 
accurate device for the assessment of parameters such as particle size and concentration. 
 
The same device was applied by Canevarolo et al. [34] to assess the melting behaviour 
during polymer extrusion in a co-rotating twin-screw extruder. Melting of two polyamide 
tracers was studied by changing the barrel temperature and keeping all other operating 
conditions constant. Increasing the barrel temperature led to a fast growth of the 
normalized intensity due to melting of the tracer, eventually saturating once all tracer was 
molten. This type of detector can be applied in pharmaceutical HME during both the 
formulation development stage and during pharmaceutical production. It can be applied as a 
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monitoring device, to determine the optimal process settings to obtain a completely molten 
or dissolved API with minimal energy input but it is also relevant for process control during 
manufacturing, to monitor and control the state of the melt.  
 
3.4.1.7. Nuclear magnetic resonance (NMR) spectroscopy 
 
Gottwald and Scheler [35] designed a surface NMR probe to monitor extrusion processes. 
Surface NMR gives access to molecular mobility, correlated to temperature, composition and 
homogeneity. Two main obstacles are the temperature, which decreases the magnetic field 
strength and the ferromagnetic materials in the extruder which deform the static field. The 
device was located next to the die of a single-screw extruder (30 mm diameter) and 
measurements were performed on a sheet of soft polyvinyl chloride (PVC). The probe 
withstood the harsh conditions although the melt was in direct contact with its surface. The 
detected signal of the PVC melt could be clearly distinguished from the background signal. 
Based on these results, the authors plan to modify an extruder element to fit the NMR 
probe, allowing the in-line monitoring of any NMR-detectable parameter, rheological 
information and component composition. In pharmaceutical processes, NMR is used to 
monitor interactions between drugs and excipients during production, to characterize the 
different polymorphic forms of an API, and for the identification and characterization of 
APIs. It is sensitive for small amounts of API in the formulation. 
 
3.4.2. Ultrasonic techniques 
 
Sun et al. [36] monitored the RTD at the melting, mixing and pumping zones as well as at the 
die exit of a twin-screw extruder (30 mm diameter) by mounting the ultrasonic probes on 
the extruder barrel over the screw elements and at the die. In order to relate the measured 
ultrasonic signal to the RTD, the relationship between the signal strength and the CaCO3 
concentration (the ultrasonic tracer) was calibrated, which was linear in the tested 
concentration range. Secondly, the RTD was measured by injecting a pulse of tracer and 
monitoring the ultrasonic signal strength. The change of the strength of the ultrasonic signal 
reflected from the rotating screw was caused by a change in acoustic impedance of the filled 
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material, the scattering loss by the filler and the change in the absorption of acoustic energy 
due to the presence of the filler. 
 
Lee et al. [37] also performed RTD measurements based on the ultrasonic response of CaCO3 
in PE. Measurements were performed at the die exit (slit die) of a co-rotating twin-screw 
extruder. The RTD was also evaluated at different filler concentrations, screw speeds, 
feeding rates and screw configurations. Increasing the screw speed or feed rate reduced the 
mean residence time and the variance of the residence time, whereas increasing CaCO3 
concentration increased the mean residence time and variance of residence time. Both were 
also increased by the presence of reverse screw elements in the configuration. The in-line 
determination of RTD by ultrasound during extrusion was successfully realized. 
 
 
Figure 3.5. Ultrasound scanning regions: flight region and C-chamber [38]. 
 
Wang and Min [38] developed an ultrasound in-line monitoring system to investigate the 
melting behaviour of linear low density PE (LLDPE) and PVC compounds in the barrel of an 
intermeshing counter-rotating twin-screw extruder (30 mm diameter). Monitoring of the 
CHAPTER 3 – PROCESS MONITORING AND VISUALIZATION SOLUTIONS FOR HOT-MELT EXTRUSION 
60 
 
ultrasound wave attenuation allowed the characterization of the melting process and 
uniformity across the screw channels. Various melting phenomena were described 
depending on the selected materials, processing conditions and screw configurations. 
Materials are periodically scanned by ultrasound in the flight region and in a C-chamber 
(Figure 3.5). Melting in the flight region finishes much faster than in the C-chamber for both 
LLDPE and PVC, due to the combination of heat conduction and viscous energy dissipation. 
The melting in the C-chamber always starts at the pushing side of the flight and then spreads 
to the trailing side. Melting level and uniformity increase with the increase of pressure in the 
material. During the extrusion of LLDPE and PVC compounds, dispersed or dissipation 
melting phenomena are dominant under most processing conditions. The ultrasound in-line 
monitoring method efficiently investigated the melting phenomena of various polymer 
systems fed in powder form or pellet form. 
 
Abu-Zahra [39] measured the density of a polymer melt using ultrasound shear waves 
propagating at a frequency of 2.25 MHz. At a solid-liquid interface, the amount of ultrasonic 
shear wave energy reflected back into the solid is dependent on the operating frequency 
and properties of the fluid (viscosity and density) and of the solid (density and shear 
modulus). The acoustic impedance of the polymer melt is calculated using the measured 
reflection coefficient of the polymer melt interface boundary. This ultrasound measurement 
is independent of the attenuation in the polymer melt and the thickness of the melt stream. 
A special die adapter was mounted between the extruder barrel and the die of a 19 mm 
single-screw extruder, containing a shear ultrasound sensor. Different mixtures of PVC with 
varying levels of blowing agent and acrylic processing aid were extruded. Statistical 
correlation between the density measured by energy ration of shear ultrasound waves and 
the laboratory density measurements was 96% at constant processing conditions. The main 
assumption was that a change in the melt density will be directly manifested by a change in 
the extrudate density, which is accurate for most polymer extrusion applications. The 
difference between this application of ultrasound monitoring and the three previous 
examples is the use of ultrasound shear waves instead of longitudinal waves. In longitudinal 
waves, the oscillations occur in the direction of wave propagation, whereas the particles in 
shear waves oscillate at a right angle to the direction of wave propagation. At a solid-liquid 
interface, the amount of shear wave energy reflected back into the solid depends on the 
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operating frequency and on properties of the fluid (viscosity and density) and the solid 
(density, shear modulus). A relation between the melt density and the energy ratio of shear 
ultrasound waves can be established. The longitudinal wave reflection method is used to 
measure the time of flight of ultrasonic waves and the ultrasound velocity in polymer melt. 
These data are then used to calculate the density. Longitudinal waves can be generated in 
liquids, as well as solids because the energy travels through the atomic structure by a series 
of compressions and expansion movements, whereas shear waves require an acoustically 
solid material for effective propagation, and therefore, are not effectively propagated in 
liquids. 
 
In polymer extrusion, ultrasound techniques have been used to monitor melt temperature 
and pressure, changes in material type, effects of process settings on rheological 
characteristics of the melt and filler concentration [40]. Besides qualitative and quantitative 
monitoring of the polymer melt, ultrasonic sensors can be used to monitor the barrel and 
screw integrity at the melting, mixing and pumping zones of the extruder via barrel or flange. 
This application was discussed by Jen et al [41]. Extrusion of low density PE (LDPE) was 
performed on a 30 mm co-rotating twin-screw extruder and on a 50 mm counter-rotating 
twin-screw extruder. Four types of high pressure ultrasound transducers were developed 
and used at the melting, mixing and pumping zones of the extruder to monitor the screw 
and barrel wear. 
 
3.4.3. Rheological techniques 
 
Chiu et al. [42] developed a new in-line viscometer that can directly test melt viscosity as a 
function of shear rate. The viscometer contains a stress sensor and a shear rate sensor which 
were installed between the screw and the die of a single-screw extruder. During extrusion of 
LDPE, different temperatures and screw speeds were applied, and a decreasing viscosity 
with increasing temperature was detected, due to the shear thinning behaviour of LDPE. The 
in-line results were compared to measurements with an off-line capillary rheometer, where 
the viscosity results were lower when the shear rate was lower than 600 s-1, and higher 
when the shear rate was higher than 600 s-1, possibly due to the instability of both the flow 
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meter and the stress sensor. Further research and adaptations are required to improve the 
accuracy of this device. 
 
Covas et al. [43] presented new equipment to monitor the evolution of relevant 
characteristics of polymer systems along the screw axis. A sampling device was constructed, 
allowing the extraction of material from the screw channel. First, an on-line capillary 
rheometer was connected to the sampling device. When the material extracted from the 
barrel is pushed through the die, the torque is recorded, wall shear stress is determined and 
wall shear rate is calculated. The tool can also be applied for the on-line measurement of 
melt flow index/melt volume flow rate. This equipment was used to measure the rheological 
response of a 12% (w/w) PP-based carbon fibre composite after melting in an intermeshing 
co-rotating twin-screw extruder. The coherence between on-line and off-line shear data was 
clear. Large deformations and relatively high shear rates associated with the flow in a 
capillary rheometer may affect the morphology of the material and consequently its 
rheological response. Therefore, an on-line oscillatory rheometer was manufactured to 
determine the linear viscoelastic behaviour and the non-linear properties of the melt 
extracted from the screw channel. On-line monitoring along the axis of an extruder can 
provide a wealth of data, contributing to the understanding of the physical and chemical 
phenomena occurring inside the barrel. 
 
In a subsequent study, Covas et al. [44] also developed an on-line rotational rheometer, 
enabling the determination of morphology development and reaction kinetics along the 
screw axis (Figure 3.6). The rheometer is very accurate when compared to commercial 
laboratorial instruments, an average deviation in linear viscoelasticity results between the 
new device and two off-line rheometers varied between 3 and 8% for various melts and 
blends. Results also showed that the on-line rheometer was more accurate in capturing 
structural evolutions of the materials along the extruder than analysis performed off-line on 
samples collected on-line for complex multiphase systems. 
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Figure 3.6. General overview of the on-line rotational rheometer (O2R) [44]. 
 
Mould et al. [45] monitored the dynamic rheological response of PP in a co-rotating twin-
screw extruder using a new version of the on-line rotational rheometer developed by Covas 
et al. [44]. The technique was validated with off-line measurements at room temperature 
and at high temperatures, and on-line, and the validation step was considered successful. 
The usefulness of the instrument was first demonstrated with PP, and G’ (storage modulus) 
and G” (loss modulus) decreased along the extruder. Then, PP grafted with maleic anhydride 
(PP-g-MA) was extruded, and a decrease of the rheological moduli was anticipated, due to 
chain scission during grafting. The on-line rheometer confirmed the shift of the moduli to 
lower values. Next, a PP/PP-g-MA system was extruded with 8.8% (w/w) montmorillonite 
organoclay, to produce a nanocomposite. As expected, G’ and G” shifted to higher moduli 
values, the elasticity increased and evolution along the barrel was clearly observed. The 
results were in line with observations reported in literature, and evidenced the sensitivity 
and reliability of the apparatus. 
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Rajan et al. [46] monitored the thermal degradation of polyoxymethylene (POM) during 
extrusion on a co-rotating twin-screw extruder. The degradation is indicated by the emission 
of formaldehyde (FA) gas, which was monitored off-line with acetyl acetone colour 
measurements and by a reduction of viscosity. The on-line viscosity of the melt was 
measured by the difference in melt pressure when the melt was forced through a slit die at 
constant volume flow rate. When the throughput decreased and the screw speed increased, 
an enhanced thermal degradation was found. A good correlation between the viscosity 
measured in the slit die and the off-line FA measurements was observed. The thermal 
degradation of POM is successfully monitored by means of on-line viscosity measurements. 
With the use of on-line extensional rheometry on a co-rotating twin-screw extruder and off-
line rotational rheometry, Kracalik et al. [47] tested different nanocomposites and 
investigated the effect of screw speed and geometry on the elongational and viscoelastic 
properties. In extensional rheometry, the extruded strand is elongated by rotating wheels. 
The rotation speed is increased to the time when the molten string breaks, to measure the 
melt strength level. The fast assessment of the melt strength measured by extensional 
rheometry correlates with a high accuracy with dynamic rheological data measured by 
rotational rheometry. cot δ (G’/G” ratio), which reflects the rigidity of the melt can be 
correlated with the melt strength level. The main benefit of extensional rheometry is the 
simplicity without the need for expensive equipment. 
 
During extrusion, the raw materials are subjected to shear, increased temperatures and 
pressure conditions resulting in physicochemical changes within the mixture. The rheological 
response of a material to an imposed stress depends on the composition, morphology, 
degree of mixing and temperature. For process control purposes, it is important to obtain 
rheological properties of the melt that has experienced the complete history within the 
extruder, since these physicochemical changes are highly sensitive to the processing history. 
However, monitoring the rheological characteristics of the melt at several locations 
throughout the barrel will improve understanding of the process, and will provide useful 
information for optimization of the screw configuration and the operating conditions. 
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3.4.4. Other process analytical techniques 
 
Chen et al. [48] determined the differences in melting behaviour between a PP/polystyrene 
(PS) 80:20 and a PP/PS 20:80 blend in a twin-screw extruder under identical operating 
conditions. Therefore, a perturbation method was used together with temperature and 
pressure measurements along the channel of a co-rotating twin-screw extruder. A glass 
window was fitted in one of the nine barrel segments of the extruder, and a spacer plate was 
installed upstream of the segment with the glass window. Three pressure transducers, one 
RTD probe and three thermocouples were mounted in the spacer plate. In the perturbation 
method, a material mass pulse is added to the extruder feed to generate a disturbance to 
the steady-state operation. The pressure, temperature, residence time and drive motor 
power are monitored. The time history of the pulse material in the channel can be tracked 
with the RTD data, and can be combined with information from the motor power signals to 
detect the location of reactions in the extrusion channel. The melting process was visualized 
through the glass window using a high-speed video recording device. Once measurements at 
one position were completed, the barrel was moved to the next position. Three distinct 
regions for the melting of the PP/PS blends were determined: the partially filled region, the 
transition region and the fully filled region. The location of the transition region was 
determined from visualization results, temperature and pressure information and the pulse 
signals. Solid polymer pellets melted through an erosion mechanism in all three regions. The 
end of the melting process was identified using the visualization results, and the pressure 
profile. With these techniques, the melting profile of several materials in the barrel can be 
visualized using dyes. In pharmaceutical HME, the glass window in the barrel might also be 
applied to visualize other phenomena such as dispersion and distribution of API within the 
melt, given that the API has a different colour than the other components in the 
formulation. 
 
Abeykoon et al. [49] evaluated five different melt temperature measurement techniques on 
a single-screw extruder. The point/bulk temperature of the die melt was measured with a 1 
mm diameter non-insulated wall mounted thermocouple, a 3 mm diameter semi-insulated 
wall mounted thermocouple, a 0.5 mm diameter insulated wall mounted thermocouple and 
a Methotrexate infrared (IR) sensor. Melt temperatures at different radial locations of the 
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die were measured using a thermocouple mesh (TCM) with seven junctions placed between 
the adapter and die. LDPE was selected for the experiments. The three wall mounted 
thermocouples provided poor results in capturing variations in temperature. The IR sensor 
showed a better performance in detecting thermal variations, but even here the information 
is limited to a small volume of the melt flow. The TCM demonstrated that the thermal 
fluctuations varied significantly across the melt flow cross-section, and these variations 
increased with screw speed. However, the TCM does interfere with the melt flow, and is 
difficult to implement. Accurately monitoring the melt temperature remains one of the main 
challenges in HME. When only the surface temperature is monitored, information on the 
melt temperature at the screws is not known. A too high temperature in the melt can cause 
API and excipient degradation and affects the rheological properties of the melt. These 
consequences can be monitored separately with other process analytical tools described in 
this review, such as UV-VIS spectroscopy, ultrasonic techniques and rheometers. However, 
knowing the true temperature of the melt at any point within the barrel will eliminate the 
need to use several complementary techniques providing the same information. 
 
Commonly used process monitoring devices, such as temperature and pressure sensors, 
provide limited information on process dynamics inside the extruder barrel. Therefore, 
Abeykoon et al. [50] performed inferential monitoring of the screw load torque signal by 
monitoring the motor current. The torque signal was dominated by the solid friction in the 
barrel and did not correlate well with melting fluctuations. However, torque measurements 
were proven useful for on-line identification of solids conveying issues. This technique to 
monitor polymer behaviour can be adapted in pharmaceutical HME without the requirement 
of barrel and/or die modifications and without the need for additional sensors. 
 
3.4.5. Combinations and comparison of complementary process analytical 
techniques 
 
Sun et al. [36] compared RTD measurements with an ultrasound probe and a reflective 
optical probe. Both probes were implemented at the mixing zone of the screws of a twin-
screw extruder, in the same cross section of the barrel. A tracer was added to the polymer 
melt to monitor the RTD. Dependent on the optical characteristics of the extruded polymer 
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and tracer, the optical probe measured the RTD of either the entire channel volume or that 
of a surface layer of the volume, whereas the ultrasonic measurements always determined 
the RTD of the entire channel volume. For certain polymer systems, the ultrasound 
generated by the probe has a larger penetration depth than the light. The ultrasonic 
technology uses signals reflected from the screw, whereas the optical probe detects signals 
scattered by the tracer in the surface layer of the screw channel. The ultrasonic probe was 
proven to be more appropriate for measuring the RTD of the entire channel volume, and 
both techniques could provide complementary information to improve understanding of the 
extrusion process. 
 
Abu-Zahra [51] attached a special die adapter to a 19 mm diameter single-screw extruder. 
An ultrasound transducer and a dielectric sensor were mounted in this die. PVC was 
extruded with varying levels of chemical blowing agent (AZO)4 and processing aid (K400). 
Ultrasound measurements are correlated to the melt density and the dielectric properties of 
the melt provide information on the mechanical viscosity. Both complementary techniques 
allow the simultaneous monitoring of the rheological properties density and viscosity of the 
melt. 
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3.5. CONCLUSION 
 
So far, monitoring of pharmaceutical HME processes remains limited to conventional 
monitoring of the process settings and parameters (barrel and die temperatures, feed rate 
or throughput, screw speed, torque and drive amperage, melt pressure and melt 
temperature) and the application of NIR and Raman spectroscopy to monitor the API 
concentration and the physicochemical state of the melt. However, the quality of an 
extrudate cannot simply be assessed by monitoring its drug load and solid state. Promising 
steps towards a thorough process understanding have been taken recently, but further 
monitoring of component degradation, rheological properties of the melt and their effect on 
processing efficiency and accurate melt temperature measurements are required to 
guarantee the quality of the extrudates and to predict the physical and chemical 
characteristics of the extrudates before starting the downstream processing. 
 
Various sensors are available for observation of critical process and product parameters 
during extrusion, as reported in literature related to polymer extrusion. The implementation 
of the different process analytical techniques evaluated in this chapter will lead to a 
thorough process understanding and will allow monitoring of the critical process and 
product parameters. This monitoring will eventually lead to optimization of the HME process 
and the formulations, and provide the possibility for improved process control in routine 
manufacturing. 
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ABSTRACT 
 
Chapter 4 evaluates the suitability of Raman spectroscopy as a Process Analytical Technology 
(PAT) tool for the in-line determination of the active pharmaceutical ingredient (API) 
concentration and the polymer-drug solid state during a pharmaceutical hot-melt extrusion 
process.  
For in-line API quantification, different metoprolol tartrate (MPT) - Eudragit® RL PO mixtures, 
containing 10, 20, 30, and 40% MPT (w/w), were extruded and monitored in-line in the die 
using Raman spectroscopy. A PLS model, regressing the MPT concentrations versus the in-
line collected Raman spectra, was developed and validated, allowing real-time API 
concentration determination. The correlation between the predicted and real MPT 
concentrations of the validation samples is acceptable (R²=0.997). The predictive 
performance of the calibration model is evaluated by the root mean square error of 
prediction (RMSEP), which is 0.59% (w/w). 
Two different polymer-drug mixtures were prepared to evaluate the suitability of Raman 
spectroscopy for in-line polymer-drug solid state characterization. Mixture 1 contained 90% 
Eudragit® RS PO and 10% MPT (w/w), and was extruded at 140°C, hence producing a solid 
solution. Mixture 2 contained 60% Eudragit® RS PO and 40% MPT (w/w), and was extruded at 
105°C, producing a solid dispersion. The Raman spectra collected during these extrusion 
processes provided two main observations. First, the MPT Raman peaks in the solid solution 
broadened compared to the corresponding solid dispersion peaks, indicating the presence of 
amorphous MPT. Secondly, peak shifts appeared in the spectra of the solid dispersion and 
solid solution compared to the physical mixtures, suggesting interactions between Eudragit® 
RS PO and MPT, most likely hydrogen bonds. These shifts were larger in the spectra of the 
solid solution. DSC analysis and ATR FT-IR confirmed these Raman solid state observations 
and the interactions seen in the spectra. Raman spectroscopy is a potential PAT-tool for the 
in-line determination of the API-concentration and the polymer-drug solid state during 
pharmaceutical hot-melt extrusion. 
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CHAPTER 4 
RAMAN SPECTROSCOPY FOR THE IN-LINE 
POLYMER-DRUG QUANTIFICATION AND 
SOLID STATE CHARACTERIZATION DURING 
PHARMACEUTICAL HOT-MELT EXTRUSION  
 
 
4.1. INTRODUCTION 
 
Hot-melt extrusion (HME) is one of the most widely used processing technologies in the 
plastic, food and rubber industry [1]. Recently, it also found its application in pharmaceutical 
manufacturing operations, offering many advantages compared to traditional 
pharmaceutical processing techniques [1-5]. Nowadays, extruders allow in-line monitoring 
and control of the process parameters barrel and die temperature, feed rate and screw 
speed, and in-line monitoring of the motor load and the melt pressure in the extruder and 
die. The in-line monitoring and control of quality parameters corresponding to the extruded 
product itself, such as drug load and solid state, will allow real-time product quality 
evaluation and an increased understanding of the product behaviour during extrusion. 
 
Recently, there is a tendency within the pharmaceutical industry to move from traditional 
batch processes towards continuous processing, hereby increasing process efficiency and 
production. Continuous processes offer many advantages: there is no difficult scale-up 
necessary, resulting in a shorter development time, an automatic production line would be 
possible, production costs can be reduced, it ensures faster product release and improved 
product quality [6]. Hot-melt extrusion can be operated as a continuous process, capable of 
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consistent product flow at relatively high throughput rates [1], making it a suitable technique 
for large scale production. 
 
The FDA has introduced the concept of PAT in 2004 [7]. Pharmaceutical products must meet 
very strict specifications. Conventional pharmaceutical manufacturing is generally 
accomplished using batch processing followed by time-consuming, expensive and less 
efficient off-line laboratory testing on randomly collected samples to evaluate the end 
product quality, with an increased risk of batch rejection after manufacturing. The processes 
themselves are not fully understood and are often inefficient black-boxes. The general 
principle of PAT is to build quality into products rather than testing it into products. PAT-
tools such as Raman spectroscopy provide in-line and real-time process information 
concerning critical formulation parameters, which allows the steering of processes towards 
their desired state through adaptations of process settings. Consequently, final product 
quality is guaranteed, end product characteristics can be predicted and real-time release can 
be ensured, hence avoiding batch losses. 
 
Raman spectroscopy enables rapid, non-destructive and in-line measurements, and has 
previously been used during hot-melt extrusion (single-screw extrusion) to monitor EVA 
copolymer melt composition [8, 9], to analyze film formulations [10], and to monitor the 
composition of a series of high-density polyethylene (HDPE)/polypropylene (PP) blends [11, 
12]. It has also been implemented in a twin-screw extrusion process to determine the 
concentration of Irganox additive in PP [13]. Raman spectroscopy has also been applied for 
off-line confirmation of drug dispersion within PEO and interaction with PEO in extrudates 
[14], for characterization of the hydrogen bonding nature in α- and amorphous 
indomethacin [15], and for comparison of the solid state properties of solid dispersions 
prepared by HME and solvent co-precipitation processes [16]. 
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4.2. MATERIALS AND METHODS 
 
4.2.1.  Materials and hot-melt extrusion 
 
Hot-melt extrusion was performed using a Prism Eurolab 16 co-rotating, fully intermeshing 
twin-screw extruder (Thermo Fisher Scientific, Germany). The hot-melt extruder was 
equipped with a DD Flexwall® 18 gravimetric feeder (Brabender® Technologie, Germany), 
which was set in its gravimetric feeding mode.  
 
For the development of a calibration model allowing in-line API quantification, 4 different 
polymer-drug mixtures, containing 10, 20, 30 and 40% (w/w) API respectively, were 
extruded. Eudragit® RL PO (Evonik Röhm, Germany) was used as polymer and metoprolol 
tartrate (MPT) was used (Esteve Quimica, Spain) as API. Before extrusion, the polymer and 
drug were mixed in a mortar. Each mixture was hot-melt extruded with a feeder speed of 0.3 
kg/h and a screw speed of 50 rpm. The barrel temperature profile was set at 90-140-140-
140-140-140°C (from hopper to die). The torque dropped from 70% motor capacity for the 
10% MPT mixture, over 35% for the 20% MPT mixture and 20% for the 30% MPT mixture to 
15% for the mixture containing 40% MPT (w/w). The die pressure, measured with a pressure 
probe, decreased with increasing MPT content, from 2 bar in the 10% MPT mixture to 0 bar 
in the 40% (w/w) mixture. 
 
Two different polymer-drug mixtures were prepared to evaluate the suitability of Raman 
spectroscopy for in-line polymer-drug solid state characterization. Mixture A contained 10% 
MPT and 90% Eudragit® RS PO (w/w) (Evonik Röhm, Germany), which has an identical 
molecular structure as the RL PO form, but contains fewer ammonium groups. It was 
extruded with a barrel temperature profile of 90-140-140-140-140-140°C, which is above the 
melting temperature of pure MPT, 120°C, to produce a solid solution. This resulted in a 
torque of 50% of the motor capacity and a die pressure of 1 bar. Mixture B consisted of 60% 
Eudragit® RS PO and 40% MPT (w/w), and was extruded with a barrel temperature profile of 
90-105-105-105-105-105°C, resulting in a solid dispersion. The torque was 65% and the die 
pressure 0 bar. For both mixtures, the feeder speed rate was set at 0.4 kg/h and the screw 
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speed at 80 rpm. The minimum batch size used was 700g of mixture. The Hansen solubility 
parameters of all polymers and MPT were calculated using SPWin version 2.1 [17]. 
 
4.2.2. Raman spectroscopy 
 
Raman spectra were collected with a Raman Rxn1 spectrometer (Kaiser Optical Systems, Ann 
Arbor, MI, USA), equipped with an air-cooled CCD detector. A fibre-optic Raman Dynisco 
probe was built into the extrusion die, behind the pressure probe, to monitor the process 
stream before the melt is forced through the die. The laser wavelength was the 785 nm line 
from a 785 nm Invictus NIR diode laser. All spectra were recorded with a resolution of 4 cm-1 
and an exposure time of 1 second, using a laser power of 400 mW. Spectra were collected 
every 5 seconds. Data collection and data transfer were automated using the HoloGRAMS™ 
data collection software, the HoloREACT™ reaction analysis and profiling software and the 
Matlab software (version 7.1, The MathWorks Inc., Natick, MA). The analyzed spectral region 
was 50 – 1800 cm-1, since this region contained all useful drug and polymer information. 
 
Data analysis was performed using SIMCA P+ (Version 12.0.1.0, Umetrics, Umeå, Sweden). 
Mean centering, Savitzky-Golay and SNV pre-processing were applied on the in-line collected 
spectra before principal components analysis (PCA) and partial least squares analysis (PLS), 
to exclude inter-batch variation and variation caused by baseline-shifts, respectively. For PCA 
and PLS, 20 spectra of each polymer-drug mixture were used to develop the models. A PLS 
model was developed, regressing the MPT-concentrations (Y) versus the corresponding in-
line collected Raman spectra (X). This model was validated with 20 other spectra from each 
polymer-drug mixture, which were not used to develop the PLS model. 
 
4.2.3. Differential scanning calorimetry (DSC) 
 
Differential scanning calorimetry with a DSC Q 2000 (TA Instruments, Belgium) was used to 
confirm the Raman findings. Thermograms were produced with the Thermal Advantage 
Release 5.1.2 software and analysed with TA Instruments Universal Analysis 2000 4.7A (TA 
Instruments, Belgium). Aluminium hermetic pans (TA Instruments, Belgium) were used to 
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contain the samples. Measurements were carried out in a nitrogen atmosphere, with a 
heating/cooling rate of 10°C/min. 
 
4.2.4. Attenuated total reflectance Fourier transform infrared (ATR FT-IR) 
 
Besides DSC analysis, attenuated total reflectance (ATR) Fourier transform (FT) infrared (IR) 
spectroscopy was used to confirm the observations in the Raman spectra. Spectra were 
collected from the pure components, MPT and Eudragit® RS PO, from the physical mixtures 
A and B and from the extrudates of physical mixture A at 140°C and B at 105°C. The ATR FT-
IR spectra were measured with a Bruker Vertex 70 FT-IR spectrometer, equipped with a 
DTCS detector and a PIKE accessory, equipped with a diamond ATR crystal. 
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4.3. RESULTS AND DISCUSSION 
 
4.3.1. In-line API concentration monitoring 
 
10, 20, 30 and 40% MPT - Eudragit® RL PO (w/w) mixtures were extruded. The concentration 
variations were visible in the in-line collected Raman spectra (Figure 4.1). PCA on all in-line 
collected spectra showed that two principle components covered nearly all spectral 
variation. The PC 1 versus PC 2 scores plot (Figure 4.2) shows a clear distinction between the 
spectra of the different mixtures and confirms that the first principal component captures 
the variation caused by differences in API-polymer concentration.  
 
 
Figure 4.1. In-line collected Raman spectra of different MPT – Eudragit® RL PO mixtures. Red = 10% MPT, green 
= 20% MPT, blue = 30% MPT, yellow = 40% MPT (w/w). 
 
For the development of the PLS model, allowing prediction of the MPT concentration in 
unknown samples during hot-melt extrusion processes, the in-line Raman collected spectra 
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(X) were regressed versus the known MPT concentrations (Y). Two PLS components were 
chosen, since the goodness of prediction of the model (Q² =0.997) did not increase 
significantly after adding extra components [18]. To evaluate the predictive performance of 
this model, 20 test spectra of each mixture were used (i.e., other spectra than used for 
composing the PLS model) and were projected onto the model to predict the corresponding 
MPT concentrations. Figure 4.3 shows the predicted versus the observed MPT concentration 
values for these validation spectra (R² = 0.997). The resulting root mean square error of 
prediction (RMSEP) is 0.59% (w/w).  
 
 
Figure 4.2. PC 1 vs. PC 2 scores plot of the in-line collected Raman spectra. Red = 10% MPT, green = 20% MPT, 
blue = 30% MPT, yellow = 40% MPT (w/w). 
 
 
Figure 4.3. Predicted vs. observed MPT concentrations for the validation spectra. Red = 10% MPT, green = 20% 
MPT, blue = 30% MPT, yellow = 40% MPT (w/w). 
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4.3.2. In-line solid state monitoring 
 
To obtain a good compatibility between polymer and drug, the difference in solubility 
parameters (δ) of polymer and drug should not be more than 7.0 MPa1/2 [19]. When this is 
achieved, miscibility is significant and, therefore, glass solution formation during melt 
extrusion can possibly be obtained. The Hansen solubility parameter for MPT is 23.6 MPa1/2, 
19.7 MPa1/2 for Eudragit® RS PO and 19.6 MPa1/2 for Eudragit® RL PO. The smaller the 
difference in solubility parameters, the greater the miscibility between two compounds. 
Hence, a good miscibility and possible formation of a solid solution between Eudragit® RS PO 
and MPT was expected. 
 
Two mixtures (A and B) were extruded at two different extrusion temperatures (140°C and 
105°C respectively). Mixture A was expected to result in a solid solution where the MPT has 
transferred from the crystalline to the amorphous state. This would be the result of a high 
processing temperature (above the melting temperature of pure MPT) and a good miscibility 
between both components. Mixture B was expected to result in a solid dispersion, since the 
extrusion temperature is lower than the melting temperature of MPT, which will prevent the 
transfer of all MPT in the melt into the amorphous state. Hence, a fraction of the MPT will 
remain crystalline and the extrudate of mixture B will exist of at least 2 phases. 
 
Figure 4.4a shows a detail of the in-line collected Raman spectra for the extruded mixtures A 
and B and the Raman spectra of the physical mixtures before extrusion. Comparison of these 
spectra resulted into two major observations. First, throughout the entire Raman spectrum, 
the extrudates show peak shifts compared to the spectra of the pure components and the 
spectra of the physical mixtures. These peak shifts in the spectra of the extrudates indicate 
interactions between MPT and Eudragit® RS PO. These interactions are stronger for extruded 
mixture A, as the shifts are larger. All MPT in extruded mixture A was amorphous, which 
enhances interaction with the polymer. In extruded mixture B, some MPT has transferred to 
the amorphous state, but the largest fraction remained crystalline, explaining the smaller 
peak shifts for this mixture. The occurring interactions are most likely hydrogen bonds 
between MPT and Eudragit® RS PO, which can take place between the hydroxyl functions or 
amino functions from MPT and the carbonyl groups from the polymer (Figure 4.5). Shifts of 
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the corresponding Raman peaks from these groups are indeed visible (Figure 4.4b). 
Hydrogen bonding in Raman and IR spectra can be mainly observed as a broadening of the 
spectral bands and a shift of these bands to lower frequencies [19]. The peak of ν(C=O) 
stretch vibration[20] of Eudragit® RS PO has shifted from 1729.5 cm-1 in pure Eudragit to 
1729.2 cm-1 in extruded mixture B and 1729.2 cm-1 in extruded mixture A. The shift of the 
vibration of this bond is much smaller than that of the O-H or N-H stretch [19]. The peak of 
ν(C-N) in pure MPT can be found at 1181 cm-1 [21], and shifts over 1179.6 cm-1 in extruded 
mixture B to 1178.7 cm-1 in extruded mixture A. The ν(C-O) peak of pure MPT [21] is located 
at 1109.7 cm-1, but shifts cannot be seen in the in-line collected spectra, since Eudragit® RS 
PO also has a ν(C-O) peak, appearing at 1116.3 cm-1. These peaks overlap in the spectra of 
the extruded mixtures, causing difficulties to see the peak shifts. The decrease in vibration 
frequency of ν(C-N) adjacent to the hydrogen bond is due to weakening of these bonds, 
caused by the hydrogen bond formation.  
 
 
 
Figure 4.4. a) Raman spectra of the physical mixtures of 10% MPT in Eudragit® RS PO (w/w) (PM A, orange) and 
40% MPT in Eudragit® RS PO (w/w) (PM B, blue) and the in-line collected Raman spectra of extruded mixture A 
(red) and extruded mixture B (green). b) Raman spectra of pure MPT (yellow) and pure Eudragit® RS PO 
(purple) and the in-line collected Raman spectra of extruded mixture A (red) and extruded mixture B (green). 
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A second observation of interest lies in the peaks of MPT. Since pure MPT is crystalline, its 
Raman spectrum contains narrow, well defined peaks. Extruded mixture B still contains a 
fraction of MPT in the crystalline state. The peaks of MPT have slightly broadened, but are 
still well defined. In extruded mixture A, the MPT peaks have broadened or even 
disappeared, indicating the presence of amorphous MPT. In the physical mixtures, the peaks 
of MPT remain as sharp as the original peaks. Interactions or transitions have not taken 
place in these physical mixtures. 
 
 
Figure 4.5. Molecular structures of a) Eudragit® RL/RS PO and b) Metoprolol tartrate. 
 
The spectra in the 50 – 150 cm-1 region of the Raman spectrum contain information about 
lattice vibrations corresponding to vibrations and translations of the entire molecule in the 
lattice [15]. These vibrations are characteristic for the crystal structure and sensitive to local 
order or disorder. For the spectrum of pure MPT, this region has sharp, well defined peaks, 
which are still present in the spectra of extruded mixture B, but which have nearly 
disappeared in the spectra of extruded mixture A. In extruded mixture A, broad bands are 
visible, indicating a more disordered structure (Figure 4.6). 
 
DSC analysis (Figure 4.7) was performed to confirm these interpretations from the Raman 
spectra. For the samples containing Eudragit® RS PO, the maximum heating temperature 
was restricted to 140°C, to avoid degradation of the polymer, which can occur above 150°C. 
The glass transition temperature (Tg) of Eudragit® RS PO reaches a lower temperature in the 
extrudates, due to the plasticizing effect of MPT on the polymer, and due to the extrusion 
process, which slightly lowers the Tg of a polymer [22]. A lower Tg indicates a molecular 
dispersion of the drug in the polymer, whereas an unchanged Tg implies separation of the 
polymer- and drug phase [23]. The Tg of Eudragit® RS PO in the extrudates of 10% and 40% 
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MPT (w/w) is 46.6°C and 46.5°C, respectively, whereas the Tg of Eudragit® RS PO of the 
physical mixtures A and B used to prepare these extrudates is 55.1°C and 58.1°C, 
respectively, which is higher than the Tg after extrusion. This decrease in Tg after extrusion is 
caused by the interaction between Eudragit® RS PO and MPT during hot-melt extrusion. The 
chain mobility of the polymer increases due to incorporation of MPT in the polymer 
matrices, which translates into a decrease in Tg. 
 
  
 
Figure 4.6. Detail of the Raman spectra for the 50 cm
-1
 to 150 cm
-1
 spectral region. Yellow = pure MPT; Purple = 
pure Eudragit® RS PO; red = extruded mixture A; green = extruded mixture B. 
 
A similar shift in the endothermous melting peak of the crystalline MPT appears. The melting 
temperature of pure MPT is measured at 124°C, and its onset temperature at 122.3°C. In the 
physical mixtures A and B, this melting temperature has shifted to 110°C and 122.3°C, 
respectively, and the onset temperature to 103.3°C and 117.3°C respectively. An even larger 
shift occurs in the thermogram of extrudate B, where the Tm of MPT is 105.6°C and its onset 
temperature 102.5°C. This shift again implies interactions between the polymer and the 
drug. These interactions are more explicit in extrudate B, but also appear in the physical 
mixtures. This endothermic peak has disappeared in the thermogram of extrudate A, 
indicating that all of the MPT has become amorphous during processing. Since there is only 
one Tg present, MPT and Eudragit® RS PO have interacted to form one single phase. Hence, 
the extrudate of mixture A is a solid solution. 
-1,0
-0,5
0,0
0,5
1,0
1,5
2,0
47,4 69,6 92,1 114,6 137,1 159,6
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Raman Shift (1/cm)
SIMCA-P+ 12.0.1 - 2010-07-12 12:02:14 (UTC+1) 
MPT
Extruded mixture A
Extruded mixture B
Eudragit® RS PO
CHAPTER 4 – RAMAN SPECTROSCOPY FOR THE IN-LINE POLYMER-DRUG QUANTIFICATION AND SOLID STATE 
CHARACTERIZATION DURING HOT-MELT EXTRUSION 
86 
 
 
 
Figure 4.7. a) Thermograms of pure MPT and Eudragit® RS PO and of mixture A and B after hot-melt extrusion. 
b) Thermograms of physical mixtures A and B before hot-melt extrusion and of mixture A and B after hot-melt 
extrusion. 
 
The first derivative of the thermogram of extrudate B shows 2 Tg’s, one for Eudragit® RS PO 
(46.5°C) and one for MPT (12°C, Tg of pure MPT = 14.2°C). A fraction of the MPT in this 
mixture has become amorphous during processing, but has not interacted with the polymer 
phase. Hence, this extrudate exists of three phases: an amorphous polymer phase, an 
amorphous drug phase and a crystalline drug phase. This extrudate is in fact a solid 
dispersion which is partially crystalline and partially amorphous. Therefore, the DSC 
thermograms confirm the observations from the in-line Raman spectra. 
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Figures 4.8a and 4.8b represent the ATR FT-IR spectra of metoprolol tartrate and Eudragit® 
RS PO, respectively. The IR spectra of the physical mixtures of metoprolol tartrate and 
Eudragit® RS PO (Figure 4.8c and 4.8d) can be seen as the combinations of the IR spectra of 
the independent products in their respective ratios. The MPT signals are sharp and the 
fingerprint area (1500 cm-1 – 600 cm-1) shows an explicit pattern. The position of the bands 
in the IR spectra of the physical mixtures remains unchanged compared to the 
corresponding bands in the spectra of the pure components. No new bands or band shifts 
occur. 
 
The IR spectrum of mixture B, which was extruded at a temperature of 105°C, results in a 
significantly changed IR pattern (Figure 4.8f). In the spectral area of 3800 cm-1 – 2800 cm-1, 
the C-H stretch vibrations of the acrylate polymer are dominantly present. The pattern of the 
different OH and NH vibrations of the API has disappeared. They are replaced by a broad 
band between 3700 cm-1 and 2300 cm-1, which can be assigned to associated hydroxyl 
groups due to hydrogen bonding with the carbonyl functions of the polymer. The bond 
representing the ester group of the acrylate polymer is dominantly present compared to the 
corresponding physical mixture (Figure 4.8f vs. 4.8d). The bands in the 1610 cm-1 – 1585 cm-1 
area, belonging to the metoprolol carboxylate groups, have shifted. In the fingerprint area 
(1500 cm-1 – 600 cm-1), the pattern has disappeared and the bonds arising from the polymer 
are explicitly present compared to the physical mixture. This indicates a strong association of 
the API with the polymer, forming coupled vibrations of MPT with the polymer. 
 
In the IR spectrum of mixture A, which was extruded at a temperature of 140°C, this effect is 
even more distinct (Figure 4.8e), showing only the vibrational state (and thus spectrum) of 
the polymer. Due to the formation of strong hydrogen bonds between the hydroxyl groups 
of MPT and the ester carbonyl groups of the polymer, a macromolecular structure with its 
own vibrations is generated, where the MPT is no longer present as an independent 
molecule. With exception of very weak IR absorption bands at 1612 cm-1 and 1513 cm-1, no 
typical absorption bands of MPT can be detected in the IR spectrum. The spectral area of 
3500 cm-1 – 2800 cm-1 also shows only 1 weak and broadened band of the associated 
hydroxyl groups of the drug. 
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Figure 4.8. ATR FT-IR spectra of a) MPT, b) Eudragit® RS PO, c) physical mixture A 
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Figure 4.8. ATR FT-IR spectra of d) physical mixture B, e) extrudate of mixture A at 140°C, f) extrudate of 
mixture B at 105°C. 
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To demonstrate that the broadening of peaks and the peak shifts occurring in the in-line 
collected spectra are not an effect of the measurement environment (i.e. caused by the 
effect of temperature changes on the Raman measurements), samples were collected during 
extrusion of a mixture containing 40% MPT and 60% Eudragit ® RS PO (w/w), and cooling at 
room temperature was monitored with Raman spectroscopy immediately after sample 
collection. After one day of storage at room temperature, Raman spectra of the samples 
were collected again. All of these spectra were compared to the spectra of the physical 
mixtures and the spectra gathered in-line during extrusion. During extrusion, a throughput 
of 0.3 kg/h, a screw speed of 80 rpm and a barrel temperature of 140°C were applied. 
 
 
Figure 4.9. Raman spectra from the physical mixture (MPT – Eudragit® RS PO 40-60) (black), the extrudates 
during extrusion (red) and the extrudates after cooling at room temperature (blue). 
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As demonstrated in Figure 4.9, the spectral difference between the physical mixture and the 
in-line measurements is manifested as peak broadening, due to a transition from crystalline 
to amorphous MPT, and as peak shifts, caused by the interaction of MPT with Eudragit® RS 
PO. After cooling the extrudates at room temperature, the broadening of the peaks 
remained visible, as well as the peak shifts, indicating that this is an actual physicochemical 
difference between sample and physical mixture, rather than an effect of measurement 
environment. 
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4.4. CONCLUSION 
 
In this chapter, Raman spectroscopy was evaluated as a PAT tool to monitor the API 
concentration and polymer-drug melt solid state during pharmaceutical hot-melt extrusion 
processes. Comparison between the in-line collected Raman spectra and the off-line 
obtained DSC thermograms and ATR FT-IR spectra demonstrated that information about the 
physicochemical state of a polymer-drug melt can be obtained from the Raman spectra, 
allowing monitoring and prediction of the polymer-drug solid state throughout the extrusion 
process. With Raman spectroscopy, it was possible to detect differences between 
amorphous and crystalline polymer drug melts. The in-line collected Raman spectra also 
gave an indication of the occurring interactions during the hot-melt extrusion process, which 
leads to a better understanding of the process.  
 
A PLS model was developed and validated, allowing drug concentration monitoring of 
unknown samples during hot-melt extrusion. Raman spectroscopy was able to detect 
variations in drug concentration and to predict drug concentrations with an RMSEP of 0.59% 
(w/w). 
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ABSTRACT 
 
A calibration model for in-line API determination was developed based on Raman spectra 
collected during hot-melt extrusion. This predictive model was validated by calculating the 
accuracy profile based on the analysis results of validation experiments. Furthermore, based 
on the data of the accuracy profile, the measurement uncertainty was determined. Finally, 
the robustness of the model was evaluated. 
A Raman probe was implemented in the die of a twin-screw extruder, to monitor the drug 
concentration during extrusion of physical mixtures containing 15, 20, 25, 30 and 35% (w/w) 
metoprolol tartrate (MPT) in Eudragit® RS PO. Different calibration models for the 
prediction of the MPT content were developed, based on the use of single spectra or 
averaged spectra, and using partial least squares (PLS) regression or multivariate curve 
resolution (MCR). These predictive models were validated by extruding and monitoring 
mixtures containing 17.5, 22.5, 25.0, 27.5 and 32.5% (w/w) MPT. Each validated 
concentration was monitored on three different days, by two different operators. The β-
expectation tolerance intervals were calculated for each model and for each of the validated 
MPT concentration levels (β was set at 95%), and acceptance limits were set at 10% (relative 
bias), indicating that at least 95% of future measurements should not deviate more than 
10% from the true value. The only model where these acceptance limits were not exceeded, 
was the MCR model based on averaged Raman spectra. The uncertainty measurements for 
this model showed that the unknown true value can be found at a maximum of ± 7.00% 
around the measured result, with a confidence level of 95%. The robustness of this model 
was evaluated via an experimental design varying throughput, screw speed and barrel 
temperature. The robustness designs showed no significant influence of any of the 
fluctuating process settings on the predicted concentration values. 
Raman spectroscopy proved to be a fast, non-destructive and reliable method for the 
quantification of MPT during hot-melt extrusion. From the accuracy profile of the MCR 
model based on averaged spectra, it was concluded that for each MPT concentration in the 
validated concentration range, 95 out 100 future routine measurements will be included 
within the acceptance limits (10%). 
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5.1. INTRODUCTION 
 
Raman spectroscopy is a molecular vibrational spectroscopic technique, allowing fast and 
non-destructive measurements which do not require any sample pretreatment. The use of 
custom made fibre optic probes connected to the spectrometers allows the implementation 
into the process stream [1]. A Raman spectrum is an overlay of the fingerprints (i.e., a 
combination of spectral bands) of the individual components in a mixture, making Raman 
spectroscopy a suitable tool for quantification purposes. Hence, Raman spectroscopy can be 
applied as a process analytical tool to monitor and predict the concentration of an active 
pharmaceutical ingredient (API) during hot-melt extrusion. 
 
So far, only two quantitative applications of Raman spectroscopy during hot-melt extrusion 
have been reported. In a first application [2] the API concentration was monitored behind 
the extrusion die, where a Raman probe was clamped above an extruded film. In the second 
application [3], the Raman probe was implemented in the extrusion die to monitor the API 
content of the extrudates. In both applications, a partial least squares (PLS) regression 
model was developed for the prediction of the API concentration, and a traditional 
chemometric validation approach [4] was used to validate the predictive models. First, the 
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root mean square error of calibration (RMSEC) and the root mean square error of the cross 
validation (RMSECV) are calculated, and then an external validation dataset is used to 
validate the predictive model. The quantitative performance of the Raman spectroscopic 
models is evaluated by calculating the root mean square error of prediction (RMSEP) based 
on the prediction results of the validation experiments. Small values of RMSEC, RMSECV and 
RMSEP indicate a good quantitative performance of the models. However, this validation 
approach does not fulfil the regulatory requirements in the ICH Q2 [5] and FDA [6] 
guidelines for validation of analytical procedures. 
 
Many official documents [5, 6] describe the validation criteria which should be assessed, but 
no experimental protocols are provided. The ICH Q2 guideline [5] requires the assessment 
of accuracy, precision (repeatability and intermediate precision), specificity, linearity and 
range to validate an analytical quantification method for the active pharmaceutical 
ingredient in a drug product. The same validation characteristics are entailed by the FDA 
guidelines for validation [6], with addition of the robustness of the method. However, these 
guidelines are most often limited to these general concepts [7]. The determination of the 
validation parameters and the chemometric values (RMSEC, RMSECV, and RMSEP) does not 
suffice to evaluate the risk that every future measurement will be close enough to the 
unknown true value of the sample. These statistics only provide information concerning 
previously performed experiments. Statistics allowing to make a decision related to the 
validity of a method for future analyses are necessary. 
 
The Société Française des Sciences et Techniques Pharmaceutiques (SFSTP) has developed a 
validation strategy based on the total error of the procedure (bias + standard deviation). 
Each analytical measurement reflects its true value, the bias of the method and its precision 
[8]. This approach minimizes the risk to accept an inaccurate calibration method or to reject 
a capable method. The objective of validation is to guarantee that every measurement 
performed in future analysis is close enough to the unknown true value [7], and that the 
difference will be lower than a preset acceptance limit. In this chapter, a Raman 
spectroscopic method for the quantification of metoprolol tartrate (MPT) in a polymer 
matrix during a hot-melt extrusion process was developed and validated by calculating the 
accuracy profile based on the analysis results of validation experiments. 
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5.2. MATERIALS AND METHODS 
 
5.2.1. Materials 
 
Physical mixtures containing MPT (Esteve Quimica, Spain), Eudragit® RS PO (Evonik, 
Germany) and magnesium stearate (Mg St) (Fagron, Belgium) were blended in a Turbula 
mixer before extrusion. The Mg St was added to the formulation to improve feeding 
behaviour of the mixtures in the extruder. Preparation of the validation mixtures was 
performed in triplicate, to allow extrusion on three different days, by two different 
operators. 
 
5.2.2. Hot-melt extrusion 
 
All physical mixtures were extruded on a 16 mm twin-screw extruder (Prism Eurolab 16, 
Thermo Fisher Scientific, Germany). The hot-melt extruder was equipped with a DD 
Flexwall® 18 gravimetric feeder (Brabender® Technologie, Germany), which was set in its 
gravimetric feeding mode and supplied the physical mixtures with a throughput of 0.3 kg/h. 
The applied screw speed was 80 rpm for all experiments, and the barrel temperature from 
feeding area to die was set at 70-142-142-142-142-120°C. 
 
5.2.3. Raman spectroscopy 
 
In-line Raman spectra were collected with a Raman Rxn1 spectrometer (Kaiser Optical 
Systems, Ann Arbor, MI, USA). A fibre-optic Raman Dynisco probe was implemented into the 
die head (Figure 5.1) [3], to monitor the MPT concentration of the melt before it is forced 
through the die. The laser wavelength was the 785 nm line from a 785 nm Invictus NIR diode 
laser. All in-line collected spectra were recorded with a resolution of 4 cm-1 and an exposure 
time of three seconds, using a laser power of 400 mW. Spectra were collected every 15 
seconds. Data collection and data transfer were automated using the HoloGRAMSTM data 
collection software, and the Matlab software (version 7.1, The MathWorks Inc., Natick, MA). 
Once an experiment was started, 15 minutes stabilization time was applied before starting 
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the collection of the spectra. After this, the experiments were continued for another 15 
minutes, during which 60 in-line spectra were collected. 
 
 
Figure 5.1. Experimental setup: Raman Dynisco probe (1) implemented in the die (2) of a 16 mm twin-screw 
extruder. 
 
5.2.4. Development of the Raman calibration models 
 
Four different calibration models based on the Raman spectra collected during extrusion of 
the calibration mixtures (Table 5.1) were developed and evaluated. First, a PLS model was 
developed using the SIMCA P+ software (Version 12.0.1.0, Umetrics, Umeå, Sweden) (Model 
1). Prior to modelling, SNV pre-processing and Savitzky-Golay smoothing were applied on 
the spectral range of 0 – 1800 cm-1 to eliminate the additive baseline offset variations and to 
allow noise reduction in the spectra. The PLS model was built by regressing the 300 in-line 
collected and preprocessed spectra (5 concentration levels x 60 spectra/concentration level) 
versus the actual MPT concentration values (Table 5.1). 
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Table 5.1. Composition of the calibration and validation mixtures. 
 
Calibration 
mixtures 
Metoprolol tartrate 
(MPT) 
(% w/w, theoretical) 
Eudragit® RS 
PO 
(% w/w) 
Magnesium 
stearate 
(% w/w) 
Actual MPT 
concentration 
(% w/w) 
  
1 15,0 84,5 0,5 15,0141   
2 20,0 79,5 0,5 20,0090   
3 25,0 74,5 0,5 25,0072   
4 30,0 69,5 0,5 30,0077   
5 35,0 64,5 0,5 35,0025   
Validation 
mixtures 
MPT (% w/w, 
theoretical) 
Eudragit® RS 
PO 
(% w/w) 
Magnesium 
stearate 
(% w/w) 
Actual MPT 
concentration 
(% w/w) day 1 
Actual MPT 
concentration 
(% w/w) day 2 
Actual MPT 
concentration 
(% w/w) day 3 
1 17,5 82,0 0,5 17,5056 17,4989 17,5078 
2 22,5 77,0 0,5 22,5049 22,5049 22,5032 
3 25,0 74,5 0,5 25,0037 25,0012 24,9993 
4 27,5 72,0 0,5 27,4995 27,4995 27,5071 
5 32,5 67,0 0,5 32,4979 32,5012 32,5023 
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Model 2, a PLS model as well, was not based on the original spectra collected during 
extrusion of the calibration mixtures, but on the averaged spectra of ten successively 
collected spectra. Therefore, this model was developed using 30 spectra (5 concentration 
levels x 6 averaged spectra/concentration level). No official regulations on sample size for 
extrusion processes exist, but the FDA guidance on content uniformity [9] states that sample 
quantities larger than three times the dosage unit range can only be used with an adequate 
scientific justification. The amount of MPT passing the probe window during one 
measurement (three seconds) in the mixture with the highest MPT concentration (i.e. 35% 
w/w), at a throughput of 0.3 kg/h is 87.5 mg. Since the unit dosage is 200 mg, and the 
Raman signal does not penetrate the entire melt volume, the combination of ten spectra 
does not exceed this limit. 
 
For a third predictive model (Model 3), multivariate curve resolution (MCR) was applied, 
using the HoloREACTTM reaction analysis and profiling software (Kaiser Optical Systems, Ann 
Arbor, MI, USA). In MCR, a two-way data matrix D (m x n) is decomposed into two matrices 
C (m x k) and ST (k x n), containing the pure concentration profiles for each modelled 
component in the system and the corresponding pure spectra of the k species of the 
unknown mixture, respectively [10]. This decomposition is performed according to Eq. (5.1): 
 
             (5.1) 
 
Where E (m x n) is the error matrix containing the residual variation. Before analysis, a 
baseline correction and normalization were applied on two spectral ranges. The first range, 
1600 -1630 cm-1, represents a peak specific for MPT, and the second range from 1710 – 
1750 cm-1 contains a peak for Eudragit® RS PO. Next, a model based on the MCR scores of 
the MPT peak from 300 spectra (5 concentration levels x 60 spectra/ concentration level) 
versus the actual MPT concentration, was developed. The same approach was used to 
develop Model 4, but using the average spectra of ten successively collected spectra. 
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5.2.5. Validation of the Raman method and estimation of its uncertainty 
 
The strategy suggested by the SFSTP [7, 8, 11, 12] was applied for validation of the 
developed calibration models. The main objective of this commission was the harmonization 
of approaches for the validation of quantitative analytical procedures. The objective of 
validation is to guarantee that the difference between every single measurement (xi), which 
will be performed in routine analysis, and the unknown true value of the sample (µT) will be 
lower than an acceptable limit (λ) [7] (Eq. (5.2)): 
 
              (5.2) 
 
For this particular analytical procedure, λ was set at 10%. A procedure is qualified as 
acceptable when it can assure that the probability (Eq. (5.3)) that measurements will fall 
outside the preset acceptance limits is less or equal to the risk that the analyst is able to 
take during routine use: 
 
                  (5.3) 
 
with β being the proportion of measurements inside the acceptance limits. The expected 
proportion of measurements falling outside the acceptance limits evaluates the risk of an 
analytical procedure. In this study, the desired proportion of measurements found within 
the acceptance limits was set at 95%. 
 
The MPT concentration levels of the validation samples are overviewed in Table 5.1, and the 
mean concentrations as calculated by the four different models are shown in Table 5.2. Each 
validation mixture was extruded on three different days by two operators, accounting for 
the inter-day and operator variation. Problems occurred during extrusion of the validation 
mixture with a 32.5% (w/w) MPT concentration on the third day, caused by a defect in the 
temperature monitoring device. Therefore, these spectral data were excluded from the data 
analysis. 
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Table 5.2. Mean predicted MPT concentrations (% w/w). 
 
MPT 
concentration 
(% w/w) 
Actual MPT 
concentration 
(% w/w) 
Mean predicted MPT 
concentration (% w/w) 
Model 1 
Mean predicted MPT 
concentration (% w/w) 
Model 2 
Mean predicted MPT 
concentration (% w/w) 
Model 3 
Mean predicted MPT 
concentration (% w/w) 
Model 4 
17,5 - day 1 17,5056 13,6026 13,7674 16,2110 17,0442 
17,5 - day 2 17,4989 14,8947 14,8176 18,0945 17,6324 
17,5 - day 3 17,5078 15,0605 15,2321 17,9913 17,7284 
22,5 - day 1 22,5049 20,7349 21,0132 20,9911 22,0764 
22,5 - day 2 22,5049 21,6028 21,7217 21,3559 21,7461 
22,5 - day 3 22,5032 19,5813 19,8187 22,3763 21,4988 
25,0 - day 1 25,0037 21,7440 22,0244 23,3160 23,4095 
25,0 - day 2 25,0012 23,1770 23,4599 23,8353 24,2815 
25,0 - day 3 24,9993 22,9997 23,2904 24,0506 24,0160 
27,5 - day 1 27,4995 25,0717 25,3138 25,0914 25,3532 
27,5 - day 2 27,4995 27,7401 27,7172 27,8007 26,8305 
27,5 - day 3 27,5071 27,5212 27,6717 27,1136 27,0039 
32,5 - day 1 32,4979 31,4534 31,6651 31,7784 32,1468 
32,5 - day 2 32,5012 33,1504 33,3448 33,8719 32,9962 
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The objective of validation is to evaluate the risks or confidences that every single 
measurement that will be performed, will be close enough to the unknown true value of the 
sample. Therefore, the determination of trueness, precision, linearity and other validation 
criteria is not sufficient to provide these guarantees. The adapted decision tool was the 
accuracy profile of the analytical procedure based on the β-expectation tolerance interval 
and the concept of total error (bias + standard deviation). Every analytical method is 
characterized by a systematic error or true bias and a random error or true variance 
(measured by a standard deviation) [7]. Both these parameters are inherent of the analytical 
method and always unknown as well as the true value. The accuracy profile of a method is 
acquired by calculating the β-expectation tolerance interval at every concentration level 
[13], and is used to decide whether the analytical procedure is considered as valid or not [8]. 
 
The variance used to estimate the β-expectation tolerance interval is equal to the sum of 
the total variance of the method plus the variance of the bias. The standard deviation of the 
β-expectation tolerance interval can be used as an estimate of the standard uncertainty in 
the measurements. Using the data collected for the development of the accuracy profile, 
the measurement uncertainty was estimated [14]. The uncertainty is defined as a parameter 
associated with the result of a measurement, which characterizes the dispersion of the 
values that could reasonably be attributed to the measurand [15]. 
 
5.2.6. Evaluation of the robustness of the Raman calibration models 
 
Finally, a robustness testing design was created with the MODDE software (version 9.1.0.0, 
Umetrics, Umeå, Sweden) to evaluate whether the performance of the quantification 
method is sensitive to small fluctuations in process settings. The factors throughput, screw 
speed and barrel temperature were varied during extrusion of a physical mixture containing 
25% MPT, 74.5% Eudragit® RS PO and 0.5% Mg St (w/w). The robustness testing design used 
was a linear 23-1+3 fractional factorial design (resolution III) (Table 5.3). The factor levels 
were chosen by considering which changes may occur in the laboratory. The responses used 
in these designs were the MPT concentrations predicted by the developed models. The ideal 
result in a robustness testing study is identical response values for each trial [16]. The 
significance and lack of fit of the robustness design models were assessed via an F-test, to 
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evaluate the robustness of the responses. The robustness testing design was performed for 
Model 4, which delivered the best accuracy profile. 
 
 
Table 5.3. Robustness design. 
 
Experiment 
number 
Run Order Throughput 
(kg/h) 
Screw speed 
(rpm) 
Temperature (°C) 
1 7 0,275 70 70-144-144-144-144-120 
2 4 0,325 70 70-140-140-140-140-120 
3 5 0,275 90 70-140-140-140-140-120 
4 1 0,325 90 70-144-144-144-144-120 
5 3 0,3 80 70-142-142-142-142-120 
6 6 0,3 80 70-142-142-142-142-120 
7 2 0,3 80 70-142-142-142-142-120 
 
 
CHAPTER 5 – VALIDATION OF AN IN-LINE RAMAN SPECTROSCOPIC METHOD FOR CONTINUOUS API 
QUANTIFICATION DURING PHARMACEUTICAL HOT-MELT EXTRUSION 
107 
 
5.3. RESULTS AND DISCUSSION 
 
5.3.1. Development of the Raman calibration models 
 
For the development of Model 1, the first predictive model for MPT concentration 
monitoring, all in-line collected preprocessed Raman spectra (300 spectra in total) (X) were 
regressed versus the actual MPT concentrations (Y). Two principal components were 
chosen, since the goodness of prediction of the model (Q² = 0.993) did not improve 
significantly when adding extra components. The scores and loading plot for the first 
principal component (R² = 0.937) confirm that this component represents the variation in 
the Raman spectra caused by the difference in MPT concentration level in the calibration 
mixtures (Figure 5.2). Positive peaks in the loading of the first component correspond to 
MPT-peaks, whereas the negative peaks belong to the polymer. A higher PC 1 score value 
therefore indicates a higher MPT concentration. The RMSECV of this two-component PLS 
model is 0.61% (w/w). The predictive performance of this model was evaluated by 
calculating the MPT concentrations for the spectra collected during extrusion of all 
validation mixtures. This resulted in an RMSEP value of 2.28% (w/w). 
 
A second PLS model, referred to as Model 2 in section 5.2.4., was developed using the 
averaged spectra collected during extrusion of the calibration mixtures. A two-component 
model was developed (Q² = 0.994), and the first principal component (R² = 0.941) captured 
the variation in the Raman spectra originating from concentration level differences in the 
calibration mixtures. The RMSECV of this two-component PLS model was 0.57% (w/w). The 
predictive performance of the model was evaluated by calculating the MPT concentrations 
for the averaged spectra collected during extrusion of all validation mixtures. This resulted 
in an RMSEP value of 2.09% (w/w). 
 
Models 3 and 4 are calibration models based on the MCR scores for one MPT peak (1600 – 
1630 cm-1) from the original (300) and averaged (30) spectra, respectively. Linear regression 
of these MPT scores resulted in an R² of 0.95 and 0.99, and an RMSEP of 1.57% and 1.09% 
(w/w) for Models 3 and 4, respectively. 
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Figure 5.2. a) PC 1 versus PC 2 scores scatterplots of in-line collected Raman spectra during extrusion of the 
calibration mixtures and b) loading plot of the first principal component. 
 
5.3.2. Validation of the Raman method and estimation of its uncertainty 
 
The MPT concentration of the validation mixtures was predicted during extrusion, using the 
four developed calibration models. The mean calculated concentrations for each model are 
presented in Table 5.2. Since the introduced MPT concentrations for each concentration 
level differed slightly, an alignment on the concentration level was performed prior to data 
analysis. For each validation concentration level, trueness, precision, and β-expectation 
tolerance intervals were calculated (Table 5.4) and the linearity was assessed (Table 5.4 and 
Figure 5.3). The specificity of the method was demonstrated by the loadings of PC 1 (Figure 
5.2b), which clearly showed that the largest source of variation (93.7%) in the in-line 
collected Raman spectra is related to changes in MPT concentration. For all four models, a 
linear relation between the introduced MPT concentration and the MPT concentration as 
calculated by the model was found, and the R² values (Figure 5.3) all approach 1. The 
calculated values for precision (Table 5.4) show that the results for intermediate precision 
are equal to or worse than the repeatability results for all MPT concentration levels in all 
applied calibration models. The intermediate precision comprises both the variability caused 
CHAPTER 5 – VALIDATION OF AN IN-LINE RAMAN SPECTROSCOPIC METHOD FOR CONTINUOUS API 
QUANTIFICATION DURING PHARMACEUTICAL HOT-MELT EXTRUSION 
109 
 
by the extrusion of the validation mixtures on different days, and the fact that the 
experiments were performed by two different operators. This difference between 
repeatability and intermediate precision indicates that the inter-day variability in the 
dataset is larger than the within-day variability, which is caused by an operator or day effect. 
Regarding the operator effect, each operator might for instance fixate the Raman probe 
more tightly or loosely in the extrusion die, also causing variations in the in-line collected 
Raman spectra. 
 
 
Figure 5.3. Assessment of linearity (computed concentration = ƒ(introduced concentration)) for a) Model 1, b) 
Model 2, c) Model 3, d) Model 4. 
 
For models 1, 2 and 3, the β-expectation tolerance intervals exceeded the preset acceptance 
limits (10% relative bias) for each of the validated concentration levels (Figure 5.4). In model 
4, the only validated concentration of which the acceptance limits were exceeded by the β-
expectation tolerance interval, is the mixture with 27.5% MPT (w/w). Table 5.2 shows that 
for this concentration level, the mean predicted concentration for Model 4 is much lower on 
day 1, 25.3532% MPT, than on day 2 and 3, 26.8305% MPT and 27.0039% MPT (w/w) 
respectively. The Raman spectra collected on this day showed larger background signal 
variations than on day 2 and 3, which might cause the larger error in prediction of the MPT 
concentration. However, a clear cause for these background variations was not found. 
When the data from day 1 were excluded from the accuracy profile calculations, the β-
expectation tolerance intervals for all validated concentrations remained within the 
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acceptance limits of 10% (Figure 5.5). Thus the entire accuracy profile, created after 
connecting the upper and lower tolerance limits for the validated concentration levels in 
order to interpolate the behaviour of the limits for the entire method range, was found 
within the preset acceptance limit. This indicates that, for at least 95 out of 100 future 
routine measurements, the predicted concentrations will be included within the acceptance 
limits. 
 
 
Figure 5.4. Accuracy profiles for a) Model 1, b) Model 2, c) Model 3, d) Model 4. The red lines represent the 
acceptance limits which were set at 10% relative bias. 
 
 
Figure 5.5. Accuracy profile for Model 4, with exclusion of the spectra collected during extrusion of the 
validation mixture with 27.5% MPT (w/w) on day 1. The red lines represent the acceptance limits which were 
set at 10% relative bias. 
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Table 5.4. Validation parameters for each calibration model: trueness, precision, accuracy and linearity. 
 
Trueness Model 1 Model 2 Model 3 Model 4 
MPT 
concentration 
(% w/w) 
Relative bias 
(%) 
Recovery 
(%) 
Relative bias 
(%) 
Recovery 
(%) 
Relative bias 
(%) 
Recovery 
(%) 
Relative bias 
(%) 
Recovery 
(%) 
17,50 -17,05 82,95 -16,56 83,44 -0,41 99,59 -0,20 99,80 
22,50 -8,29 91,71 -7,35 92,65 -4,13 95,87 -3,18 96,82 
25,00 -9,45 90,55 -8,31 91,69 -5,07 94,93 -4,40 95,60 
27,50 -2,63 97,37 -2,19 97,81 -3,03 96,97 -4,02 95,98 
32,50 -0,61 99,39 0,02 100,02 1,00 101,00 0,22 100,22 
Precision Model 1 Model 2 Model 3 Model 4 
MPT 
concentration 
(% w/w) 
Repeatability 
standard 
deviation (%) 
Intermediate 
precision 
standard 
deviation (%) 
Repeatability 
standard 
deviation (%) 
Intermediate 
precision 
standard 
deviation (%) 
Repeatability 
standard 
deviation (%) 
Intermediate 
precision 
standard 
deviation (%) 
Repeatability 
standard 
deviation (%) 
Intermediate 
precision 
standard 
deviation (%) 
17,50 4,98 5,64 3,04 4,63 6,03 8,02 1,71 2,34 
22,50 3,41 5,66 2,47 5,11 7,30 7,30 2,31 2,31 
25,00 3,63 4,55 2,72 3,74 4,09 4,09 2,37 2,49 
27,50 3,97 6,64 1,06 5,74 4,78 6,71 1,08 4,09 
32,50 2,56 4,32 2,96 4,07 4,48 5,94 3,29 3,29 
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Table 5.4. Validation parameters for each calibration model: trueness, precision, accuracy and linearity (continued). 
 
Accuracy 
MPT 
concentration 
(% w/w) 
Model 1 
β-expectation tolerance limits 
(%)  
Model 2 
β-expectation tolerance limits 
(%)  
Model 3 
β-expectation tolerance limits 
(%)  
Model 4 
β-expectation tolerance limits 
(%)  
17,50 [-29,19; -6,38] [-28,46; -4,72] [-22,82; 22,00] [-7,04; 6,10] 
22,50 [-26,54; 10,39] [-30,13; 15,97] [-20,35; 12,09] [-8,08; 2,31] 
25,00 [-19,95; 2,02] [-17,71; 1,65] [-14,07; 3,93] [-9,47; 1,94] 
27,50 [-24,69; 21,77] [-29,50; 26,47] [-22,86; 16,80] [-22,857; 16,10] 
32,50 [-64,34; 63,85] [-20,17; 19,47] [-28,30; 30,30] [-8,49; 8,62] 
 
Linearity 
 
Model 1 
 
Model 2 
 
Model 3 
 
Model 4 
R² 0,9574 0,9663 0,9102 0,9676 
Intercept -6,4101 -6,3373 -0,8193 -0,1888 
Slope 1,1914 1,1957 1,0082 0,9821 
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Table 5.5. Estimates of the different uncertainties for each level of the accuracy profile in each calibration model. 
 
 MPT concentration level Uncertainty of the bias Uncertainty  Expanded uncertainty  Relative expanded uncertainty 
 (% w/w) (% w/w) (% w/w) (% w/w) (%) 
Model 1 17,5 0,30 0,87 1,79 9,89 
22,5 0,58 1,31 2,61 11,60 
25,0 0,43 1,12 2,25 8,98 
27,5 0,89 2,01 4,01 14,60 
32,5 0,85 1,64 3,28 10,10 
Model 2 17,5 0,32 0,75 1,50 8,55 
22,5 0,56 1,21 2,41 10,72 
25,0 0,38 0,94 1,88 7,53 
27,5 0,89 1,79 3,58 13,00 
32,5 0,73 1,51 3,01 9,30 
Model 3 17,5 0,61 15,30 3,05 17,44 
22,5 0,45 1,64 3,28 14,56 
25,0 0,28 1,01 2,02 8,08 
27,5 0,81 1,96 3,93 14,30 
32,5 1,05 2,21 4,43 13,60 
Model 4 17,5 0,18 0,45 0,89 5,11 
22,5 0,15 0,52 1,05 4,66 
25,0 0,20 0,63 1,26 5,05 
27,5 0,14 0,37 0,74 2,70 
32,5 0,38 1,14 2,27 7,00 
 
 
CHAPTER 5 – VALIDATION OF AN IN-LINE RAMAN SPECTROSCOPIC METHOD FOR CONTINUOUS API 
QUANTIFICATION DURING PHARMACEUTICAL HOT-MELT EXTRUSION 
114 
 
According to a recent draft of guide ISO/DTS 21748 [14, 17], the measurement uncertainty 
can be estimated from trueness and precision (repeatability and reproducibility). Table 5.5 
shows the estimates for the uncertainty of bias, the uncertainty which combines the 
uncertainty of bias with the intermediate precision standard deviation, the expanded 
uncertainty and the relative expanded uncertainty for each level of the accuracy profile in 
each calibration model. The expanded uncertainty defines a 95% probability interval around 
the mean value in which the unknown true value is found. The relative expanded 
uncertainty is the expanded uncertainty divided with the corresponding introduced 
concentration [15]. For Model 4, the relative expanded uncertainty was not higher than 
7.00% (after exclusion of the data generated during extrusion of the validation mixture 
containing 32.5% MPT (w/w) on day 1). This demonstrates that with a confidence level of 
95%, the unknown true value is found at a maximum of ± 7.00% around the measured 
result. 
 
5.3.3. Evaluation of the robustness of the Raman calibration models 
 
Since Model 4, based on the averaged Raman spectra and developed with MCR resulted in 
the best accuracy profile, the robustness was only assessed for this model. During 
robustness testing, the sensitivity of the responses to small changes in the factors was 
determined. A physical mixture containing 25% MPT, 74.5% Eudragit ® RS PO and 0.5% Mg 
St (w/w) was extruded according to a linear 23-1+3 fractional factorial design, where the 
effects of small changes in barrel temperature (140 – 144°C), throughput (0.275 – 0.325 
kg/h) and screw speed (70 – 90 rpm) on the predicted MPT concentration (response) were 
evaluated (Table 5.3). 
 
The model parameters of interest for robustness evaluation are listed in Table 5.6. An ideal 
result is a Q² near zero, indicating a weak relationship between the factors and the 
response. Model 4 resulted in a Q² of -0.2, demonstrating that the response, i.e. the 
predicted MPT concentration, was robust. A negative Q² suggests a very poor model. 
Besides the calculation of Q², two F-tests were performed. The first F-test, the regression 
model significance test, was used to determine whether the modellable variation in the 
dataset is larger than the residual variation. When p1 is smaller than 0.05, the variance 
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explained by the model is larger than the unexplained variance, and the model is significant 
[18]. For Model 4, the p1 value exceeded the 0.05 reference value, indicating that the model 
was insignificant. A second F-test, the lack of fit test, compared the model error (the fact 
that the model is imperfect) to the replicate error (presence of variation when performing 
replicate experiments) [18]. A p2 value higher than the reference value of 0.05, indicates 
that both errors are small and of the same magnitude. p2 is 0.050 for model 4, 
demonstrating that it showed (or bordered on) lack of fit. From these parameters, it can be 
concluded that there was no significant relationship between the predicted MPT 
concentrations and the small factor changes. Therefore, the response is robust to the 
applied variations in process settings.  
 
Table 5.6. Model parameters of interest for robustness evaluation. 
 
 Q² p1 
(Regression model significance test) 
p2 
(Lack of fit test) 
Model 4 -0,2 0,19 0,05 
CHAPTER 5 – VALIDATION OF AN IN-LINE RAMAN SPECTROSCOPIC METHOD FOR CONTINUOUS API 
QUANTIFICATION DURING PHARMACEUTICAL HOT-MELT EXTRUSION 
116 
 
5.4. CONCLUSION 
 
An in-line Raman spectroscopic method was developed and validated for the determination 
of the active content during pharmaceutical hot-melt extrusion, based on multivariate curve 
resolution modelling of the averaged in-line collected Raman spectra. The method was 
thoroughly validated, and showed good precision, trueness, linearity, specificity and 
accuracy over the applied concentration range. The accuracy profile guaranteed that 95 out 
of 100 future routine measurements will be included within the preset acceptance limits of 
10%. The uncertainty of the measurements was assessed via the uncertainty of bias and the 
expanded uncertainty at each concentration level. The robustness of the response was also 
evaluated, and demonstrated that the determined MPT concentration was insensitive to the 
applied fluctuations in process settings. 
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ABSTRACT 
 
The aim of Chapter 6 was to improve the understanding of material behaviour in 
pharmaceutical hot-melt extrusion by implementing a Raman probe in each section of the 
barrel. FT-IR measurements were performed to confirm the Raman observations. 
Metoprolol tartrate (MPT) concentration (10 and 40% in Eudragit® RS PO (w/w)), extrusion 
temperature (100, 120 and 140°C) and screw speed (80 and 160 rpm) were varied to 
examine their influence on polymer/drug solid state throughout the barrel. When extruding 
a formulation with a 40 (w/w) MPT concentration, broadening of MPT peaks indicates 
melting of MPT between sections 2 and 3 of the extrusion barrel, caused by the presence of 
a first kneading zone. Decreasing the concentration to 10% (w/w) shows an additional 
spectral difference (i.e. peak shifts indicating interactions between MPT and carrier) 
between sections 5 and 6, due to formation of a solid solution. At a 10% MPT load (w/w), 
increasing the extrusion temperature does not influence the solid state or the barrel section 
where the final solid state is obtained. At a drug load of 40% (w/w), the solid state of the 
end product is reached further down the barrel when the temperature decreases. Doubling 
the screw speed when processing a 10% MPT (w/w) formulation does not affect the solid 
state of the product or the location where it is obtained. In contrast, at 40% drug load 
(w/w), the section where the final product is produced, is situated earlier in the barrel when 
a higher speed was applied. The Raman spectra provide real-time information about 
polymer/drug behaviour throughout the barrel, facilitating process understanding and 
optimisation. 
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VISUALIZATION AND PROCESS 
UNDERSTANDING OF MATERIAL BEHAVIOUR 
IN THE EXTRUSION BARREL DURING A HOT-
MELT EXTRUSION PROCESS USING RAMAN 
SPECTROSCOPY 
 
 
6.1. INTRODUCTION 
 
Hot-melt extrusion (HME) is one of the most widely applied processing technologies in the 
plastic, food and rubber industry [1]. In pharmaceutical manufacturing, HME is used to 
obtain formulations where (poorly soluble) drugs are embedded in polymer matrices, 
offering many advantages compared to conventional pharmaceutical processing techniques. 
This processing technique does not require water or solvents; products have a short 
residence time; bioavailability of poorly soluble drugs can be improved; production of 
formulations with controlled, sustained or targeted release is possible and HME is a 
continuous production process [1, 2].  
 
Today, the pharmaceutical industry intends to move from the traditional batch processes 
towards continuous processes, hereby increasing process efficiency and production. 
Continuous processes are based on the ‘one-in-one-out’ principle and offer many 
advantages: no scale-up issues resulting in a shorter development time; possible 
automation of the production line; reduction of production costs; faster product release; 
less product variability and improved product quality [3, 4]. The currently applied quality 
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control methods for intermediate or end products are mainly based on time-consuming and 
off-line analytical techniques, and annul the advantages of continuous pharmaceutical 
production. Evidently, continuous in-process measurements are required to obtain a 
continuous production process. The ICH Q8 guideline on pharmaceutical development 
states that real-time control of drug product quality is recommended rather than end-
product testing on limited samples of the final product [5]. Understanding the sources of 
variability and their impact on drug product quality provides an opportunity to minimize the 
need for end product testing.  
 
Thermal stability of the individual compounds is a requirement for hot-melt extrusion, 
although not all thermolabile compounds are excluded because of the short residence times 
in the extrusion barrel. Another drawback of the hot-melt extrusion technology is related to 
the high energy input from the shear forces in the extrusion barrel, leading to higher, 
uncontrolled product temperatures, which could induce drug or polymer degradation, 
having a significant impact on the product quality [1, 2]. This setback can be overcome by 
adjusting the process parameters as well as the screw design and die, which requires a 
thorough process understanding. Sufficient process understanding can be generated by 
implementing PAT tools such as Raman spectroscopy, allowing the visualization of the 
materials in the process environment and linking these observations to applied process and 
formulation parameters. Appropriate custom made fibre optic probes connected to the 
spectrometer can be implemented into the HME equipment [6]. In-die monitoring of 
formulation parameters such as drug load and solid state during a pharmaceutical hot-melt 
extrusion process, has already been demonstrated using Raman spectroscopy [7] and NIR 
spectroscopy [8]. By using Raman spectroscopy along the extruder barrel, physical and 
chemical properties of the melt throughout the entire barrel can be examined. This will be 
demonstrated in this chapter.  
 
The in-barrel monitoring of melt characteristics and behaviour during twin-screw extrusion 
(TSE) has not yet been reported for pharmaceutical hot-melt extrusion processes, but has 
been investigated in the field of polymer extrusion. An ultrasound in-line monitoring system 
was used to investigate the melting behaviour of linear low density polyethylene and 
polyvinyl chloride compounds in an intermeshing counter-rotating twin-screw extruder [9]. 
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Monitoring of the ultrasound wave attenuation allowed characterization of the melting 
process and uniformity across the screw channels. Various melting phenomena were 
described depending on the selected materials, processing conditions and screw 
configurations. An on-line capillary rheometer was used to measure the rheological 
response of a 12 wt-% polypropylene-based carbon fibre composite after melting in an 
intermeshing co-rotating twin-screw extruder [10]. The recorded torque was used to 
determine the apparent wall shear stress, which is used to calculate the true values for wall 
shear rate and stress. The linear viscoelastic behaviour of linear low-density polyethylene 
(LLDPE) was measured on-line with an oscillatory rheometer [11]. Rheological 
measurements are sensitive to composition, morphology, degree of mixing and 
temperature. Finally, determination of the residence time distribution along a kneading 
block has been performed by on-line monitoring of the light emission of a fluorescent tracer 
at several locations along the extruder [12]. Concentration versus time curves were 
generated to characterize the residence time distribution along a mixing block with 
staggered kneading disks in a twin-screw extruder. 
 
To allow the optimization and to improve the understanding of a pharmaceutical hot-melt 
extrusion process, all process and formulation variables must be considered in combination 
with the behaviour of the melt in the different extruder sections. So far, the majority of the 
PAT tools used in hot-melt extrusion has been inserted between the extruder barrel and the 
die, whereas the major material changes occur within the extruder barrel [11]. The aim of 
this chapter was to improve the understanding of the material behaviour in a 
pharmaceutical hot-melt extrusion process environment by monitoring and visualizing the 
polymer-drug processing throughout the entire extrusion barrel using Raman spectroscopy. 
Additionally, the in-line collected Raman spectra allow to assess the impact of process 
settings such as barrel temperature and screw speed on the interactions between polymer 
and drug. The spectroscopic measurements throughout the barrel might therefore help to 
optimize the process settings, the screw design and the barrel length required to obtain 
extrudates with predefined solid state properties. 
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6.2. MATERIALS AND METHODS 
 
6.2.1. Materials 
 
Metoprolol tartrate (MPT) (Esteve Quimica, Barcelona, Spain) was chosen as model drug. It 
has a melting temperature (Tm) of 120°C. Eudragit
® RS PO (Evonik Rohm, Germany) was used 
as polymer to form the matrix systems. Eudragit® RS PO is an amorphous copolymer of 
acrylic and methacrylic acid esters with a low content of quaternary ammonium groups, 
which are present as salts. It has a glass transition temperature (Tg) of approximately 65°C. 
The solubility parameters of both components are 23.6 MPa½ and 19.7 MPa½ for MPT and 
Eudragit® RS PO, respectively [13]. Components with similar solubility parameters are likely 
to be miscible (t < 7 MPa
½) and components with t > 10 MPa
½ are likely to be 
immiscible. As the difference in total solubility parameter is less than 4 MPa½, a good 
miscibility and possible formation of a solid solution can be expected [14].  
 
6.2.2. Hot-melt extrusion 
 
Hot-melt extrusion was performed with a Prism Eurolab 16 co-rotating, fully intermeshing 
twin-screw extruder (Thermo Fisher Scientific, Germany). The hot-melt extruder was 
equipped with a DD Flexwall® 18 gravimetric feeder (Brabender® Technologie, Germany), 
which was set in its gravimetric feeding mode and supplied the physical mixtures with a 
throughput of 0.3 kg/h. The applied screw configuration is shown in Figure 6.1. The screws 
consist of three kneading blocks, surrounded by transport zones. The kneading elements are 
required for intensive mixing [15], both distributive and dispersive, since they retain the 
melt in the extruder for a longer period under intense shear. Furthermore, they also play a 
key role in transforming the drug from its crystalline to its amorphous form [16]. The first 
kneading block, located in sections 2 and 3, contains five kneading elements at a 30° angle 
towards each other, three elements at a 60° angle and finally four elements at a 90° angle. 
The second, smaller kneading block, in section 4 has only three elements at a 30° angle 
followed by one element at a 60°angle. The final, third kneading element, situated in 
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sections 5 and 6, consists of three kneading elements at a 30° angle, three elements at a 60° 
angle and finally 6 elements at a 90° angle. 
 
 
Figure 6.1. Applied screw configuration. The arrows indicate the insert positions of the Raman probe. 
 
The extruder has a modular design with 6 sections (S) (one feeding zone and 5 barrel 
sections, Figure 6.1) and a die. The temperature of each section can be controlled 
separately, with exception of the feeding zone. MPT concentration (10 and 40% w/w), barrel 
temperature (120 and 140°C, and 100 and 140°C for 10% and 40% MPT (w/w), respectively) 
and screw speed (80 and 160 rpm) were varied during hot-melt extrusion (Table 6.1). The 
temperature of barrel section 2 was kept constant at 70°C to prevent sticking of the physical 
mixture in the feed zone. Each physical mixture was extruded for 25 minutes, where the first 
10 min were process stabilization time, followed by 15 minutes of in-line Raman monitoring. 
 
6.2.3. Raman spectroscopy 
 
Raman spectra were collected with a Raman Rxn1 spectrometer (Kaiser Optical Systems, 
Ann Arbor, MI, USA). A fibre-optic Raman Dynisco probe was built into each of the 5 free 
barrel sections (Figure 6.2), to monitor the physicochemical state of the melt and to 
understand the polymer-drug behaviour throughout the entire extruder barrel during 
extrusion. The diameter of this probe at interface point is 7.7 mm, and the diameter of the 
laser beam on the sample surface is approximately 100 micron. The laser wavelength was 
CHAPTER 6 – VISUALIZATION AND PROCESS UNDERSTANDING OF MATERIAL BEHAVIOUR IN THE EXTRUSION 
BARREL DURING A HOT-MELT EXTRUSION PROCESS USING RAMAN SPECTROSCOPY 
126 
 
the 785 nm line from a 785 nm Invictus NIR diode laser. All spectra were recorded with a 
resolution of 4 cm-1 and an exposure time of two seconds, using a laser power of 400 mW. 
The Raman spectra were acquired in dynamic mode. When determining the acquisition time 
of one spectrum, the signal intensity (and noise) of the sample and the amount of material 
passing by the probe window during this exposure time should be considered. At two 
seconds, the acquisition time is long enough to obtain sufficient signal intensity and at the 
same time short enough to avoid large amounts of material passing by the probe window. 
Spectra were collected every 20 seconds. The analyzed spectral region was 100 – 1800 cm-1, 
since this region contains all useful drug and polymer information. Data collection and data 
transfer were automated using the HoloGRAMSTM data collection software, the 
HoloREACTTM reaction analysis and profiling software and the Matlab software (version 7.1, 
The MathWorks Inc., Natick, MA). 
 
Table 6.1. Extrusion experiments. 
Experiment 
number 
Metoprolol 
tartrate 
Eudragit® 
RS PO 
Barrel temperature 
profile 
Screw 
speed 
 (% w/w) (% w/w) S2-S3-S4-S5-S6-Die (°C) (rpm) 
1 10 90 70-120-120-120-120-120 80 
2 10 90 70-140-140-140-140-140 80 
3 10 90 70-120-120-120-120-120 160 
4 10 90 70-140-140-140-140-140 160 
5 40 60 70-100-100-100-100-100 80 
6 40 60 70-140-140-140-140-140 80 
7 40 60 70-100-100-100-100-100 160 
8 40 60 70-140-140-140-140-140 160 
 
Data analysis was performed using SIMCA P+ (Version 12.0.1.0, Umetrics, Umeå, Sweden). 
Standard normal variate (SNV) pre-processing was applied on the in-line collected spectra 
before principal components analysis (PCA), to remove undesirable scatter effects which 
could be caused by the variation in the angle of incidence from the laser light, and the 
varying probe-sample distance due to the rotating screws. Twenty subsequent spectra of 
CHAPTER 6 – VISUALIZATION AND PROCESS UNDERSTANDING OF MATERIAL BEHAVIOUR IN THE EXTRUSION 
BARREL DURING A HOT-MELT EXTRUSION PROCESS USING RAMAN SPECTROSCOPY 
127 
 
each extrusion experiment (Table 6.1) were selected for PCA. Once an experiment was 
started, a period of 15 minutes was allowed for stabilization of the process. The residence 
time of this formulation is shorter than ten minutes, indicating that the 20 succeeding 
spectra were collected when the process was stable.  
 
 
Figure 6.2. Experimental setup with Raman Dynisco probe mounted in section 2. 
 
6.2.4. Fourier transform infrared spectroscopy (FT-IR) 
 
To confirm the in-line Raman observations, samples were collected for off-line analysis by 
pausing the extrusion operation, opening the extrusion barrel and collecting the samples 
from the screws at the position where the Raman probe is inserted in the barrel. FT-IR was 
selected to confirm the crystallinity of the collected samples. FT-IR measurements were 
performed with a Bruker Vertex 70 FT-IR spectrometer, equipped with a DTGS detector and 
a PIKE accessory, equipped with a diamond ATR crystal. 
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6.2.5. Differential scanning calorimetry (DSC) 
 
Differential scanning calorimetry was performed with a DSC Q 2000 (TA Instruments, 
Belgium). The thermograms were produced with the Thermal Advantage Release 5.1.2 
software and analysed with TA Instruments Universal Analysis 2000 4.7A (TA Instruments, 
Belgium). Hermetically sealed aluminium pans (TA Instruments, Belgium) were filled with 
the samples collected from every barrel section. Measurements were carried out in a 
nitrogen atmosphere. The flow rate of dry nitrogen gas was 50 mL/min. Temperature and 
enthalpic calibration was performed using indium as standard. Samples were subjected to 
three cycles. First, the pans were heated with a heating rate of 10,0°C/min from -30°C up to 
140°C in the first heating cycle. After heating, a cooling cycle was started with a cooling rate 
of -10,0°C/min to -30°C, followed by a second and final heating cycle which was identical to 
the first. 
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6.3. RESULTS AND DISCUSSION 
 
Raman spectra collected during extrusion provide information regarding the 
physicochemical state of the polymer-drug melt and the interactions that occur during 
processing [7]. Broadening of the spectral MPT bands indicates the transition from its 
crystalline state, usually represented by sharp and well defined peaks in the Raman 
spectrum, to its amorphous form. Peak shifts in Raman spectra collected during extrusion 
compared to the spectrum of the physical mixture, are indicative of interactions between 
MPT and Eudragit® RS PO. 
 
6.3.1. Influence of MPT concentration on the solid state of the extrudates 
 
Principal component analysis was applied on the dataset containing the in-line collected 
Raman spectra from all extrusion experiments (800 spectra: 20 spectra per experiment per 
section, 8 experiments, Table 6.1). The loadings of principal component 1 (PC 1) show that 
PC 1 distinguishes between the background signals from the probe itself and the signals 
from the formulation (65% of the total spectral variation) (Figure 6.3a). In TSE, most screw 
elements are not completely filled with material, since TSE is a starve-fed process. The 
background signal from the probe itself contains three peaks, at 418 cm-1, 577cm-1 and 750 
cm-1, with a rather low intensity. These three peaks will be overwhelmed by the spectrum of 
the formulation when the sapphire window of the probe is completely covered by material. 
However, when parts of the sapphire window do not contain material or when the distance 
between this window and the sample increases, these three peaks appear in the collected 
Raman spectra with varying intensity dependent on the percentage of fill of the screw 
element where measurements were performed. In Figure 6.3b, the average spectra of the 
Raman spectra collected during extrusion of mixtures with 40% MPT (w/w) at 140°C with a 
screw speed of 160 rpm in S2 and S6 are shown. The increased level of filling in S6 can be 
distinguished from the loss of intensity of the peaks specific for the Raman probe (indicated 
by the arrows), whereas the intensity of the peaks representing Eudragit® RS PO and MPT at 
600 cm-1 and 640 cm-1 respectively, remains constant. 
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The second principal component (PC 2, capturing 16% of the total variation) describes the 
spectral variation originating from the different applied MPT concentrations during the 
experiments (Figure 6.4). In the loading of PC 2, all positive peaks represent Raman peaks 
originating from MPT, and the negative bands can be found as peaks in the Raman spectrum 
of Eudragit® RS PO. The higher the score value in PC 2, the more MPT is present in the 
extruded mixtures. To eliminate this overwhelming concentration-dependent spectral 
variation when examining differences in polymer/drug solid state, the spectra collected 
during the experiments with different concentration levels are analyzed separately.  
 
 
Figure 6.3. a) Comparison of the PC 1 loading, the spectrum inherent to the probe and the spectrum of the 
Eudragit® RS PO – MPT mixture. b) mean Raman spectra collected during extrusion of a mixture with 40% MPT 
(w/w) at 140°C and with 160 rpm in segments 2 and 6. 
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Figure 6.4. Comparison of the loading from the second principal component (black) and the spectra of pure 
Eudragit® RS PO (red) and MPT (blue). 
 
Figures 6.5a and 6.5b show the PC 1 versus PC 2 scores scatterplot of the Raman spectra 
collected during the extrusion experiments with a drug load of 10% (w/w) (experiments 1 to 
4, Table 6.1) and 40% MPT (w/w) (experiments 5 to 8, Table 6.1), respectively. PC 1 captures 
the variation in the Raman spectra caused by differences in degree of filling in the screw 
elements. This component describes 76% of the total spectral variation of the 40% MPT 
(w/w) spectra and 78% of the total variation of the 10% MPT (w/w) spectra. PC 2, 
representing 13% of the variation of both the 40% MPT (w/w) spectra and 10% MPT (w/w) 
spectra, explains the spectral differences in the solid state of MPT (Figure 6.6). In this figure, 
the PC 2 loading is compared to the mean spectra collected in sections 2 and 6 during an 
extrusion experiment of a mixture with a drug load of 40% (w/w), at a temperature of 100°C 
and with a screw speed of 160 rpm (Table 6.1, experiment 7). Positive peaks in this loading 
represent MPT in its crystalline form, and can be found in the spectra gathered in section 2, 
where the Raman probe is still collecting spectra of the physical mixture. The sharp negative 
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peaks represent the amorphous MPT that has interacted with the polymer, causing peak 
shifts in the spectra of section 6 compared to section 2. 
 
 
 
Figure 6.5. PC 1 versus PC 2 scores scatterplots of in-line collected Raman spectra of all extrusion runs with 
mixtures containing a) 10% MPT, and b) 40% MPT (w/w). (red = spectra collected in S2, blue = S3, purple = S4, 
green = S5, black = S6). 
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Figure 6.6. Comparison of the PC 2 loading (red) with the spectra collected in sections 2 (blue) and 6 (green) 
during extrusion of a mixture containing 40% MPT (w/w) with a screw speed of 160 rpm and at a temperature 
of 100°C. 
 
At a high drug load (40% MPT (w/w), Figure 6.5.b), the variation between the Raman spectra 
collected in section 2 and section 3 is larger compared to the variation between other 
neighbouring sections (i.e. sections 3 and 4, sections 4 and 5, sections 5 and 6) according to 
PC 2. This indicates that the main changes in solid state, caused by the melting of MPT, 
occur at this position in the extrusion barrel. The Raman spectra (Figure 6.7) illustrate peak 
broadening in the absorption bands of MPT and peak shifts when the melt arrives in section 
3, compared to the material in section 2. This is primarily caused by the retention of the 
melt between both sections, due to the presence of the first kneading block. The melt is 
subjected for a longer time to the higher temperature and shear forces between section 2 
and 3, causing MPT to melt. Although extrusion at 100°C is performed at a set temperature 
20°C below the melting temperature of the drug, the addition of kneading zones allows 
melting of MPT due to input of mechanical energy generated by the high shear forces 
applied on the mixture. When looking more in detail at Figure 6.5.b, an additional difference 
between sections 5 and 6 is present in the PC 1 versus PC 2 scores scatterplot of the mixture 
containing 40% MPT (w/w) which was extruded at 140°C with a screw speed of 160 rpm 
(black data points outside the ellipse) (Table 6.1, experiment 8). The high temperature and 
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high shear forces originating from the increased screw speed allow the formation of a solid 
solution in section 6, which was not stable due to the high drug load of the extrudate. 
 
Figure 6.7. Detail of the Raman spectra collected in barrel sections 2 and 3 during extrusion of mixtures 
containing 40% MPT (w/w) at all screw speed settings at a) 100°C and b) 140°C. 
 
When extruding a mixture with a low drug load (10% MPT (w/w), Figure 6.5.a), a similar 
variation between section 2 and section 3 is observed. However, in contrast to the 
experiments at higher drug load, an additional difference can also be noticed between the 
last two sections of the barrel. At a 40% drug load (w/w), MPT melt when passing through 
the first kneading zone due to the higher temperature and shear forces in section 3 and a 
solid glassy suspension is produced, but a solid solution is not formed, due to the high drug 
load. In the extrudates with a 10% drug load (w/w), the final kneading zone, located in 
section 5 facilitates the dissolution of the drug into the polymer matrix and a complete solid 
solution is created due to shear forces. The formation of a solid solution was confirmed by 
the DSC thermograms from the samples collected in section 6 (Figure 6.8). All thermograms 
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exhibit only one Tg, and no melting peaks for MPT are visible. This indicates that MPT is 
dissolved into the polymer and that a one phase system is created when the melt passes 
through the final kneading zone in section 5. The extrudates created with a 10% MPT 
concentration (w/w) are all transparent, in contrast with the opaque end products 
containing 40% MPT (w/w). 
 
 
Figure 6.8. DSC thermograms of samples collected in barrel section 6 from all extrusion runs with mixtures 
containing 10% MPT (w/w). 
 
The off-line FT-IR measurements of the samples collected in the barrel confirm that 
extrusion of physical mixtures containing 10% MPT (w/w) results in the formation of a solid 
solution for all experimental runs. The IR spectra from the samples collected in section 6 
during all 10% MPT (w/w) experiments (Table 6.1, experiments 1-4) show that the IR 
absorption bands of the polymer are more explicitly present in both the fingerprint area and 
the X-H region, indicating the dissolution of MPT into the polymer (data not shown). In the 
spectral region of 3000 cm-1 – 3100 cm-1 [17], the absence of OH stretch vibrations of 
alcohol groups in the spectra collected in section 6 shows that all MPT molecules have 
interacted with the polymer through the formation of hydrogen bonds, and that there are 
no independent MPT molecules present. In sections 2 to 5, peaks representing these 
vibrations can still be detected. The hydrogen bond formation is thus facilitated by the 
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kneading zone located in section 5. These OH stretch vibrations and other absorption bands 
specific for MPT are still present in spectra obtained in section 6 from all extrusion runs with 
mixtures of 40% MPT (w/w). However, in-line Raman spectra indicated an additional 
difference when extrusion was performed at a temperature of 140°C and with a screw 
speed of 160 rpm (Table 6.1, experiment 8). This difference between in-line collected 
Raman spectra and off-line gathered FT-IR spectra can be explained by the instability of this 
solid solution, containing a high drug load. The time delay between extrusion and collection 
of the FT-IR spectrum was sufficient for MPT to recrystallize. This recrystallization is caused 
by the decrease in temperature when the samples are taken from the screws and barrel. 
 
6.3.2. Influence of the barrel temperature on the solid state of the extrudates 
 
Since the extruder barrel is modular, the temperature can be set for each section 
individually. A straight temperature profile [18] was used, where the temperature of section 
2 was kept at 70°C throughout all experiments, and the temperatures of sections 3 to 6 
were set according to Table 6.1. Physical mixtures with a drug load of 10% (w/w) could not 
be extruded at temperatures below 120°C, as the extrusion torque exceeded its limits. MPT 
has a plasticizing effect on Eudragit® RS PO [7], allowing extrusion of the physical mixture 
containing 40% (w/w) MPT at a barrel temperature of 100°C. 
 
During extrusion of the physical mixtures containing 10% MPT (w/w), there is no noticeable 
spectral variation related to solid state caused by varying the barrel temperature, since the 
actual product temperature exceeds the melt temperature of the drug in all cases. 
 
The PC 1 versus PC 2 scores scatterplot of the spectra collected during extrusion of a 
mixture containing 40% MPT (w/w) applying a screw speed of 80 rpm (Fig 6.9.a) (Table 6.1, 
experiments 5 and 6) shows clustering into three different groups (along PC 2) at both 
temperatures. A first group represents the physical mixture as measured in section 2, 
followed by a second cluster where MPT is molten. In the third group, some of the MPT has 
interacted with the polymer, inducing spectral shifts, but there still are molten MPT 
molecules that did not interact with the polymer present in the mixture. An increase of 40°C 
in temperature does not affect the solid state of the end product, but it does determine 
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how fast the solid state of the final product is reached. When extruding at 100°C, this end 
state is reached in section 6, with the help of the kneading zone located ahead of this 
section. This kneading zone is not required at a barrel temperature of 140°C, since the final 
solid state is attained in section 4. These observations can be found in the Raman spectra 
collected during extrusion as well (Figure 6.9.b). The peak situated at 812 cm-1 represents 
the C-C stretching vibration of Eudragit® RS PO [19], and the peak located at 819 cm-1 
corresponds to the out-of-plane vibration of the COOH groups of MPT [17]. This peak 
becomes wider when the mixture reaches a temperature higher than 120°C, due to the 
melting of MPT.  
 
 
Figure 6.9. a) PC 1 versus PC 2 scores scatterplot of the in-line collected Raman spectra during extrusion of 
mixtures containing 40% MPT (w/w) with a screw speed of 80 rpm at 100°C and 140°C and b) mean Raman 
spectra collected in all different sections during extrusion of mixtures containing 40% MPT (w/w) with a screw 
speed of 80 rpm at 100°C and 140°C. 
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When extruding the 40% MPT (w/w) mixture with a screw speed of 160 rpm (Table 6.1, 
experiments 7 and 8), an increase in barrel temperature from 100°C to 140°C enables the 
formation of an instable solid solution, as previously mentioned. Since a high screw speed is 
applied, shear forces on the material are much higher, and the additional energy input due 
to the higher barrel temperature allows the molecular dispersion of MPT into the polymer. 
 
6.3.3. Influence of the rotational screw speed on the solid state of the extrudates 
 
The second process parameter which was varied throughout the experiments, was the 
rotational screw speed (80 - 160rpm). In a twin-screw extruder, the screw speed is a critical 
parameter in controlling mixing of polymer, drug and excipients; melting behaviour; 
pressure and melt temperature [18]. The selected screw speed determines the percentage 
of fill of the screws, the residence time of materials in the extruder and the torque level. An 
increase in screw speed (for a constant barrel temperature profile and throughput) will 
result in a higher shear rate [20] which reduces the viscosity of the melt due to the shear 
thinning effect, resulting in a lower torque. Moreover, higher screw speeds raise the melt 
temperature, reducing the torque level as well. Additionally, a higher screw speed results in 
improved mixing, a shorter residence time and a lower percentage of screw fill [18]. 
 
The PC 1 versus PC 2 scores scatterplot of the in-line collected Raman spectra during 
extrusion of a mixture containing 10% MPT (w/w) at 120°C (Figure 6.10.a) (Table 6.1, 
experiments 1 and 3) demonstrates that at both screw speeds, three different groups can be 
distinguished regarding solid state (PC 2). A first group includes the spectra collected in 
section 2, which show sharp peaks for MPT. This mixture still contains crystalline MPT. A 
second cluster displays the spectra obtained in sections 3, 4 and 5, where MPT is molten. 
The third and final group shows the Raman spectra from section 6 where MPT molecules 
have interacted with the polymer and a solid solution is produced. In this figure, it can be 
seen that doubling the screw speed does not have an impact on the solid state of the final 
product, since the spectra in section 6 show a similar solid state for both 80 and 160 rpm. 
However, a small difference caused by changes in screw speed can be noticed in-line, more 
specific in sections 3, 4 and 5. The higher screw speed increases the shear rate and the melt 
temperature, which results in a solid state that leans more towards the solid state of the 
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end product than when using a low screw speed. This small difference in solid state can be 
distinguished in the Raman spectra collected in sections 3, 4 and 5 during extrusion (Figure 
6.11a). The spectra display larger peak shifts at a screw speed of 160 rpm compared to 80 
rpm, indicating stronger interactions between the polymer and the drug. The same results 
can be observed during extrusion of a mixture with 10% MPT (w/w) at 140°C (Table 6.1, 
experiments 2 and 4). 
 
 
Figure 6.10. PC 1 versus PC 2 scores scatterplots of the in-line collected Raman spectra during extrusion of 
mixtures containing 10% MPT (w/w) at a temperature of 120°C and with screw speeds of 80 and 160 rpm (a), 
and mixtures containing 40% MPT (w/w) at a temperature of 140°C and with screw speeds of 80 and 160 rpm 
(b). (red = 80 rpm, blue = 160 rpm). 
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During extrusion of a mixture containing 40% MPT (w/w) at 140°C (Table 6.1, experiments 6 
and 8), changes in screw speed have a significant impact on the solid state of the end 
product (Figure 6.10.b). In this case, an increase of the screw speed from 80 rpm to 160 rpm 
enables the formation of a solid solution with a drug load of 40% (w/w), as shown in the 
difference in solid state (PC 2) in section 6 for both screw speeds. Even though a higher 
screw speed reduces the residence time, the higher shear forces and temperature induce 
interactions between polymer and drug, which can be noticed in the spectra obtained in 
section 6 (Figure 6.11b). The kneading zone located between sections 5 and 6 facilitates the 
formation of a solid solution in this extrusion run. However, due to the high MPT 
concentration, the produced solid solution is instable and recrystallizes during cooling at 
room temperature. It can also be noticed that the PC 2 scores for section 2 and 3 of the 
extrusion run at 140°C and 160 rpm (Table 6.1, experiment 8) have almost identical values 
for PC 2. This could be due to conduction of heat in the mixture that is retained in front of 
the kneading zone between these sections of the barrel, which initiates MPT melting even 
before it reaches the kneading zone.  
 
At 100°C (Table 6.1, experiments 5 and 7), doubling of the screw speed does not influence 
the solid state of the end product (data not shown). However, it does change the location in 
the barrel where this solid state is reached. When extruding at a screw speed of 80 rpm, the 
solid state corresponding to the final product is obtained in section 6, as a result of the 
kneading element located between sections 5 and 6 which increases the shear forces on the 
melt. At higher screw speed, the solid state of the end product is already obtained in section 
5, without the requirement of additional kneading elements, since the higher screw speed 
induces higher shear forces earlier in the barrel. Consequently, increasing the screw speed 
during extrusion of mixtures with a high drug load reduces the number of barrel sections 
required to obtain the end product. By reducing the barrel length, the mean residence time 
and therefore the time in which the mixture is in contact with a high temperature can be 
decreased, avoiding degradation problems. 
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Figure 6.11. Detail of the mean Raman spectrum collected in barrel sections 3, 4 and 5 during extrusion of 
mixtures containing 10% MPT (w/w) at 120°C, with a screw speed of 80 rpm (red) and 160 rpm (blue). b) Detail 
of the mean Raman spectrum collected in barrel sections 3, 4 and 5 during extrusion of mixtures containing 
40% MPT (w/w) at 140°C, with a screw speed of 80 rpm (red) and 160 rpm (blue). 
 
Throughout the experiments it has also been demonstrated that the second kneading zone, 
located in section 4, does not have a relevant influence on the solid state of this 
formulation. Almost no differentiation can be detected between spectra collected in 
sections 3, 4 and 5. This second, smaller kneading zone does not affect the extrusion process 
for this formulation.  
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6.4. CONCLUSION 
 
Raman spectroscopy is a suitable PAT-tool for the monitoring of the polymer-drug solid 
state during hot-melt extrusion. By implementing the probe in the different sections of the 
extruder barrel, a complete visualization and improved understanding of the polymer-drug 
behaviour throughout the entire extrusion barrel is gained, leading to a more profound 
understanding of the hot-melt extrusion process. The impact of variations in process and 
formulation parameters on the physicochemical state of the extrudates was evaluated in 
the different barrel sections, allowing the optimization of barrel and screw design 
depending on the selected settings and formulation. The spectroscopic visualisation of the 
entire extrusion barrel might therefore be helpful to optimize the process settings, the 
screw design and the barrel length required to obtain extrudates with predefined solid state 
properties.  
 
CHAPTER 6 – VISUALIZATION AND PROCESS UNDERSTANDING OF MATERIAL BEHAVIOUR IN THE EXTRUSION 
BARREL DURING A HOT-MELT EXTRUSION PROCESS USING RAMAN SPECTROSCOPY 
143 
 
6.5. REFERENCES 
 
[1] J. Breitenbach, J. Eur J Pharm Biopharm 54 (2002) 107-1171. 
[2] M.M. Crowley, F. Zhang, M.A. Repka, S. Thumma, S.B. Upadhye, S.K. Battu, J.W. 
McGinity, C. Martin, Drug Dev Ind Pharm 33 (2007) 909-926. 
[3] C. Vervaet, J.P. Remon, Chem Eng Sci 60 (2005) 3949-3957.  
[4] K. Plumb, Chem Eng Res Des 83 (2005) 730-738. 
[5] International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use, Pharmaceutical Development Q8 
(R2), 2009. 
[6] T. De Beer, A. Burggraeve, M. Fonteyne, L. Saerens, J.P. Remon, C. Vervaet, Int J 
Pharm 417 (2011) 32-47. 
[7] L. Saerens, L. Dierickx, B. Lenain, C. Vervaet, J.P. Remon, T. De Beer, Eur J Pharm 
Biopharm 77 (2011) 158-163. 
[8] L. Saerens, L. Dierickx, T. Quinten, P. Adriaensens, R. Carleer, C. Vervaet, J.P. Remon, 
T. De Beer, Eur J Pharm Biopharm 81 (2012) 230-237. 
[9] D. Wang, K. Min, Polym Eng Sci 45 (2005) 998-1010. 
[10] C.W. Macosko, Rheology: Principles, Measurements and Applications, 1st ed., Wiley-
VCH, New York, USA, 1994. 
[11] J.A. Covas, O.S. Carneiro, P. Costa, P.; A.V. Machado, J.M. Maia, Plast Rubber Compos 
33 (2004) 55-61. 
[12] O.S. Carneiro, J.A. Covas, J.A. Ferreira, M.F. Cerqueira, Polym Test 23 (2004) 925-937. 
[13] J. Breitkreutz, Pharm Res 15 (1998) 1370–137. 
[14] A. Forster, J. Hempenstall, I. Tucker, T. Rades, Int J Pharm 226 (2001) 147-161. 
[15] E. Verhoeven, T.R.M. De Beer, G. Van den Mooter, J.P. Remon, C. Vervaet, Eur J 
Pharm Biopharm 69 (2008) 312-319. 
[16] K. Nakamichi, T. Nakano, H. Yasuura, S. Izumi, Y. Kawashima, Int J Pharm 241 (2002) 
203-211. 
[17] A. Bright, T.S. Renuga Devi, S. Gunasekaran, ChemTech 2 (2010) 379-388. 
[18] H.F. Giles Jr., J.R. Wagner Jr., E.M. Mount III, Extrusion: The Definitive Processing 
Guide and Handbook, 1st ed., William Andrew, Inc., New York, USA, 2005. 
CHAPTER 6 – VISUALIZATION AND PROCESS UNDERSTANDING OF MATERIAL BEHAVIOUR IN THE EXTRUSION 
BARREL DURING A HOT-MELT EXTRUSION PROCESS USING RAMAN SPECTROSCOPY 
144 
 
[19] M. De Veij, P. Vandenabeele, T. Beer, J.P. Remon, L.J. Moens, Raman spectrosc 40 
(2008) 297-307. 
[20] H. Liu, P. Wang, X. Zhang, F. Shen, C.G. Gogos, Int J Pharm 383 (2010) 161-169. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7 – IN-LINE SOLID STATE PREDICTION DURING PHARMACEUTICAL HOT-MELT EXTRUSION IN A 12 MM 
TWIN SCREW EXTRUDER USING RAMAN SPECTROSCOPY 
145 
 
 
 
 
 
CHAPTER 7 
 
IN-LINE SOLID STATE PREDICTION 
DURING PHARMACEUTICAL HOT-MELT 
EXTRUSION IN A 12 MM TWIN SCREW 
EXTRUDER USING RAMAN 
SPECTROSCOPY 
 
 
 
 
 
 
 
 
Parts of this chapter are published in: 
 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, J. Manz, R. Krüger, S. Krüger, C. Vervaet, 
J.P. Remon, T. De Beer. In-line solid state prediction during pharmaceutical hot-melt 
extrusion in a 12 mm twin-screw extruder using Raman spectroscopy. Submitted to 
European Journal of Pharmaceutics and Biopharmaceutics (2013). 
CHAPTER 7 – IN-LINE SOLID STATE PREDICTION DURING PHARMACEUTICAL HOT-MELT EXTRUSION IN A 12 MM 
TWIN SCREW EXTRUDER USING RAMAN SPECTROSCOPY 
146 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
In Chapter 7, Raman spectroscopy was used for the in-line monitoring of the solid state of 
materials during pharmaceutical hot-melt extrusion in the die head of a 12 mm 
(development scale) twin-screw extruder during formulation development.  
A full factorial (mixed) design was generated to determine the influence of variations in 
concentration of Celecoxib (CEL) in Eudragit® E PO, three different screw configurations and 
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varying barrel temperature profiles on the solid state, melt temperature and die pressure of 
continuously produced extrudates in real-time. Off-line XRD and DSC analysis were used to 
evaluate the suitability of Raman spectroscopy for solid state predictions. First, principal 
component analysis (PCA) was performed on all in-line collected Raman spectra from the 
experimental design. The resulting PC 1 versus PC 2 scores plot showed clustering according 
to physicochemical state of the extrudates, and two classes, one class where crystalline CEL 
is still present and a second class where no crystalline CEL was detected, were found. Then, a 
soft independent modelling of class analogy (SIMCA) model was developed, by modelling 
these two classes separately by disjoint PCA models. These two separate PCA models were 
then used for the classification of new produced extrudates and allowed distinction between 
glassy solid solutions of CEL and crystalline dispersions of CEL. All extrudates were classified 
similarly by Raman spectroscopy, XRD and DSC measurements, with exception of the 
extrudates with a 30% CEL concentration (w/w) extruded at 130°C. The Raman spectra of 
these experiments showed bands which were sharper than the amorphous spectra, but 
broader than the crystalline spectra, indicating the presence of CEL that has dissolved into 
the matrix and CEL in its crystalline state. XRD and DSC measurements did not detect this. 
Modifications in the screw configuration did not affect the solid state and did not have an 
effect on the solid state prediction of new produced extrudates. 
Secondly, the influence of variations in die pressure on the Raman spectra was examined. 
The applied drug concentration, processing temperature and feeder performance influence 
the die pressure, which was reflected in the Raman spectra as a change in spectral intensity. 
When applying PCA on the raw spectra from the experimental design, the first principal 
component described the influence of die pressure on the spectra, which was seen as a 
decrease in Raman intensity of the whole spectrum when the pressure in the sample 
increased. Clustering according to processing temperature was found, although the 
temperature in the die remained constant, indicating that a difference in viscosity, resulting 
in a changed die pressure, was detected. When the feeder was stopped, the score values of 
the first principal component almost simultaneously decreased, and only stabilized once the 
die pressure became stable. Since Raman spectra collected in the extrusion die are 
influenced by changes in die pressure, disturbances upstream of the extrusion process can 
be observed and identified in the Raman measurements. 
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7.1. INTRODUCTION 
 
The high throughput screening of potential therapeutic agents has increased the amount of 
poorly soluble drug candidates. In the Biopharmaceutical Classification System (BCS), many 
active pharmaceutical ingredients (APIs) such as Celecoxib (CEL) have been categorized as 
Class II, implying that they have a high permeability, but a low aqueous solubility. The 
bioavailability of this type of compounds is limited by their dissolution rate. The low water 
solubility of these compounds makes it challenging to formulate them for oral delivery. 
Several manners of improving the dissolution of the drug have been proposed [1], but the 
preferred option to enhance the solubility and therefore the bioavailability of the drug is 
through formulation approaches. Presenting the compound as a solid dispersion will reduce 
the particle size of the API, improve the wettability, increase the porosity, and allow the 
formulation of drugs in their amorphous state [2]. The current method of choice for the 
manufacturing of solid dispersions is hot-melt extrusion (HME) [1]. Melt extrusion has 
several advantages over solvent based methods for the formation of glass solid solutions 
(solid dispersions where the API is completely dissolved in an amorphous carrier). When 
applying solvent evaporation methods, the first challenge is to find a solvent in which both 
API and carrier are soluble [3]. Other disadvantages of solvent methods include difficulties of 
removing the residual (organic) solvent, toxicity issues due to residual solvent, the 
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requirement of a secondary drying step and possible ecological problems [1, 2, 4]. Using hot-
melt extrusion to produce solid dispersions requires high processing temperatures, but 
avoids the need for solvents. Furthermore, HME is a one step continuous process with 
decreased ecological implications. It has been shown that glassy solid solutions of CEL can be 
produced via hot-melt extrusion using several polymer carriers, each increasing the 
dissolution rate of the drug [5, 6]. 
 
Process analytical tools such as Raman spectroscopy can provide in-line and real-time 
information about critical process and formulation parameters. Raman spectroscopy has 
been used off-line in previous studies for the physical characterization of solid dispersions. It 
can be applied to determine the type of solid dispersion (solid solution, glass suspension, 
etc.), the solid state of the API and polymers and the occurring molecular interactions 
between polymer and drug [6-9]. Custom made fibre optic probes connected to the 
spectrometer can be implemented into the HME equipment [10]. In-die monitoring of solid 
state and molecular interactions during a pharmaceutical hot-melt extrusion process has 
already been demonstrated using Raman spectroscopy [9] and NIR spectroscopy [11]. In this 
chapter, the application of Raman spectroscopy as a PAT tool during formulation 
development and to determine the influence of varying process settings on the material 
properties was demonstrated. Therefore, the physicochemical properties of the melt were 
determined in-line during hot-melt extrusion on a 12 mm development scale twin-screw 
extruder with low material need, avoiding the dissipation of materials and making off-line 
analysis redundant.  
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7.2. MATERIALS AND METHODS 
 
7.2.1. Materials 
 
Celecoxib (CEL) (Selectchemie, Zürich, Switzerland) was selected as a model drug. CEL is an 
example of a poorly soluble (BCS Class II) drug with a water solubility of 3-7 mg/L and a 
melting temperature (Tm) of 163°C. The polymer Eudragit® E PO (Evonik®, Weiterstadt, 
Germany) was used to form the matrix system. It is a cationic copolymer based on 
dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate. Eudragit® E 
PO is an amorphous polymer, used to create the matrix in which CEL is dissolved. 
 
The solubility parameters of both components were calculated with SPWin, version 2.11 
[12], to give an indication of miscibility of polymer and drug. The calculated values were 26.7 
MPa½ and 19.7 MPa½ for CEL and Eudragit® E PO respectively. For components with a 
difference in solubility parameters (t) smaller than 7.0 MPa
1/2, miscibility is likely, whereas 
components with t > 10 MPa
½ are expected to be immiscible [13]. When t lays between 
5 MPa1/2 and 10 MPa1/2, prediction of glass solution formation requires further investigation 
with thermal analysis. As the difference in total solubility parameters is 7.0 MPa½, further 
DSC measurements were performed to assess the solubility of CEL in Eudragit® E PO.  
 
Physical mixtures of both components were prepared with a Turbula® T2F mixer (Willy A. 
Bachofen GmbH, Muttenz, Switzerland). The concentration of CEL was varied between 30% 
and 50% (w/w) in Eudragit® E PO throughout the experiments (Table 7.1). 
 
7.2.2. Hot-melt extrusion 
 
Hot-melt extrusion was performed with a development scale co-rotating twin-screw 
extruder with a screw diameter of 12mm (PTSE 12/36, Brabender® Pharma, Duisburg, 
Germany). The extruder was equipped with a loss in weight feeder (Brabender® Technologie, 
Duisburg, Germany), which was used in its gravimetric feeding mode and supplied the
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Table 7.1. Performed extrusion experiments (full factorial (mixed) screening design). 
 
 Process and formulation settings Responses 
Experiment Drug load Screw Barrel temperature profile Melt temperature Die pressure PC 1 
number (% w/w) Configuration (feeding zone → die) (°C) in die (°C) (bar) Score values 
1 30 FF 20-70-130-130-130-110 110,90 13,77 4,5461 
2 30 FF 20-70-150-150-150-110 113,58 11,22 -3,4645 
3 30 FB 20-70-130-130-130-110 111,31 18,28 2,6151 
4 30 FB 20-70-150-150-150-110 114,20 16,36 -4,1576 
5 30 2F 20-70-130-130-130-110 111,11 16,65 1,9484 
6 30 2F 20-70-150-150-150-110 113,70 15,67 -3,1045 
7 50 FF 20-70-130-130-130-110 111,35 16,89 8,7996 
8 50 FF 20-70-150-150-150-110 114,06 7,75 -4,8359 
9 50 FB 20-70-130-130-130-110 111,00 11,93 11,5758 
10 50 FB 20-70-150-150-150-110 113,35 5,81 -5,7765 
11 50 2F 20-70-130-130-130-110 111,18 14,45 8,0646 
12 50 2F 20-70-150-150-150-110 113,55 7,11 -4,5921 
13 40 FB 20-70-140-140-140-110 112,20 10,63 -2,3848 
14 40 FB 20-70-140-140-140-110 112,01 10,77 -5,5010 
15 40 FB 20-70-140-140-140-110 112,11 11,27 -3,7324 
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physical mixtures with a throughput of 1.5 g/min. Three different screw configurations were 
applied during experiments (Table 7.1): the first configuration included 2 consecutive 
forward kneading elements (FF), a second configuration contained a forward kneading 
element followed by a backward kneading element (FB), and the third screw setup 
comprised 2x2 consecutive forward kneading elements (2F) (Figure 7.1). The FF 
configuration will induce the lowest amount of shear on the mixture and will result in the 
shortest residence time. When the shear forces on the mixture increase, and the time of 
exposure to a high temperature becomes longer, the formation of a glass solution will be 
facilitated. Shear forces and residence time values will increase when two more forward 
kneading elements are added to the design, or when a forward kneading element is replaced 
by a backward kneading element. The impact of these design alterations is expected to be 
more distinct at lower processing temperatures than at the higher barrel temperatures. The 
processing temperature was varied from 130°C to 150°C throughout the experiments, and 
the die temperature was kept constant (110°C) for each experiment to guarantee a solid end 
product (Table 7.1). Logging of the extrusion settings (throughput, screw speed, barrel and 
die temperature) and parameters (actual barrel, die and product temperature, actual 
throughput, actual screw speed, die pressure, motor load) was performed with the 
WinExtXT® software (Brabender® Pharma, Duisburg, Germany). Extrudate samples were 
collected during the experiments and stored at room temperature. 
 
 
Figure 7.1. Applied screw configurations: FF, FB and 2F. 
 
7.2.3. Raman spectroscopy 
 
Both in-line and off-line Raman spectra were collected with a Raman Rxn1 spectrometer 
(Kaiser Optical Systems, Ann Arbor, MI, USA). For in-line measurements, a fibre-optic Raman 
Dynisco probe was built into the die head (Figure 7.2), to monitor the physicochemical state 
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of the extrudate before it is forced through the die. The laser wavelength was the 785 nm 
line from a 785 nm Invictus NIR diode laser. All in-line collected spectra were recorded with a 
resolution of 4 cm-1 and an exposure time of one second, using a laser power of 400 mW. 
Spectra were collected every 20 seconds. The analyzed spectral region was 100 – 1800 cm-1, 
since this region contains all envisaged drug and polymer information. Prior to data analysis, 
SNV pre-processing was applied on the in-line collected spectra to eliminate the additive 
baseline offset variations and multiplicative scaling effects in the spectra, induced by 
pressure variations at the measurement point. 
 
Figure 7.2. Experimental setup. 1) Extruder control panel, 2) Feeder control panel, 3) Feeder unit, 4) Extrusion 
barrel, 5) Extrusion die with implemented Raman probe. 
 
After storage of the samples collected during extrusion at room temperature for one year, 
off-line Raman spectra of the extrudates were collected to verify the stability of the end 
products. These spectra were recorded with a resolution of 4 cm-1 and an exposure time of 
five seconds, using a laser power of 400 mW. 
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7.2.4. Data collection, alignment and analysis 
 
An experimental design (Table 7.1) was created using the MODDE software (version 9.1.0.0, 
Umetrics, Umeå, Sweden) to study the influence of the above described factors (drug load, 
screw configuration and processing temperature) on extrusion. The applied design was a full 
factorial (mixed) screening design with two quantitative factors, CEL concentration and 
processing temperature, and screw configuration as a qualitative factor with three levels (FF, 
FB and 2F, Figure 7.1). The monitored responses in the design were the melt temperature as 
measured by the temperature probe in the die head, die pressure and the physicochemical 
state of the extrudates, which was monitored with Raman spectroscopy. Data collection 
during each design experiment (Raman spectral data + logged data) and data alignment 
were automated using the SIPAT software (Siemens NV, Brussels, Belgium) and SIMCA Q 
(Umetrics, Umeå, Sweden). Raman spectral data analysis was performed using SIMCA P+ 
(version 12.0.1.0, Umetrics, Umeå, Sweden).  
 
The analysed spectral region was the region from 0 to 1800 cm-1. Since the formulation 
coloured slightly yellow (due to the use of Eudragit® E PO) during extrusion, the background 
signal of all Raman spectra gained intensity. Coloured substances will absorb laser beam 
energy, and generate fluorescence which contaminates the Raman spectrum. However, the 
peaks of CEL were still detectable in the in-line collected spectra. Soft independent 
modelling of class analogy (SIMCA) was used to distinguish between extrudates containing 
crystalline CEL, and extrudates where a glassy solid solution was formed, where CEL is 
molecularly dissolved into the polymer matrix. Therefore, principal component analysis 
(PCA) was in first instance performed on all spectra collected during the design experiments 
(Table 7.1), hence providing a general overview of the data and giving an indication of 
present class separation (i.e., glassy solid solution versus crystalline suspension), trends and 
outliers [14]. Subsequent to this initial overview, each class of observations determined from 
this PCA was modelled separately by disjoint PCA models. These two separate PCA models 
were then used to predict a likely class membership for new observations. Based on the 
residual variation of each class, the distance to the model (DModX) for each (new) 
observation can be calculated [14]. DModX values are calculated by Eq. (7.1): 
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Where eik are the sum-squared residuals after projection of the observation on the PCA 
model of a certain class, A is the number of principal components retained to model this 
class and K is the number of variables. A critical distance (Dcrit) to the model is calculated 
(from the F-distributed values of the residual standard deviation of each observation divided 
by the pooled residual standard deviation of the model) and is set at the 0.05 probability 
level. When the probability of belonging to the model is higher than 95%, the observation is 
considered as a member of that particular class. Observations that do not fit any class, i.e. 
observations found outside Dcrit are considered as either outliers or members of a new, 
unseen class. In a Coomans’ plot, DModX values for two classes are plotted against each 
other in a scatter plot. By plotting the class membership limits (Dcrit) as well, four areas of 
diagnostic interest are created. The upper left-hand and lower right-hand area contain 
observations belonging to one of both classes can be found. In the lower left-hand area of 
the plot, there is a region where prediction set samples that fit both models are found, and 
in the upper right-hand area the observations that do not conform with either of the models 
are found. 
 
The ability of a class model to classify observations correctly cannot be realistically assessed 
if only training set samples are considered. It is recommended that an independent 
prediction set of observations that has not influenced the model calculations is employed. 
This will enable a more realistic assessment of the classification performance of each model 
[14]. The classification model developed for classification of new samples was implemented 
in the SIPAT software, and applied for real-time data analysis and solid state predictions of 
new runs.  
 
7.2.5. Differential scanning calorimetry 
 
From each experiment (Table 7.1), samples were collected after extrusion. Differential 
scanning calorimetry was performed with a DSC Q 2000 (TA Instruments, Belgium). The 
thermograms were produced with the Thermal Advantage Release 5.1.2 software and 
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analysed with TA Instruments Universal Analysis 2000 4.7A (TA Instruments, Belgium). 
Hermetically sealed aluminium hermetic pans (TA Instruments, Belgium) were used to 
contain the samples. Measurements were carried out in a nitrogen atmosphere. The flow 
rate of dry nitrogen gas was 50 mL/min. Samples were subjected to three cycles. First, the 
pans were heated with a heating rate of 10,0 °C/min from 0°C up to 200°C in the first heating 
cycle. Then, a cooling cycle was started with a cooling rate of -10,0 °C/min to 0°C, followed 
by a second and final heating cycle which was identical to the first. The results from the first 
heating cycle reflect the influences of the hot-melt extrusion processing on the mixture, 
whereas the second heating cycle provides insight in the possible interactions between both 
pure components. 
 
7.2.6. X-ray powder diffraction 
 
The crystallinity of CEL was assessed using X-ray diffraction on the pure compounds, the 
physical mixtures and the produced extrudates. X-ray diffraction was performed with a D2 
Phaser (Bruker) in the angular range of 5° < 2θ < 70° using a step scan mode (step size = 
0.020°, step time = 1s). 
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7.3. RESULTS AND DISCUSSION 
 
7.3.1. In-line monitoring of solid state 
 
DSC measurements were performed on the pure components CEL and Eudragit® E PO and 
on a physical mixture (50:50) of both to assess the solubility of CEL in Eudragit® E PO (Figure 
7.3). To determine the Tm for CEL and the Tg for Eudragit®, the first heating cycle was used. 
The Tm of CEL was found at 164.1°C with an onset temperature of 162.9°C, and the Tg of 
Eudragit® E PO was located at 55.6°C with an onset temperature at 54.8°C. To determine 
whether CEL is soluble in the Eudragit® E PO matrix, a physical mixture containing 50% of 
each component (w/w) was first heated, then cooled and reheated to verify the absence of 
crystalline CEL. No endothermic melting peak for CEL was detected in the thermogram of the 
second heating cycle, and only one Tg is visible at 62.5°C with an onset temperature of 
57.1°C. This indicates that, in this 50:50 (% w/w) mixture, all CEL has interacted with the 
polymer on a molecular level, resulting in a glassy solution. Since CEL is soluble in the 
Eudragit® E PO matrix, it was not required to perform hot-melt extrusion at or above the Tm 
of CEL, hence lowering the processing temperatures required during the experiments. 
 
 
Figure 7.3. DSC thermograms of 1) pure CEL, first heating cycle, 2) pure Eudragit® E PO, first heating cycle and 
3) a physical mixture of both (50:50), second heating cycle. 
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PCA was performed on the off-line obtained XRD and DSC data from the extrudate samples 
collected after each design experiment (Table 7.1). The resulting principal component (PC) 1 
versus PC 2 scores plot and corresponding PC 2 loadings plot for the XRD data are shown in 
Figure 7.4a and 7.4b. PC 1 captures the variation in the XRD diffraction pattern caused by 
differences in baseline intensities between the extrudates of the different experiments.  
 
Figure 7.4. PC 1 versus PC 2 scores plots and loadings obtained after principal component analysis of the XRD 
diffraction patterns (a and b) and of the DSC thermograms (c and d) from the end products of each design 
experiment (experiment numbers according to Table 7.1). 
 
The second principal component (R²=0.15) distinguishes between the extrudates still 
containing crystalline CEL and the samples where no crystalline peaks were visible in the XRD 
patterns. The PC 2 loadings have very sharp, negative peaks. These peaks correspond to the 
signals of crystalline CEL that were found in the diffraction pattern of pure CEL, indicating 
that the observations with a low score value for PC 2 will contain the most CEL in its 
crystalline form. All design experiments resulted in amorphous extrudates, except for three 
experiments where physical mixtures containing 50% CEL (w/w) were extruded at 130°C 
(experiments 7, 9 and 11, Table 7.1). In these three extrudates, crystalline CEL can be seen in 
the XRD patterns, resulting in low PC 2 score values (Figure 7.4a, blue observations). These 
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extrudates were also opaque, whereas all other formulations resulted in transparent end 
products.  
 
PCA was also performed on all thermograms (first heating cycle) collected after each design 
experiment. Only a small region of the thermograms was used for analysis, from 100°C to 
190C°, since this region captures information related to the presence of a melt peak for CEL. 
The PC 1 (R²=0.93) versus PC 2 (R²=0.06) scores plot and the loadings plots for both 
components are shown in Figure 7.4c and 7.4d, respectively. The loadings for both PC 1 and 
PC 2 show a peak at the position where crystalline CEL displays a melting peak in the 
thermogram. This indicates that measurements with low score values in both components 
will contain crystalline CEL. Hence, DSC analysis of the extrudates clustered the end products 
in an identical manner as the XRD analysis. In the three experiments with a concentration of 
50% CEL (w/w) at a temperature of 130°C (blue observations in Figure 7.4c), an endothermic 
melting peak was visible at 143.3°C, 143.7°C and 145.3°C when using the FF, FB and 2F screw 
configurations, respectively. 
 
During each extrusion experiment (15 experiments, Table 7.1), 15 in-line Raman spectra 
were collected resulting in a data set of 225 spectra. In first instance, a general overview of 
the data was envisaged by applying PCA on this training set. The resulting PC 1 versus PC 2 
scores plot (Figure 7.5a) shows three clusters of spectra oriented along PC 1 (R²=0.96). The 
spectra having the highest PC 1 score values correspond to the extrudates containing 50% 
CEL (w/w) extruded at 130°C. The loadings of this component (Figure 7.5b) indeed represent 
the sharp peaks of crystalline CEL, indicating that the spectra having a high PC 1 score value 
correspond to extrudates containing crystalline CEL. This was confirmed by the off-line XRD 
and DSC analysis. However, Raman spectroscopy seems to distinguish two groups within the 
spectra collected during all other experiments of the design. The spectra obtained during 
extrusion of 30% CEL (w/w) mixtures at 130°C (experiments 1, 3 and 5, Table 7.1) have lower 
PC 1 score values than the spectra collected during extrusion of 50% CEL (w/w) mixtures at 
130°C, but these score values are remarkably higher than those for all other experiments of 
the design. Raman spectroscopy apparently detects an additional difference between the 
spectra collected during extrusion of 30% CEL (w/w) at 130°C and the other experiments, 
which was not found in XRD and DSC analysis. According to the latter two, these extrudates 
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did not contain any crystalline CEL. Nevertheless, the Raman spectra suggest that there is 
some crystalline CEL present when extruding a 30% CEL (w/w) mixture at 130°C.  
 
Figure 7.5. a) PC 1 versus PC 2 scores scatterplot obtained after PCA of the in-line collected Raman spectra and 
b) PC 1 loadings plot. 
 
When the scores of PC 1 are used as responses in the experimental design (Table 7.1), only 
the factor temperature has a significant (negative) effect on the scores of PC 1, which 
captures the spectral variation related to physicochemical state of the extrudates. It is 
possible to create glassy solutions with 30%, 40% and 50% CEL (w/w), as long as the selected 
processing temperature is high enough. A negative effect of temperature on the score values 
for PC 1 was registered, indicating that the lower the processing temperature is, the higher 
the score values in PC 1 will be and thus the more crystalline CEL will be. The tested 
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modifications in the screw configuration did not affect the physicochemical state of the 
extrudates for this formulation. 
Figure 7.6. Coomans’ plot for the validation set: Distances of the new Raman observations to the models with 
(y-axis) and without crystalline CEL (x-axis). 
 
In a next step, a classification model was developed allowing the classification according to 
solid state of new extruded physical mixtures. Therefore, SIMCA modelling was applied. The 
dataset used for PCA with Raman spectra was split into two separate groups (classes) 
according to the off-line DSC and XRD measurements (one class where crystalline CEL is still 
present and a second class where no crystalline CEL was detected) and a separate PCA 
model was fit for each class. The class where crystalline CEL was detected in the off-line 
measurements contained 45 spectra (experiments 7, 9 and 11, Table 7.1) and the class 
where no crystalline CEL was found comprised 180 spectra (all other experiments). The class 
membership of a validation set containing 75 in-line collected Raman spectra (5 non 
subsequent spectra from each experiment) which were not used to build the model was 
estimated by calculating the distance to the model of these new spectra (observations). A 
Coomans’ plot was used as a diagnostic tool to interpret the classification results of this 
validation set (Figure 7.6). The experiments at 130°C with 50% CEL (w/w) (experiments 7, 9 
and 11, Table 7.1) are assigned to the group containing crystalline CEL, and all other 
experiments, with exception of the spectra collected during extrusion of 30% CEL (w/w) at 
130°C (experiments 1, 3 and 5, Table 7.1), belong to the group where no crystalline CEL is 
detected. In-line Raman measurements do not classify the spectra of the latter as 
completely crystalline or without any crystallinity, since the critical distance (Dcrit, red lines) 
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is exceeded for both models. The Raman spectra of these three experiments showed bands 
which were sharper than the amorphous spectra, but broader than the crystalline spectra 
(Figure 7.7), indicating the presence of CEL that has dissolved into the matrix and CEL in its 
crystalline state. This indicates a possible higher sensitivity of in-line Raman spectroscopy to 
determine the physicochemical state of the extrudates compared to the off-line XRD and 
DSC results. This developed classification model was added to the measuring method in the 
SIPAT software, allowing real-time determination of the solid state in the continuously 
produced extrudates. 
 
 
Figure 7.7. In-line collected Raman spectra during extrusion of 50% CEL (w/w) at 130°C (purple) and 150°C 
(green) and of 30% CEL (w/w) at 130°C (red) and 150°C (blue). 
 
A Coomans’ plot was calculated for the off-line XRD and DSC measurements as well (Figure 
7.8a and 7.8b, respectively). Two separate PCA models were fit for each class observed in 
the original PCA models, i.e. a class where crystalline CEL was detected, and a class where no 
crystalline CEL was found. The class with crystalline CEL contained the off-line data from 
experiments 7, 9 and 11 (Table 7.1), and all other off-line measurements were assigned to 
the class without crystalline CEL. The distance to these two new PCA models for new off-line 
measurements performed on extrudate samples collected after each experiment was 
calculated and plotted. The XRD diffraction patterns show that all measurements with 
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exception of the three experiments with physical mixtures containing a 50% CEL 
concentration (w/w) that were extruded at 130°C, have a DModX lower than Dcrit for the 
PCA model without the crystalline data. In the Coomans’ plot based on the DSC 
measurements, four datapoints exceed the critical distance to the model without crystalline 
CEL. Three of these points are the measurements conducted on extrudates containing 50% 
CEL (w/w) and extruded at 130°C, and the other datapoint, only slightly exceeding the limit, 
is the extrudate with 40% CEL (w/w). 
 
 
Figure 7.8. a) Coomans’ plot for the prediction of off-line measurements: distance of the new observations in 
XRD (a) and DSC (b) measurements to the models with (y-axis) and without crystalline CEL (x-axis) 
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From each run of the experimental design, extrudate samples were collected and stored at 
room temperature for one year. Then, off-line Raman spectra were collected from these 
samples, to verify the stability of the extrudates. Principal component analysis was applied 
to these measurements, and the resulting PC 1 (R²=0.81) versus PC 2 (R²=0.15) scores plot 
(Figure 7.9a) demonstrates that the spectra collected from extrudates with 30% CEL (w/w) 
extruded at 130°C (experiments 1, 3 and 5, Table 7.1) and with 50% CEL (w/w) extruded at 
130°C (experiments 7, 9 and 11, Table 7.1) have higher PC 1 score values than the spectra 
collected from all other extrudate samples. The loadings of this component (Figure 7.9b) 
again represent crystalline CEL. This indicates that recrystallization has occurred in the 
extrudates containing 30% CEL (w/w) which were extruded at 130°C. The Raman spectra for 
these samples show sharp bands for CEL. Therefore, the developed classification model for 
solid state also provides an indication of the storage stability of the extrudates. 
 
 
Figure 7.9. a) PC 1 versus PC 2 scores scatterplot obtained after PCA of the off-line collected Raman spectra 
after storage at room temperature for 1 year and b) PC 1 loadings plot. 
CHAPTER 7 – IN-LINE SOLID STATE PREDICTION DURING PHARMACEUTICAL HOT-MELT EXTRUSION IN A 12 MM 
TWIN SCREW EXTRUDER USING RAMAN SPECTROSCOPY 
165 
 
7.3.2. Influence of die pressure on in-line collected Raman spectra 
 
In addition to solid state properties, Raman spectra collected during extrusion in the die 
head also provide information on processing history. When PCA is applied on the raw 
spectra of all experiments in Table 7.1 (without any pre-processing), clustering in the PC 1 
versus PC 2 scores plot along PC 1 according to processing temperature can be observed 
(Figure 7.10a). This is expressed in the Raman spectra as differences in background signal 
(Figure 7.10b). However, the temperature at the Raman measurement point, the die, was 
kept constant at 110°C, and the average monitored melt temperature in the die did not vary 
more than ± 3°C between al the experiments from the design (Table 7.1). On the other hand, 
a large variation in average die pressure can be noticed between the different experiments 
(Table 7.1 and Figure 7.10b). This variation is caused by two factors. First, a higher 
processing temperature reduces the viscosity of the melt, and lowers the die pressure. 
Secondly, CEL has a plasticizing effect on Eudragit® E PO [5]. The CEL molecules settle 
between the polymer chains and decrease the interaction between the polymer molecules. 
The more CEL interacts with the matrix, the lower the viscosity of the melt, resulting in the 
lowest die pressures when 50% CEL (w/w) is extruded at a temperature of 150°C and the 
highest pressures when 30% and 50% CEL (w/w) are processed at 130°C. A higher pressure 
at the measurement point results in a decrease in Raman intensity [15]. Possible causes for 
this intensity decrease are the scattering losses due to heterogeneities induced by pressure 
gradients, and a change of absorption coefficient with pressure. This is a general 
observation, and is manifested as an intensity decrease in the whole spectrum (Figure 
7.10b). 
 
Die pressure changes during hot-melt extrusion are not only related to drug concentration or 
processing temperatures, but can also be caused by changes in feeder performance. Since 
the in-line collected Raman spectra are influenced by the relative pressure in the die, Raman 
spectroscopy also reflects the performance of the feeding equipment during processing. PCA 
was applied on all Raman spectra collected during experiment number 10 from the design 
(Table 7.1) with a physical mixture containing 50% CEL (w/w), at a temperature of 150°C and 
with the FB screw configuration. The scores from the first principal component were plotted 
together with the feed rate and the die pressure versus process time (Figure 7.11). The 
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product temperature remained constant throughout the experiment and therefore did not 
influence the die pressure. During this extrusion experiment, Raman spectra were collected 
every 20 seconds. At timepoint 161 (53 minutes and 40 seconds after the start of the 
experiment), the feeder stopped due to insufficient filling volume. A refill was required, and 
the feeding unit was restarted at timepoint 168 (140 seconds later). This drop in feed rate 
induced almost immediately (at timepoint 162) a decrease in die pressure. This decrease in 
die pressure simultaneously causes a drop in the score values of PC 1 at time point 162. The 
Raman signal did not immediately return to its steady state value when the feed rate was 
increased again, but stabilized only when the die pressure stabilized. As a result, it can be 
concluded that pressure fluctuations in the die are reflected in the Raman spectra which are 
collected in the die. Hence, disturbances upstream of the extrusion process can be observed 
and identified in the Raman measurements. 
 
 
Figure 7.10. a) PC 1 versus PC 2 scores scatterplot obtained after PCA of the in-line collected raw Raman 
spectra. b) In-line collected raw Raman spectra with mean melt temperatures and die pressures. 
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Figure 7.11. PC 1 score values for the Raman spectra from the first principal component plotted with the feed 
rate (kg/h) and the measured die pressure (bar). 
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7.4. CONCLUSION 
 
The results in chapter 7 demonstrate that Raman spectroscopic measurements allowed the 
differentiation between glassy solid solutions and crystalline dispersions. A classification 
model was developed to classify continuously produced extrudates according to solid state 
in real-time. Off-line analysis with DSC and XRD appeared not to be sensitive enough to 
detect small fractions of crystalline CEL that later on induced recrystallization of CEL in the 
extrudates during storage. This small fraction was noticed in the Raman spectra, which 
therefore also provided information on the stability of the extrudates. Consequently, Raman 
spectroscopy can be used for the monitoring of product quality during hot-melt extrusion on 
the development scale. Additionally, die pressure fluctuations caused by feeding 
disturbances upstream the extrusion process are reflected in the Raman spectra. 
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ABSTRACT 
 
Chapter 8 evaluates the use of near-infrared spectroscopy for the in-line determination of 
the drug concentration, the polymer-drug solid state behaviour and molecular interactions 
during hot-melt extrusion. 
Kollidon®SR was extruded with varying metoprolol tartrate (MPT) concentrations (20, 30, and 
40% w/w) and monitored using NIR spectroscopy. A PLS model allowed drug concentration 
determination. The correlation between predicted and real MPT concentrations was good 
(R²=0.97). The predictive performance of the model was evaluated by the root mean square 
error of prediction, which was 1.54%. Kollidon®SR with 40% MPT (w/w) was extruded at 
105°C and 135°C to evaluate the suitability of NIR spectroscopy for in-line polymer-drug solid 
state characterization. 
NIR spectra indicated the presence of amorphous MPT and hydrogen bonds between drug 
and polymer in the extrudates. More amorphous MPT and interactions could be found in the 
extrudates produced at 135°C than at 105°C. Raman spectroscopy, DSC and ATR FT-IR were 
used to confirm the NIR observations. Due to the instability of the formulation, only in-line 
Raman spectroscopy was an adequate confirmation tool. NIR spectroscopy is a potential 
PAT-tool for the in-line determination of API-concentration and for the polymer-drug solid 
state behaviour monitoring during pharmaceutical hot-melt extrusion. 
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8.1.  INTRODUCTION 
 
Hot-melt extrusion (HME) is one of the most widely used processing technologies in the 
plastic, food and rubber industry [1]. Recently, it also found its application in pharmaceutical 
manufacturing operations, offering many advantages compared to traditional 
pharmaceutical processing techniques [1-5] for solids: the process is anhydrous; poorly 
compactable materials can be incorporated into tablets; the materials have a short 
residence time in the extruder during processing; HME enables superior mixing (both 
distributive and dispersive); it allows the production of formulations with modified release; it 
allows masking of the bitter taste of several active pharmaceutical ingredients (API’s) and in 
addition it improves the dissolution rate and the bioavailability of poorly water soluble drugs 
by the formation of solid solutions or solid dispersions [6]. A solid dispersion consists of at 
least two different components, generally a hydrophilic matrix and a hydrophobic drug [7]. 
The polymer matrix can be either crystalline or amorphous, and the drug can be dispersed 
molecularly, in amorphous clusters or in crystalline particles. Each of these solid states has 
its own properties such as storage stability, dissolution rate, etc. The degree of crystallinity 
or amorphism in pharmaceutical materials is recognized as a critical factor that will affect 
drug stability and dosage form performance [8]. 
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Nowadays, extruders already allow in-line monitoring and control of process parameters 
(e.g. barrel and die temperature, powder feed rate and screw speed, torque and melt 
pressure in the extruder and die). In-line monitoring and control of quality parameters 
corresponding to the extruded product itself, such as drug load and solid state, has been 
performed recently with Raman spectroscopy [9], but not yet with NIR spectroscopy. Besides 
real-time assessment of product characteristics, in-line spectroscopic monitoring helps to 
increase the understanding of the product behaviour during extrusion. 
 
Today, the intention within the pharmaceutical industry is to move from traditional batch 
processing towards continuous processing, hereby increasing process efficiency and 
production. Continuous processes are based on the one-in-one-out principle and offer many 
advantages: no scale-up issues resulting in a shorter development time, possible automation 
of the production line, reduction of production costs, faster product release, less product 
variability and improved product quality [10,11]. Hot-melt extrusion can be operated as a 
continuous process, capable of consistent product flow at relatively high throughput rates 
[1], making it suitable for large scale production. 
 
The FDA has introduced the concept of Process Analytical Technology (PAT) in 2004 [12]. 
Pharmaceutical products must meet very strict specifications. However, conventional 
pharmaceutical manufacturing is generally accomplished using batch processing followed by 
time-consuming, expensive and less efficient off-line laboratory testing on randomly 
collected samples to evaluate the intermediate or end product quality. The processes 
themselves are not fully understood and are often inefficient black-boxes. PAT-tools such as 
near-infrared (NIR) spectroscopy provide in-line and real-time process information 
concerning critical formulation parameters, which might contribute to steering processes 
towards their desired state through adaptations of process settings. It is evident that 
continuous manufacturing needs continuous process monitoring and control. 
 
Near-infrared spectroscopy is a fast, non-destructive analytical technique, which requires 
(nearly) no sample pre-treatments [13]. In the near infrared area (800-2500 nm or 12500-
4000 cm-1), mainly vibrations of CH, OH, NH and SH bonds are observed as overtones or 
combinations of the fundamental IR bands, resulting in overlapping absorption bands in the 
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spectra. Hence, NIR spectra are more complex and difficult to interpret compared to IR 
spectra. Therefore, chemometrics are often required to extract the useful information from 
the NIR spectra [14]. Because of its unique properties [14], like high analysis speed, no need 
for sample preparations, its non-destructive and non-invasive nature of analysis and the use 
of fibre optical probes, NIR spectroscopy is an ideal process analyzer for hot-melt extrusion. 
Furthermore, due to the fact that NIR spectra are sensitive to changes in hydrogen bonding 
and packing in the crystal lattice, NIR can be applied for solid state analysis and the 
understanding of molecular interactions [15]. 
 
NIR spectroscopy has been applied in-line and in the transmission mode during single-screw 
hot-melt extrusion to monitor the HDPE/PP [16, 17] and LDPE/PP [18] polymer melt 
composition in the extrusion die. Furthermore, NIR spectroscopy has been used to monitor 
the ethylene vinylacetate copolymer composition in the extrusion die during single-screw 
extrusion [19-21], and for the quantification of the copolymer composition in a 
polypropylene and ethylene vinyl acetate blend [22] during twin-screw extrusion. NIR has 
also been applied to measure the polymer melt flow index [21] in single-screw extrusion and 
to detect and quantify small amounts of Irganox in polypropylene [23] and Mg(OH)2 in LDPE 
[20] and HDPE [24] during twin-screw extrusion. In another application, NIR spectroscopy 
was used to monitor the content of pulverised chalk in polypropylene [22], to quantify the 
melamin cyanurate concentration in polyamid 12 [25] and to quantify the composition of a 
PE/PS blend [25] during twin-screw extrusion. 
 
In this chapter, the suitability of NIR spectroscopy in its reflectance mode for the in-line 
monitoring of pharmaceutical HME processes was evaluated. Via fibre optic cables, an NIR 
probe was implemented in the HME equipment, to monitor the API content and the 
polymer-drug behaviour (solid state and molecular interactions) during hot-melt extrusion.  
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8.2. MATERIALS AND METHODS 
 
8.2.1. Materials 
 
Metoprolol tartrate (MPT) (Esteve Quimica, Barcelona, Spain) (Figure 8.1a) was chosen as a 
model drug. It has a melting temperature (Tm) around 120°C. Kollidon® SR (Figure 8.1b) was 
kindly donated by BASF (Ludwigshafen, Germany). This amorphous polymer consists of 8 
parts polyvinyl acetate (w/w) and 2 parts polyvinyl pyrrolidone (w/w). The solubility 
parameters of both components were calculated by SPWin, version 2.11 [26] to predict the 
solid state miscibility. 
 
  
Figure 8.1. Molecular structures of a) Metoprolol tartrate (Ph. Eur. 7.0) and b) Kollidon® SR. 
 
8.2.2. Hot-melt extrusion 
 
Hot-melt extrusion was performed with a Prism Eurolab 16 co-rotating, fully intermeshing 
twin-screw extruder (Thermo Fisher Scientific, Germany). The temperature of each segment 
of the extruder and of the die can be controlled separately. The hot-melt extruder was 
equipped with a DD Flexwall® 18 feeder (Brabender® Technologie, Germany), which was set 
in its gravimetric feeding mode.  
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For the development of a calibration model allowing in-line API quantification, 3 different 
polymer-drug mixtures, consisting of Kollidon® SR and 20%, 30% and 40% (w/w) MPT 
respectively, were extruded. Prior to hot-melt extrusion, the polymer and drug were 
blended in a mortar. Each mixture was hot-melt extruded with a feeder speed of 0.5 kg/h 
and a screw speed of 80 rpm. The barrel temperature profile was set at 90-135-135-135-135-
135°C (from hopper to die) for all mixtures. The minimum batch size used was 700g of 
polymer-drug mixture. 
 
In a second part of the study, two identical polymer drug-mixtures were prepared to 
evaluate the suitability of NIR spectroscopy for in-line polymer-drug solid state 
characterization. Both physical mixtures contained 40% MPT and 60% Kollidon® SR (w/w), 
and were extruded with a powder feed rate of 0.5 kg/h and a screw speed of 80 rpm. The 
first mixture was extruded using a barrel temperature profile of 90-135-135-135-135-135°C, 
which is above the melting temperature of pure MPT. The other mixture was extruded using 
a barrel temperature profile of 90-105-105-105-105-105°C. 
 
8.2.3. NIR spectroscopy 
 
Diffuse reflectance NIR spectra were continuously collected in-line and noninvasively during 
hot-melt extrusion using a Fourier-Transform NIR spectrometer (Thermo Fisher Scientific, 
Zellik, Belgium, Nicolet Antaris II near-IR analyzer) equipped with an InGaAs detector, a 
quartz halogen lamp, and a fibre-optic probe which was mounted in the extrusion die (Figure 
8.2). Spectra were collected every 30 seconds in the 9000 – 4500 cm-1 region with a 
resolution of 16 cm-1 and averaged over 32 scans. For the monitoring of the stability of the 
extruded end products, spectra of the extrudates were continuously collected off-line for 20 
minutes immediately after extrusion at room temperature. Here, spectra were collected 
every 13 seconds with a resolution of 16 cm-1 and averaged over 32 scans. 
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Figure 8.2. In-line NIR spectroscopic monitoring setup. 
 
Data analysis was performed using the Result software (Version 3.0, Thermo Fisher 
Scientific, Zellik, Belgium) and SIMCA-P+ (version 12.0.1.0, Umetrics, Umeå, Sweden). 
Spectra collected in the diffuse reflectance mode often require spectral pre-treatment 
before analysis. The degree of scattering depends on the wavelength of the light and the 
refractive index of the sample, which causes a non-equal scatter over the whole spectrum. 
This can result in a baseline shift [22]. Therefore, multiplicative signal correction (MSC) was 
used before chemometric analysis of the spectra. Using MSC, undesired scatter is removed 
from the raw spectra to prevent it from dominating over the chemical information within 
the spectra. The result of MSC pre-processing is that each corrected spectrum has the same 
offset and amplitude, eliminating the difference in light scatter in the spectra from the 
different samples, before developing the calibration model [27]. Furthermore, second 
derivative pre-processing was performed after MSC correction. Second derivatives of NIR 
spectra magnify differences in spectral features, provide baseline normalization and remove 
data offsets due to scattering effects and path length variation [28]. For principal component 
analysis (PCA) and for the development of the partial least squares (PLS) regression model, 
20 spectra of each polymer-drug mixture (20%, 30% and 40% MPT w/w) were used. Prior to 
PCA and PLS, spectra were mean centred. The PLS model was developed by regressing the 
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MPT-concentrations (Y) versus the corresponding in-line collected NIR spectra (X). This 
model was validated using 5 new NIR spectra collected during new extrusion runs of each 
polymer-drug mixture. These validation spectra were used to evaluate the predictive 
performance of the PLS model. 
 
8.2.4. Raman spectroscopy 
 
To confirm the in-line NIR polymer-drug solid state observations, Raman spectra were 
collected using a Raman Rxn1 spectrometer (Kaiser Optical Systems, Ann Arbor, MI, USA), 
equipped with an air-cooled CCD detector. A fibre-optic Raman Dynisco probe was used to 
monitor the extrusion process in-line. The Raman Dynisco probe was implemented into the 
extrusion die [9], in an identical manner as the NIR probe (see Figure 8.2). The laser 
wavelength was the 785 nm line from a 785 nm Invictus NIR diode laser. All spectra were 
recorded with a resolution of 4 cm-1 and an exposure time of 2 seconds, using a laser power 
of 400 mW. Spectra were collected every 15 seconds. Data collection and data transfer were 
automated using the HoloGRAMS™ data collection software, the HoloREACT™ reaction 
analysis and profiling software, the Matlab software (version 7.1, The MathWorks Inc., 
Natick, MA) and SIMCA-P+ (version 12.0.1.0, Umetrics, Umeå, Sweden) was used for data 
analysis . The analyzed spectral region was 0 – 1800 cm-1, since this region contained all 
useful drug and polymer information. Savitzky-Golay and SNV pre-processing were applied 
on the in-line collected spectra to exclude inter-batch variation and variation caused by 
baseline-shifts, respectively. 
 
8.2.5. DSC analysis 
 
Differential scanning calorimetry was performed with a DSC Q 2000 (TA Instruments, 
Belgium). The thermograms were produced with the Thermal Advantage Release 5.1.2 
software and analysed with TA Instruments Universal Analysis 2000 4.7A (TA Instruments, 
Belgium). Hermetically sealed aluminium pans (TA Instruments, Belgium) were used 
containing the samples of approximately 5 mg. Measurements were carried out in a nitrogen 
atmosphere. The flow rate of dry nitrogen gas was 50 mL/min. Temperature and enthalpic 
calibration was performed using indium as standard. Samples were subjected to three 
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cycles. First, the pans were heated with a heating rate of 10,0°C/min from -30°C up to 180°C 
in the first heating cycle. Then, a cooling cycle was started with a cooling rate of -10,0°C/min 
to -30°C, followed by a second and final heating cycle which was identical to the first.  
 
8.2.6. ATR FT-IR spectroscopy 
 
In addition to DSC analysis and Raman spectroscopy, attenuated total reflectance (ATR) 
Fourier transform (FT) infrared (IR) spectroscopy was also used to confirm the solid state 
observations in the NIR spectra. Spectra were collected from MPT and Kollidon® SR, from the 
physical mixture containing 40% MPT in Kollidon® SR (w/w) and from the extrudates of this 
physical mixture extruded at 135°C and 105°C. The ATR FT-IR spectra were collected with a 
Bruker Vertex 70 FT-IR spectrometer, equipped with a DTGS detector and a PIKE accessory, 
equipped with a diamond ATR crystal. 
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8.3. RESULTS AND DISCUSSION 
 
8.3.1. In-line monitoring of API concentration 
 
Mixtures of 20, 30 and 40% (w/w) MPT in Kollidon® SR were hot-melt extruded. Figure 8.3 
shows the differences in the pre-processed in-line collected NIR spectra (6150 - 4500 cm-1). 
PCA was applied on 60 NIR spectra (20 spectra per extruded MPT concentration level) 
leading to a model with two principal components covering nearly all spectral variation. The 
first principal component (PC 1) captures 99.0% of the variation; the second component (PC 
2) covers 0.4% of extra variation. The variation captured by the first component is caused by 
differences in API concentration, as confirmed by the PC 1 versus PC 2 scores plot (Figure 
8.4). The variation captured by the second principal component, contains only a minor part 
of the total spectral variation, which is not caused by differences in drug loading.  
 
Figure 8.3. Pre-processed in-line collected NIR spectra of different MPT – Kollidon® SR mixtures. Red = 20% 
MPT, green = 30% MPT, blue = 40% MPT (w/w). 
 
A PLS model, allowing prediction of the MPT concentration in unknown samples during hot-
melt extrusion processes was developed. The in-line collected NIR spectra (X) were 
regressed versus the known MPT concentrations (Y). A model with two PLS components was 
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chosen, since the goodness of prediction of the model (Q²) did not increase significantly 
after adding extra components [27]. The predictive performance of this PLS model was 
evaluated using five test spectra collected during new hot-melt extrusion runs of three 
mixtures, also containing 20%, 30% and 40% (w/w) MPT in Kollidon® SR. The PLS model was 
used to predict the corresponding MPT concentrations of these 15 NIR test spectra. When 
plotting the predicted versus the observed MPT concentration values an R² of 0.97 was 
obtained. The resulting root mean square error of prediction (RMSEP) was 1.54%. The 
spread in predicted concentration values was larger for mixtures containing a drug load of 
20% compared to the 30% and 40% MPT mixtures (w/w). NIR absorption bands are typically 
broad, and due to overlapping of peaks, it is more difficult to accurately predict small drug 
concentrations, since the peaks of MPT are masked by larger peaks of Kollidon® SR. 
 
 
 
Figure 8.4. PC 1 (99%) versus PC 2 (0.2%) scores plot obtained after PCA on the pre-processed in-line collected 
NIR spectra during extrusion of mixtures containing Kollidon® SR and 20% (red), 30% (green) and 40% (blue) 
MPT (w/w). 
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8.3.2. In-line monitoring of solid state and polymer-drug interactions 
 
8.3.2.1. Near-infrared spectroscopy 
 
To obtain a good compatibility between polymer and drug, the difference between solubility 
parameters (δ) of polymer and drug should be less than 7.0 MPa1/2 [29]. When this is 
achieved, miscibility is likely and, therefore, a glass solution could be formed during melt 
extrusion. Components with a difference in solubility parameters higher than 10 MPa1/2 are 
likely to be immiscible. The solubility parameter for MPT is 23.6 MPa1/2 and 20.9 MPa1/2 for 
Kollidon® SR. As the difference between these solubility parameters is 2.7 MPa1/2, sufficient 
miscibility between Kollidon® SR and MPT may be expected. 
 
Two mixtures containing both 40% MPT and 60% Kollidon® SR (w/w) were extruded at 105°C 
and 135°C, respectively. It was expected that the fraction of crystalline MPT would be larger 
when extrusion was performed at 105°C, since this temperature is below the melting 
temperature of MPT (± 120°C). At 135°C, more MPT was expected to transform to the 
amorphous state. It is evident that formulations containing a mixture of crystalline and 
amorphous API are not stable and therefore not desired in pharmaceutical dosage forms. 
However, the aim of the experiments described in this chapter was not to develop a stable 
pharmaceutical formulation, but to demonstrate the potential of NIR spectroscopy to 
monitor different states of a drug within a formulation and to detect undesired changes in 
the solid state of the drug during the hot-melt extrusion process. 
  
Figure 8.5 shows the NIR spectra of the physical mixture (Kollidon® SR with a drug load of 
40% MPT (w/w)) and the in-line collected spectra during extrusion of this physical mixture at 
105°C and 135°C. When comparing the spectra of the extrudates to those of the physical 
mixture, peak shifts throughout the entire spectrum are visible (Figure 8.5a). These shifts 
indicate molecular interactions between polymer and drug. The shifts are smaller for the 
extrudate produced at 105°C compared to the extrudate processed at 135°C, suggesting 
more interaction between Kollidon® SR and MPT in the latter. Some of the MPT in the 
extrudates produced at 135°C (above Tm of MPT) is amorphous, which enhances interaction  
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Figure 8.5. Pre-processed NIR spectra of the physical mixture containing 60% Kollidon® SR and 40% MPT (w/w) 
(blue) and of the in-line collected spectra during hot-melt extrusion at 105°C (green) and 135°C (red). 
 
with the polymer. At 105°C (below Tm of MPT), a larger fraction of MPT remains crystalline, 
explaining the smaller peak shifts in the spectra of this extrudate. Polymers can improve the 
physical stability of drugs in solid dispersions, due to specific interactions such as ion-dipole 
interactions and intermolecular hydrogen bonding with functional groups of the drug [6, 30]. 
These interactions are confirmed by the appearance of a peak at 6495 cm-1 (1540 nm) in the 
spectra of the extrudates (Figure 8.5b), which is absent in the spectrum of the physical 
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mixture. This peak indicates the formation of hydrogen bonds in which the hydroxyl groups 
of MPT act as proton donors. In hydrogen bonded alcohols, a broad peak manifests in the 
6850 – 6240 cm-1 region, which is attributed to the first overtone of the bonded hydroxyl 
[31]. At 135°C, more MPT is present in the amorphous state, which means that more MPT is 
free to interact with the polymer, leading to the formation of more hydrogen bonds. This 
explains why the peak at 6495 cm-1 is slightly more intense in the spectra of the extrudates 
produced at 135°C than at 105°C.  
 
The NIR spectra of pure MPT contain well defined, rather narrow bands. Both extrudates still 
contain the MPT peaks (Figure 8.5c), though they are broader, indicating that not all MPT 
remained in its crystalline form and that some MPT became amorphous. Broad bands 
indicate a lack of long-range three-dimensional order of the molecules [32]. The peaks in the 
extrudate at 135°C are slightly broader and less defined than at 105°C, indicating the 
presence of more amorphous MPT in the extrudate at 135°C. Since Kollidon® SR is an 
amorphous polymer, this broadening does not occur in polymer peaks. In the physical 
mixture, no interactions have occurred. Consequently, the peaks of MPT in the spectrum of 
the physical mixture remain as sharp as the original MPT peaks. 
 
8.3.2.2. Differential scanning calorimetry 
 
DSC analysis, ATR FT-IR spectroscopy and Raman spectroscopy were used to confirm the 
interpretation of solid state and drug-polymer interaction from the NIR spectra. Figure 8.6a 
details the thermograms of the physical mixture and the extrudates of the physical mixture 
extruded at 105°C and 135°C. In the extrudates, the glass transition temperature (Tg) of 
Kollidon® SR decreased due to the extrusion process itself, which slightly lowers the Tg of a 
polymer [33], and due to the plasticizing effect of MPT on the polymer, shown in Figure 8.6b. 
For confirmation of the NIR spectral information, data from the first heating cycle were used, 
whereas the data from the second heating cycle were used to confirm the plasticizing effect 
of MPT on Kollidon® SR. The higher the drug loading in a physical Kollidon® SR – MPT 
mixture, the lower the Tg in the second heating cycle of the DSC experiment. A lower Tg 
indicates a molecular dispersion and thus miscibility of the drug in the polymer, whereas an 
unchanged Tg implies separation of the polymer- and drug phase [34]. The thermogram of 
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the physical mixture shows a Tg at 45.4°C for Kollidon® SR (Figure 8.6a). The Tg of Kollidon® 
SR in the extrudates containing 40% MPT (w/w) at 105°C and 135°C is 40.2°C and 40.7°C, 
respectively. The chain mobility of the polymer has increased due to incorporation of MPT in 
the polymer matrix, which results into a decrease in glass transition temperature. However, 
the decrease in Tg is identical for both extrudates, suggesting that an equal level of 
interactions has occurred in both extrudates, which is in contrast with the NIR 
measurements, where a stronger peak shift in the extrudate produced at 135°C was 
observed. 
 
A similar shift in the endothermal melting peak of the crystalline MPT appears (Figure 8.6a). 
The melting temperature of MPT in the physical mixture is measured at 120.7°C, with an 
onset temperature of the endothermal peak at 113.7°C. This melting peak is also present in 
both thermograms of the extrudates. However, the melting enthalpy for MPT in the 
extrudate at 135°C is much smaller than the one in the extrudate at 105°C, even though both 
extrudates contain 40% MPT (w/w). In the extrudate at 135°C, more MPT has transformed to 
the amorphous state, leaving a smaller fraction of crystalline MPT and thus a smaller area 
under the curve of the melting peak. The melt enthalpy for MPT in the physical mixture is 
37.2 J/g. In the extrudate at 105°C, this enthalpy has reduced to 6.7 J/g, meaning that only 
18.0% of the MPT is crystalline in this extrudate, assumed that MPT in the physical mixture is 
100% crystalline. For the extrudate at 135°C, the amount of crystalline MPT is even lower, 
9.1%, since the melt enthalpy is only 3.4 J/g. The melting points (Tm) for the extrudates 
produced at 105°C and 135°C can be found at 115.7°C and 117.1°C, with onset melting 
temperatures of the corresponding endotherms at 109.7°C and 110.0°C respectively. 
Compared to the physical mixture, this shift again implies interactions between the polymer 
and the drug, but no variations can be seen in interaction strength between both extrudates. 
 
The extrudates show a second Tg, at a lower temperature than the Tg of Kollidon® SR. This is 
the glass transition temperature of amorphous MPT, at 16.9°C and 17.0°C in the extrudates 
processed at 105°C and 135°C, respectively. A fraction of the MPT in both mixtures has 
become amorphous during processing, but has not been dispersed at a molecular level in the 
polymer matrix as there are 2 Tg’s visible in the thermograms. Hence, the extrudates  
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Figure 8.6. a) Thermograms of the physical mixture containing 60% Kollidon® SR and 40% MPT (w/w) and the 
extrudates produced at 135°C and 105°C. b) Effects of MPT loading (% w/w) on glass transition temperature 
(Tg) of Kollidon® SR in physical mixtures. 
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consist of three phases: an amorphous polymer phase, an amorphous drug phase and a 
crystalline drug phase. These extrudates are in fact solid dispersions which are partially 
crystalline and partially amorphous. The free amorphous drug fraction has the tendency to 
recrystallize due to the poor physical stability of formulations in the amorphous state. These 
results do not completely confirm the in-line NIR observations. The NIR spectra suggest that 
more and stronger interactions occur in the extrudate at 135°C than at 105°C. However, in 
the DSC thermograms, no differences were obtained between both extrudates, with 
exception of the difference in amount of amorphous MPT. 
 
8.3.2.3. ATR FT-IR spectroscopy 
 
Figures 8.7a and 8.7b represent the FT-IR spectra of metoprolol tartrate and Kollidon® SR 
respectively. The FT-IR spectrum of the physical mixture of 40% metoprolol tartrate and 60% 
Kollidon® SR (w/w) (Figure 8.7c) is a combination of the FT-IR spectra of the individual 
components (Figs. 8.7a and 8.7b). The MPT signals are sharp and the fingerprint area, 1500 
cm-1 – 600 cm-1 shows an explicit pattern. The position of the bands in the IR spectra of the 
physical mixture remains unchanged compared to the corresponding bands in the spectra of 
the pure components. No new bands or band shifts can be seen. 
 
The FT-IR spectra of the mixtures containing Kollidon® SR and MPT (60:40, w/w), which were 
extruded at a temperature of 105°C and 135°C (Figure 8.7d), result in a significantly changed 
FT-IR pattern compared to the spectrum of the physical mixture. The FT-IR spectrum of the 
extrudate produced at 105°C shows that the IR absorption bands of the polymer are more 
explicitly present (Figure 8.7). This indicates an association of the API with the polymer, 
forming coupled vibrations of MPT with the polymer. In the spectral region of 2800 cm-1 – 
3800 cm-1, the presence of OH stretch vibrations of alcohol groups indicates that some 
independent MPT molecules are still present and that not all drug molecules have interacted 
with the polymer. The infrared spectrum of the extrudate produced at 135°C is similar to the 
IR spectrum of the extrudate produced at 105°C (data not shown), showing no difference in 
interactions between the extrudates produced at different temperatures. 
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Figure 8.7. ATR FT-IR spectra of a) pure MPT, b) pure Kollidon® SR. 
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Figure 8.7. ATR FT-IR spectra of c) the physical mixture containing 40% MPT and 60% Kollidon® SR (w/w) and d) 
the extrudate of the physical mixture produced at 105°C. 
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8.3.2.4. Raman spectroscopy 
 
Both DSC analysis and the ATR FT-IR results confirm each other, but none of these off-line 
techniques confirm the differences in interaction level and amount between the extrudates 
as seen with NIR spectroscopy. Figure 8.8 shows the in-line collected Raman spectra of the 
extrudates of the mixture at 105°C and 135°C, together with the spectrum of the physical 
mixture itself. The peaks of MPT broaden in the extrudates, indicating the transition from 
crystalline to amorphous MPT. This trend is more distinct in the spectra of the extrudates 
produced at 135°C, suggesting the presence of a larger fraction of amorphous MPT than in 
the extrudates produced at 105°C. Furthermore, peak shifts emerge in the spectra of the 
extrudates compared to the physical mixture. These shifts arise from changes in vibrational 
frequencies, caused by interactions between the polymer and the drug. Hydrogen bonding in 
Raman spectra can be mainly observed as a shift of the spectral bands to lower frequencies 
[35]. The shifts to lower Raman shifts are more explicit in the extrudates produced at 135°C, 
than in the extrudates created at 105°C. This confirms the NIR observations, implying that 
there is a difference in interaction strength between both extrudates. 
 
 
Figure 8.8. In-line collected Raman spectra. Blue = physical mixture (60% Kollidon® SR and 40% MPT, w/w), 
green = extrudate produced at 105°C, red = extrudate produced at 135°C. 
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It has been demonstrated that NIR spectroscopy is a more reliable technique to determine 
the hydrogen bond interaction level and amount for the studied formulation compared to 
DSC analysis and FT-IR. Furthermore, NIR spectroscopy can be used to monitor the stability 
over time of a certain formulation. When the extrudates produced at 105°C and 135°C were 
continuously monitored with NIR spectroscopy immediately after hot-melt processing, it was 
demonstrated that this is an unstable formulation. The extrudates were monitored for 20 
minutes at room temperature (Figure 8.9). In these spectra, the peak at 6495 cm-1 (1540 
nm), attributed to hydrogen bonded hydroxyl groups, reduces, indicating the loss of 
hydrogen bond interactions between drug and polymer, and thus the separation of polymer 
and drug phase. The peaks in the NIR spectra attributed to MPT become more distinct and 
sharp, since the amorphous MPT starts to recrystallize. As recrystallization occurred rapidly, 
DSC analysis and FT-IR spectra were unable to differentiate between both extrudates since 
the sample preparation time for these techniques is longer than the time needed for the 
destabilization process. 
 
 
Figure 8.9. Pre-processed off-line collected NIR spectra of the extrudate produced at 135°C at room 
temperature, immediately after processing, as a function of time. 
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8.4. CONCLUSION 
 
In this chapter, NIR spectroscopy was evaluated to monitor the API concentration and the 
polymer-drug melt behaviour during a pharmaceutical hot-melt extrusion process. With NIR 
spectroscopy, it was possible to detect variations in drug concentrations. A PLS model was 
developed and validated, allowing continuous drug concentration monitoring. It was 
possible to predict drug concentrations with an RMSEP of 1.54% (w/w). 
 
With respect to the polymer-drug behaviour during extrusion, in-line NIR spectroscopy was 
able to detect changes in physicochemical state of the extrudates, as well as in amount and 
strength of the intermolecular interactions during processing. Furthermore, the use of NIR 
spectroscopy allowed the determination of the type of interactions occurring during hot-
melt extrusion. These interactions are manifested as hydrogen bonds between Kollidon® SR 
and MPT molecules. 
 
In-line Raman spectroscopy confirmed these NIR observations. The collected spectra 
displayed similar peak shifts and peak broadening, demonstrating the equivalent changes in 
solid state and interactions during melt extrusion. Comparison of the in-line collected NIR 
spectra and the off-line DSC analysis and off-line collected ATR FT-IR spectra showed that 
NIR is a more powerful process analyzer, able to differentiate between extrudates being 
processed under varying conditions, whereas DSC analysis and ATR FT-IR indicated no 
differences in occurring interactions between extrudates produced at different 
temperatures. 
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ABSTRACT 
 
The aim of this chapter is to evaluate the suitability of ultrasonic techniques as PAT tools for 
the in-line monitoring of drug concentration during a pharmaceutical hot-melt extrusion 
process. 
Physical mixtures of metoprolol tartrate (MPT) and Eudragit® RS PO were extruded with a 
rotational screw speed of 175 rpm, a feed rate of 0.75 kg/h and at a temperature of 110°C. 
Ultrasonic transit time and peak height were measured by the implementation of two 
ultrasound transducers in a die adapter. Die pressure and extrusion torque were also 
monitored during processing.  
A PLS model, regressing the MPT concentrations versus the in-line measured ultrasonic 
transit time and peak height, was created to allow MPT concentration monitoring. A second 
set of experiments was performed to validate this model, resulting in a root mean square 
error of prediction (RMSEP) of 1.47% (w/w). When regressing the MPT content versus the 
monitored torque and die pressure, a similar RMSEP was obtained (1.48% (w/w)). When 
combining all factors (torque, die pressure and ultrasound data), an RMSEP prediction error 
of 0.94 % (w/w) was obtained. Ultrasound monitoring techniques are potential tools for the 
in-line determination of the drug content in pharmaceutical hot-melt extrusion processes. 
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9.1. INTRODUCTION 
 
In addition to optical spectroscopy, ultrasonic monitoring is one of the potential techniques 
for in-line monitoring and control during polymer extrusion [1]. It is a fast, robust, non-
invasive and non-destructive technique which can easily be implemented in the extrusion 
equipment. Ultrasonic vibrations have a frequency higher than that detectable by the human 
ear, typically above 20 kHz. This technique has been used in polymer processing to monitor 
melt temperature and pressure, changes in material type, effects of process settings on 
rheological characteristics of the melt and filler concentration [2]. Ultrasound monitoring has 
also been applied to monitor residence time distributions in the extrusion die [3, 4] and at 
various melting, mixing and pumping zones in the barrel [3]. The melt density has been 
assessed using ultrasound monitoring in the extrusion die [5], and occurring melting 
phenomena throughout the barrel have been evaluated [6]. 
 
The results in this chapter are used to evaluate whether ultrasonic techniques, using 
longitudinal waves, can be applied as PAT tools for the in-line monitoring of drug 
concentrations in a pharmaceutical hot-melt extrusion process. During monitoring with the 
ultrasound technique, the velocity and attenuation of an ultrasound wave traversing a 
polymer melt during extrusion can be measured [7]. These values are related to the melt 
viscosity and elastic moduli, which are associated with the drug concentration in the 
polymer melt. In longitudinal waves, the oscillations occur in the direction of wave 
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propagation. The velocity of ultrasound waves is related to the type of waveform 
(longitudinal or shear), the elastic moduli and the density of the polymer melt. For 
longitudinal waves, the velocity is calculated by Eq. (9.1): 
 
     
 
 
     
           
      (9.1) 
 
Where Cl is the velocity of the longitudinal wave, E is Young’s modulus of elasticity (a 
proportionality constant between uniaxial stress and strain), ν is Poisson’s ratio (the ratio of 
radial strain to axial strain) and ρ is the density of the material. When an ultrasound wave 
travels through a melt, its intensity (peak height) will decrease with distance. This weakening 
is caused by attenuation, which includes absorption, reflection and scattering of the 
sound. Absorption is the main factor contributing to the attenuation of the signal. Ultrasonic 
velocity and attenuation vary with temperature and pressure, related to changes in elastic 
moduli and density with temperature and pressure. When temperature and pressure 
influences are constant, a change in velocity or attenuation indicates a change in extruded 
material, since the distance between transducers remains constant, and can be correlated to 
a variation in drug concentration in the melt. 
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9.2. MATERIALS AND METHODS 
 
9.2.1. Materials 
 
Metoprolol tartrate (MPT) (Esteve Quimica, Barcelona, Spain) was chosen as model drug. It 
has a melting temperature (Tm) of 123°C. Eudragit
® RS PO (Evonik, Germany) was used as 
polymer to form the matrix systems. Eudragit® RS PO is an amorphous copolymer of acrylic 
and methacrylic acid esters with a low content of quaternary ammonium groups, which are 
present as salts. It has a glass transition temperature (Tg) of approximately 65°C. The 
solubility parameters of both components are 23.6 MPa½ and 19.7 MPa½ for MPT and 
Eudragit® RS PO, respectively, and were calculated with SPWin, version 2.11 [8]. 
Components with similar solubility parameters are likely to be miscible (t < 7 MPa
½) and 
components with t > 10 MPa
½ are expected to be immiscible [9]. As the difference in total 
solubility parameter is less than 4 MPa½, a good miscibility and possible formation of a solid 
solution could be expected. 
 
9.2.2. Hot-melt extrusion 
 
Hot-melt extrusion was carried out with a Pharmalab co-rotating twin-screw extruder 
(Thermo Scientific, UK) with a screw diameter of 16 mm and length-to-diameter ratio of 
40:1. The temperature of each segment of the extruder and of the die can be controlled 
separately. The hot-melt extruder was equipped with a gravimetric twin-screw feeder 
(Brabender® Technologie, Germany). For the development of a calibration model allowing 
in-line API quantification, different polymer-drug mixtures containing 10%, 20%, 30% and 
40% (w/w) MPT in Eudragit® RS PO were extruded. Prior to hot-melt extrusion, the polymer 
and drug were blended in a Turbula mixer. Each mixture was extruded with a throughput of 
0.75 kg/h and a screw speed of 150 rpm. The barrel temperature profile was set at 20-30-40-
70-80-110-110-110-110-110°C (from hopper to die) for all mixtures. During extrusion, the 
torque (% of motor load), die pressure (bar) and melt temperature (°C) in the die were 
continuously monitored and logged every second. 
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9.2.3. Ultrasound equipment 
 
Ultrasonic transit time (µs, used to calculate ultrasonic velocity) and peak height (V, related 
to attenuation and reflection) measurements were obtained from the melt using 
instrumentation designed at the University of Bradford (Figure 9.1), containing an ultrasonic 
pulser-receiver (Panametrics 5900), a sampling digital oscilloscope (LeCroy 9350AM) and 
automated process monitoring and analysis software. Data from the pulser-receiver were 
sampled using the oscilloscope at a frequency of 1 GHz and converted to form an array of 
voltage values representing the magnitude of the received sound wave, and time values 
calculated from the known trigger time and sampling frequency. The received wave was 
analysed using custom software employing a peak detection algorithm, to provide a measure 
of transit time and peak height of the first received echo.  The method of operation was 
therefore ‘through transmission’, and the measured transit time is a total value through 
both the transducers and the melt. Data were acquired every second from the melt using 
custom-designed high temperature 3.5 MHz narrow band longitudinal wave transducers 
mounted directly opposite one another into the extrusion die adapter (Figure 9.2). 
 
 
 
 
Figure 9.1. Experimental setup with instrumentation designed at the University of Bradford. 
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Figure 9.2. Experimental setup with longitudinal wave transducers mounted directly opposite one another in 
the extrusion die adapter. 1) Feeding unit, 2) extrusion barrel, 3) custom made die adapter, 4) ultrasound 
transducers. 
 
9.2.4. Data analysis 
 
Data analysis was performed using SIMCA-P+ (version 12.0.1.0, Umetrics, Umeå, Sweden). 
The in-line collected ultrasound data (transit time and peak height) and/or the logged torque 
and die pressure measured during extrusion were used for the development of three partial 
least squares (PLS) regression models, which were developed by regressing the MPT-
concentrations (Y) versus the corresponding in-line collected ultrasound data and/or 
extrusion process parameters (X). The first predictive model linked the logged extrusion 
parameters (torque and die pressure) to the MPT concentration, in the second model the 
prediction was based on the ultrasound parameters (transit time and peak height) and a 
third model combined both extrusion and ultrasound parameters. The predictive 
performance of these PLS models was validated using data gathered during new extrusion 
experiments of each polymer-drug mixture, with identical process settings.  
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9.3. RESULTS 
 
Physical mixtures containing 10, 20, 30 and 40% (w/w) MPT in Eudragit® RS PO were 
extruded. The concentration variations were reflected in the monitored extrusion 
parameters, die pressure and torque, and in the ultrasound parameters, ultrasonic transit 
time and peak height (Table 9.1).  
 
Table 9.1. Average process parameters and ultrasound parameters for each MPT 
concentration level. 
MPT 
(% w/w) 
Average die 
pressure 
(bar) 
Average 
torque 
(% motor load) 
Average melt 
temperature 
(°C) 
Average 
transit time 
(µs) 
Average peak 
height (V) 
10 10.05 ± 71.78 ± 1.77 116 ± 0.24 39.202 ± 0.009 0.007 ± 0.001 
20 6.15 ± 59.80 ± 1.20 113 ± 0.37 39.147 ± 0.011 0.009 ± 0.001 
30 2.50 ± 48.05 ± 0.89 110 ± 0.51 39.091 ± 0.005 0.013 ± 0.002 
40 1.25 ± 38.80 ± 2.78 108 ± 0.44 39.026 ± 0.005 0.016 ± 0.002 
 
 
First of all, the data generated from the extrusion process were used to monitor and predict 
the fraction of MPT in the melt. A PLS model was developed, regressing the in-line measured 
torque and die pressure versus the MPT concentration. A clustering according to the MPT 
concentration was seen along the first principal component (Figure 9.3a), which captured 
97.4% of all variation in the dataset. The validation of this predictive model with 
measurements performed during new extrusion experiments resulted in a root mean square 
error of prediction (RMSEP) of 1.48% (w/w) MPT (Table 9.2). Die pressure and torque 
decreased with increasing drug concentration, since MPT has a plasticizing effect on the 
polymer [10], making it easier to process when the MPT concentration increases. 
 
A second PLS model was developed using the ultrasound parameters transit time and peak 
height as X-matrix, and the MPT concentration as Y-matrix. The first principal component, 
comprising 96.0% of the variation from the dataset, was related to MPT concentration 
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(Figure 9.3b). Validation of this second model resulted in an RMSEP of 1.47% (w/w) MPT. As 
the drug load in the melt increased, ultrasonic transit time decreased, and the peak height of 
the signal increased. When the MPT concentration in the extruded mixture increased, the 
average melt temperature of the melt in the die decreased (Table 9.1). This resulted in a 
lower free volume in the melt, increasing the intermolecular forces and thereby increasing 
the elastic modulus, which is represented by a higher velocity (Eq. 9.1) and thus a lower 
transit time [2]. 
 
Table 9.2. R² and RMSEP of the three different PLS models 
PLS model based on: R² (PC 1) RMSEP 
Extrusion parameters 0.974 1.48 
Ultrasound parameters 0.960 1.47 
Extrusion and ultrasound parameters 0.984 0.94 
 
 
Finally, a third PLS model was developed combining both datasources into one matrix. The 
first principal component contained 98.4% of the variation from the dataset, which can be 
explained by differences in MPT concentration (Figure 9.3c). The combination of both 
ultrasound and extrusion parameters resulted in a predictive model with an RMSEP of 0.94% 
(w/w) MPT. The PLS biplot in Figure 9.3.c also shows clustering of the responses ultrasonic 
transit time, die pressure and torque. An increase in MPT concentration in the melt 
decreased the torque and die pressure during extrusion (Table 9.1), since MPT has a 
plasticizing effect on the polymer. The lower pressure increased the ultrasound velocity and 
therefore lowered the transit time, but also caused a decrease in attenuation of the 
ultrasound wave, resulting in a higher signal intensity. 
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Figure 9.3. PLS biplots of the models developed with a) only extrusion parameters (torque and die pressure); b) 
only ultrasound parameters (transit time and peak height); c) both extrusion and ultrasound parameters. 
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9.4. CONCLUSION 
 
Ultrasound monitoring techniques are potential tools for the in-line determination of the 
drug content in pharmaceutical hot-melt extrusion processes. The results in chapter 9 show 
that the use of ultrasonic techniques improved the predictive performance of the calibration 
model when comparing it to the model based only on die pressure and torque 
measurements. 
 
The velocity of longitudinal waves through the melt can provide useful information on the 
elastic properties of the melt and on its density. Additionally, the attenuation also supplies 
information related to the concentration of the drug in the mixture during extrusion. 
However, both parameters are strongly influenced by temperature and pressure changes, 
and therefore require an extensive calibration before this technique can be applied as a 
monitoring tool for melt density and elasticity. 
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FUTURE PERSPECTIVES 
 
 
The results in this thesis demonstrate that the implementation of both Raman and NIR 
spectroscopy in pharmaceutical hot-melt extrusion processes allows the monitoring of 
drug/polymer concentration and solid state, and the visualization of solid state and 
interactions throughout the entire extrusion process.  
 
The implementation of process analytical techniques in pharmaceutical hot-melt extrusion 
serves two purposes. The results described in this thesis regarding monitoring of solid state 
and interactions contribute to the first purpose of the implementation of process analytical 
tools in hot-melt extrusion, i.e. the improvement of process understanding by monitoring 
and visualizing the material behaviour. The second objective, monitoring and analyzing 
critical product and process parameters for process control and guaranteed end product 
quality, has been addressed during the development and validation of predictive models for 
API quantification. These models are created using data collected from a 12 or 16 mm twin-
screw extruder. Both equipment types are lab scale extruders. The applicability of these 
monitoring models in larger, production scale extruders needs to be evaluated. To provide 
actual process control, the model responses from several implemented process analytical 
techniques, combined with the data collected from the standard sensors implemented in 
extrusion (temperature, pressure, torque) should trigger control loops when exceeding 
preset limits, to divert material with a inferior quality to waste (feed-forward control) and to 
allow the process to restabilize and produce extrudates with the desired quality by altering 
the process settings (feed-back control). 
 
The spectroscopic process analyzers examined in this work enable the quantification of the 
different components in the extrudates and allow monitoring of solid state and interactions. 
These formulation characteristics help in defining the quality of the extrudates, but these are 
not the only (critical) quality attributes which need to be assessed. The application of 
spectroscopic techniques in extrusion can serve other purposes as well. Using spectroscopic 
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techniques, the detection of degradation products and reactions, the quantification and the 
location of formation of these products along the screws can be determined. 
 
An additional interesting application of spectroscopic tools, since hot-melt extruded 
products often show modified or sustained release, is to link the drug release profiles 
obtained in vitro (during dissolution experiments) or in vivo to the in-line obtained process 
information. Since spectroscopic tools can provide information on the type and strength of 
interactions between drugs and polymers, it might be possible to correlate the in-line 
obtained spectroscopic data with the drug release profiles. Raman and NIR spectroscopy are 
often complementary analytical tools, and depending on the formulation used for extrusion, 
one technique will be more suitable than the other. Raman spectra can be strongly 
influenced by fluorescence and colour in the formulation, and NIR spectra, particularly in 
reflectance mode, contain a large amount of noise when monitoring a transparent 
formulation. Both tools can be applied in the reflectance or transmission mode, by using 
custom made die adapters, dependent on the properties of the formulation which needs to 
be monitored and the extrusion equipment. The transmission mode can be used to monitor 
across the entire melt channel, whereas the reflection mode will only monitor a fraction of 
the melt channel depth. 
 
Another important (critical) characteristic of the melt is its viscosity. This is particularly 
relevant for further downstream processing. The melt requires a certain viscosity when 
being further processed to form pellets, or when injection moulding is applied. In polymer 
extrusion, the use of on-line rheometers (capillary, oscillatory, rotational and extensional) 
has been illustrated. By implementing these tools, the melt viscosity, shear stress, melt flow 
index, linear viscoelastic behaviour and melt strength can be evaluated. So far, these 
rheometers only have an on-line application, which requires elaborate adaptations to the 
extrusion equipment. On-line rheometers can be implemented immediately before or after 
the extrusion die, to assess the final rheological characteristics of the melt, but they can also 
be used throughout the entire barrel to determine the influence of certain kneading zones in 
the screw configuration on the rheological features of the melt, and to assess the effect of 
varying drug concentrations on these rheological parameters. 
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As discussed in Chapter 6, both spectroscopic and rheometric in-process measurements can 
provide information concerning the effect of different types of screw elements on the 
extruded formulation. By implementing these process analytical techniques along the 
extrusion barrel, the optimal screw configuration (i.e. location and number of kneading and 
pressure building zones) for extrusion of a certain formulation can be determined. This 
allows the development of the most energy-efficient screw configuration, providing both 
dispersive and distributive mixing with an optimal mechanical energy input.  
 
The extrusion process on its own is only one step in a (continuous) manufacturing line. 
Monitoring of critical process and formulation parameters is required along the entire 
production process. Initially, the powder or premix feeding and liquid addition (upstream 
processes) need to be controlled adequately. Secondly, several downstream processes are 
available for further cooling, cutting, shaping and collection of the hot-melt extruded 
strands, and they each have a significant impact on the quality of the end product. Certain 
downstream process applications require the melt to be cooled. The effect of the 
(controlled) cooling on the quality of the extruded strands needs to be evaluated. Cooling 
might induce recrystallization of an amorphous drug, thereby altering its bioavailability. In 
addition, it also changes the viscosity of the extrudates. Other downstream equipment adds 
(mechanical) energy to the melt, thereby increasing its temperature, which also translates 
into changes in solid state and viscosity. The influence of all of these effects on the end 
product quality needs to be assessed, to allow production according to the ‘Quality by 
Design’ principle and to enable process control. Not only will this result in an improved 
product quality, but it will also enhance the process understanding and allow process 
optimization. 
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Traditionally, extruders are equipped with standard, univariate process monitoring sensors 
such as probes monitoring temperature and pressure, which are used to control the hot-
melt extrusion process in an indirect manner by correlating the extrudate properties to 
these measurements. The data generated by these sensors do not suffice to assess the 
critical quality attributes of the extrudates, will not account for process-induced variations in 
material properties, cannot guarantee stable processing and are not able to ensure the 
production of an end product with predefined and consistent quality characteristics. 
Therefore, the application of spectroscopic process monitoring tools, in particular Raman 
spectroscopy and NIR spectroscopy, was evaluated in this thesis, to monitor, visualize and 
predict the drug concentration and the material behaviour of polymer-drug mixtures during 
hot-melt extrusion, and to improve overall process understanding. 
 
In Chapter 2, the principles of hot-melt extrusion and its advantages and possible 
shortcomings as a non-conventional pharmaceutical manufacturing technique are discussed. 
Twin-screw extrusion is preferred over single-screw extrusion, since it provides a better 
mixing capability and allows the dispersion of an API into the polymer. Traditional 
monitoring and control of hot-melt extrusion processes includes the determination of barrel 
and product temperature, the measurement of pressure in the extrusion die, the continuous 
logging of torque values and the monitoring of screw speed and throughput. 
 
The pharmaceutical industry is encouraged by several regulatory authorities to implement 
more advanced and innovative process analytical techniques into manufacturing processes 
to improve both product quality and process performance. An overview and critical 
evaluation of more advanced process analytical techniques (compared to the traditional 
monitoring sensors) for monitoring and visualizing material behaviour during processing and 
improving the process understanding of hot-melt extrusion is provided in Chapter 3. Various 
sensors such as spectroscopic tools, ultrasonic techniques and rheological applications are 
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available for observation of critical process and product parameters during extrusion. An 
appropriate combination of the different process analytical techniques evaluated in this 
chapter will lead to a thorough process understanding and will allow monitoring of the 
critical process and product parameters. This monitoring will eventually lead to optimization 
of the HME process and the formulations, and provide the possibility for improved process 
control in routine manufacturing. 
 
In Chapter 4, the feasibility of Raman spectroscopy as a process analytical tool for the in-line 
monitoring and prediction of the API concentration and for the monitoring of 
physicochemical state of the extrudates and possible interactions between polymers and 
drugs during hot-melt extrusion was assessed. A Raman probe was implemented in the die 
of a twin-screw extruder, and spectra were collected every 5 seconds during extrusion. For 
the in-line API quantification, a PLS model regressing the collected Raman spectra versus the 
drug concentrations was developed. The predictive ability of this model was evaluated by 
the correlation between the predicted and real drug concentration values (R² = 0.997) and 
the prediction error for new measurements (RMSEP = 0.59% w/w), which both 
demonstrated the suitability of Raman spectroscopy for the prediction of the API 
concentration during hot-melt extrusion. A comparison between the in-line collected Raman 
spectra and the off-line obtained DSC thermograms and ATR FT-IR spectra of the extrudate 
samples collected during processing demonstrated that information concerning the 
physicochemical state of a polymer-drug melt can be obtained from the Raman spectra. 
Broadening of peaks in the spectra indicated that the drug was present in its amorphous 
state, and the manifestation of peak shifts for both peaks corresponding to the API and to 
the polymer demonstrated that interactions between both components occurred during 
hot-melt extrusion. 
 
Once the suitability of Raman spectroscopy to monitor the API concentration during hot-
melt extrusion was evaluated, an advanced validation strategy for the Raman spectroscopic 
drug quantification method was applied in Chapter 5. Different models for the prediction of 
the API content were compared, based on the use of single spectra or averaged spectra, and 
using partial least squares regression or multivariate curve resolution. The predictive models 
were developed by extruding and monitoring five calibration mixtures, each with a different 
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API concentration and were validated using five other validation mixtures, each extruded on 
three different days by two different operators. For the validation of the different models, 
the accuracy profiles of the analytical procedures were calculated, based on the β-
expectation tolerance intervals and the concept of total error (bias + standard deviation). For 
each of the validated API concentrations, the β-expectation tolerance intervals were 
calculated. These intervals allowed the determination of the proportion of future 
measurements (set at 95%) that will be found within preset acceptance limits, which were 
set at 10% of the relative bias. The model developed using averaged spectra and multivariate 
curve resolution was the only model which guaranteed that 95% of future concentration 
measurements will not deviate more than 10% from the reference value. The model showed 
good precision, trueness, linearity, specificity and accuracy over the applied concentration 
range. The robustness of the developed predictive model was evaluated via an experimental 
design varying throughput, screw speed and barrel temperature. No significant influence of 
any of these process settings on the predicted concentration values was found. The 
uncertainty of the measurements was assessed via the uncertainty of bias and the expanded 
uncertainty at each concentration level. The uncertainty measurements for this model 
showed that the unknown true value can be found at a maximum of ± 7.00% around the 
measured result, with a confidence level of 95%. 
 
In Chapter 6, the Raman probe was implemented in each section of the extrusion barrel, to 
enhance the understanding of material behaviour during hot-melt extrusion. The influence 
of variations in drug concentration, barrel temperature and screw speed on the polymer-
drug solid state and interactions was examined. Since hot-melt extrusion is a starve fed 
process, the barrel will not be completely filled with material in every segment. This causes a 
background signal in the in-line collected Raman spectra, which could not be corrected for. 
Principal component analysis was applied to separate this source of variation in the spectra 
from the relevant information. When a formulation with a high drug load was extruded, 
melting of the drug occurred in the first kneading zone, located between barrel sections 2 
and 3. This was the same for a low drug load. However, an additional spectral difference was 
found when the melt passed through a third kneading zone, where the drug dissolved into 
the polymer and a solid glassy suspension was produced due to the high shear forces applied 
on the mixture. In the Raman spectra, this was indicated by the presence of peak shifts, and 
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it was confirmed by FT-IR spectra collected from samples gathered from the extrusion barrel. 
When extruding mixtures with a low drug load, increasing the processing temperature did 
not influence the solid state of the final product or the location in the barrel where the final 
product is attained. At a high drug load however, the solid state of the end product is 
reached further down the barrel when the temperature is decreased. Doubling the screw 
speed when processing a formulation with a low drug load did not affect the solid state of 
the product or the location in the barrel where it is obtained. In contrast, at a high drug load, 
the section where the final product is produced, is situated earlier in the barrel when 
applying a higher rotational speed. The performed in-barrel measurements provide real-time 
information about polymer/drug behaviour throughout the barrel, hence allowing the 
optimization of process settings and barrel and screw design required to obtain extrudates 
with predefined, constant solid state characteristics. 
 
The aim of the experimental work discussed in Chapter 7, was to classify extrudates in-line 
according to their solid state. A Raman probe was implemented in the die head of an 
extruder, and collected spectra every 20 seconds. The influence of variations in drug 
concentration, changes in barrel temperature and three different screw configurations on 
the physicochemical state of the extrudates was assessed. Soft independent modelling of 
class analogy was performed to develop a model which allowed distinction between glassy 
solid solutions and crystalline dispersions of a poorly soluble API in a polymer, based on the 
in-line collected Raman spectra. Off-line analysis with DSC and XRD appeared not to be 
sensitive enough to detect small fractions of crystalline drug, which can later on induce 
recrystallization of all of the API during storage. These small crystalline fractions were 
detected in the Raman spectra, where the solid state characterization was based on the 
appearance of peak broadening and peak shifts. Modifications in screw configuration did not 
affect the solid state of the final products. 
 
The influence of die pressure on the Raman spectra was also examined in Chapter 7. The 
applied drug concentration, processing temperature and feeder performance all influence 
the die pressure, and this effect can be found in the background signal of the Raman spectra 
before pre-processing. Disturbances in the feeding process can thus be observed and 
identified in the Raman measurements. 
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In Chapter 8, the suitability of NIR spectroscopy for the in-line determination of the drug 
concentration, the polymer-drug solid state and molecular interactions during extrusion was 
evaluated. The NIR probe was mounted in the extrusion die, and NIR spectra of the melt 
were collected every 30 seconds. A PLS model was developed for in-line API concentration 
monitoring. A good correlation between predicted and real drug concentrations was found 
(R² = 0.97), and the prediction error for new measurements was 1.54% (w/w). The in-line 
collected NIR spectra showed peak broadening during extrusion, caused by the presence of 
amorphous API, and a new peak was found, which was not present in the spectra from the 
physical mixtures, indicating the formation of hydrogen bonds during processing. 
 
In Chapter 9, the aim was to evaluate the suitability of ultrasonic techniques as process 
analytical tools for the in-line monitoring of the API concentration. Ultrasonic transit time 
and peak height were measured by the implementation of two ultrasound transducers in a 
custom made die adapter. First, a PLS model for quantification was developed based solely 
on the monitored die pressure and torque. It was demonstrated that adding the transit time 
and peak height monitored using ultrasonic techniques improved the predictive ability of 
this PLS model. 
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De procescontrole bij hot-melt extrusie wordt traditioneel uitgevoerd met behulp van 
standaard technieken die univariate data opleveren, zoals probes die de temperatuur en 
druk meten. Deze worden gebruikt om het extrusieproces op indirecte wijze onder controle 
te houden, door de geregistreerde parameters te correleren met bepaalde eigenschappen 
van het extrudaat. De metingen die door deze sensoren uitgevoerd worden, volstaan niet 
om de kwaliteit van extrudaten te bepalen, meten geen variaties in materiaaleigenschappen 
die veroorzaakt worden door veranderingen in het extrusieproces, kunnen geen stabiel 
proces garanderen en zijn ontoereikend om een eindproduct met een vooropgestelde en 
onveranderlijke kwaliteit af te leveren. Daarom werd in deze thesis het gebruik van 
spectroscopische technieken onderzocht, voornamelijk de toepassingen van Raman 
spectroscopie en nabije-infraroodspectroscopie, om de geneesmiddelconcentratie en het 
gedrag van materialen tijdens extrusie te monitoren, te visualiseren en te voorspellen, en 
om de algemene kennis van het extrusieproces te verbeteren. 
 
In Hoofdstuk 2 worden de principes van hot-melt extrusie, samen met de voordelen en 
eventuele tekortkomingen van de techniek als farmaceutisch productieproces beschreven. 
Dubbele-schroef extrusie wordt verkozen boven enkele-schroef extrusie, door de betere 
mengeigenschappen die het dispergeren van het geneesmiddel in het polymeer mogelijk 
maken. Het monitoren en controleren van het extrusieproces gaat gebruikelijk gepaard met 
het bepalen van de temperatuur van het mengsel en de schroefkamer, het meten van de 
druk in de matrijs, het continu monitoren van de torsie, de schroefsnelheid en de snelheid 
waarmee het fysisch mengsel gevoed wordt. 
 
De regelgevende instanties moedigen de farmaceutische industrie aan om geavanceerde en 
innovatieve proces analytische technieken te gebruiken in productieprocessen om de 
kwaliteit van de ontwikkelde producten en de prestaties van de processen te perfectioneren. 
Hoofdstuk 3 geeft een overzicht en kritische evaluatie van meer geavanceerde en 
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efficiëntere technieken (in vergelijking met de traditionele sensoren) die kunnen gebruikt 
worden om het gedrag van materialen tijdens extrusie te monitoren en om het 
extrusieproces beter te begrijpen. Een gevarieerd aanbod aan sensoren, zoals 
spectroscopische technieken, ultrasone technieken en reologische toepassingen zijn 
voorhanden om kritische proces- en productparameters te observeren tijdens extrusie. Een 
geschikte combinatie van de technieken die in dit hoofdstuk beschreven worden, zal leiden 
tot een verbeterd inzicht in het extrusieproces en laat het determineren van kritische 
proces- en productparameters toe. Dit zal uiteindelijk de optimalisatie van het 
extrusieproces en de geëxtrudeerde formulaties bevorderen, en maakt een verfijnde 
procescontrole in routineproductie mogelijk.  
 
In Hoofdstuk 4 werd de toepasbaarheid van Raman spectroscopie als proces analytische 
techniek geëvalueerd voor het in-line monitoren en voorspellen van de 
geneesmiddelconcentratie en voor het monitoren van de fysicochemische eigenschappen 
(amorficiteit, kristalliniteit, de manier waarop het geneesmiddel gedispergeerd is in de 
matrix) van de extrudaten en eventuele interacties tussen polymeren en geneesmiddelen 
tijdens extrusie. Een Raman probe werd ingebouwd in de matrijs van een dubbele-schroef 
extruder, en Raman spectra van het mengsel tijdens extrusie werden elke 5 seconden 
opgemeten. Voor de in-line kwantificatie werd een PLS model ontwikkeld. Het voorspellend 
vermogen van dit model werd geëvalueerd aan de hand van de correlatie tussen de 
voorspelde en ‘echte’ geneesmiddelconcentraties (R² = 0.997) en aan de hand van de 
predictiefout voor nieuwe metingen (RMSEP = 0.59% w/w), die beiden de geschiktheid van 
Raman spectroscopie voor concentratiewaarnemingen tijdens extrusie bevestigen. Een 
vergelijking tussen in-line opgenomen Raman spectra en off-line resultaten van de DSC- en 
XRD-analyses toont aan dat de Raman spectra informatie bevatten over de fysicochemische 
eigenschappen van een polymeer-geneesmiddel mengsel tijdens extrusie. Het verbreden van 
pieken in het spectrum wijst op de overgang van het geneesmiddel van een kristallijne naar 
een amorfe toestand, en de aanwezigheid van piekverschuivingen voor zowel pieken eigen 
aan het geneesmiddel als aan het polymeer duidt op het ontstaan van interacties tussen 
beide componenten in het mengsel tijdens extrusie. 
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Nadat aangetoond werd dat Raman spectroscopie kan gebruikt worden om de concentratie 
van het geneesmiddel te bepalen tijdens extrusie, werd een verfijnde validatiestrategie 
toegepast op de kwantificatiemethode gebaseerd op Raman spectroscopie in Hoofdstuk 5. 
Verschillende voorspellende modellen, opgebouwd uit de enkelvoudige of gemiddelde 
spectra, en ontwikkeld via PLS of MCR, werden met elkaar vergeleken. De Raman spectra die 
gebruikt werden om de voorspellende modellen op te stellen, werden verzameld tijdens 
extrusie van vijf verschillende kalibratiemengsels met elk een andere 
geneesmiddelconcentratie, en gevalideerd met vijf validatiemengsels, geëxtrudeerd op drie 
verschillende dagen door twee operatoren. Voor de validatie van deze methoden werd het 
totale-fout-profiel voor elke methode berekend, gebaseerd op de ‘β-expectation tolerance 
intervals’ en het concept van de totale fout (= bias + standaarddeviatie). Voor elke 
gevalideerde concentratie werd het ‘β-expectation tolerance interval’ bepaald. Met behulp 
van deze intervallen kan het aantal toekomstige metingen (ingesteld op 95%) dat binnen 
vooropgestelde acceptatielimieten (10% relatieve bias) zal vallen, geschat worden. Het 
model ontwikkeld op basis van gemiddelde spectra en MCR was het enige dat kon 
garanderen dat minstens 95% van de toekomstige metingen niet meer dan 10% van de 
‘echte’ concentratie zullen afwijken. Het model heeft een goede precisie, accuraatheid, 
lineariteit, specificiteit en juistheid over het toegepaste concentratiebereik. De robuustheid 
van dit model werd nagegaan via een experimenteel design waarbij voedingssnelheid, 
schroefsnelheid en procestemperatuur werden gevarieerd. Geen van deze procesvariabelen 
bleek een significant effect te hebben op het voorspellen van de geneesmiddelconcentraties. 
De onzekerheid van de metingen werd geëvalueerd aan de hand van de onzekerheid van de 
bias en de uitgebreide onzekerheid voor elk concentratieniveau. De onbekende, ‘echte’ 
waarde ligt op maximum ± 7.00% van het gemeten resultaat (met een zekerheid van 95%). 
 
In Hoofdstuk 6 werd de Raman probe ingebouwd in elk segment van de schroefkamer, om 
het gedrag van materialen tijdens extrusie te visualiseren. De invloed van variaties in 
geneesmiddelconcentratie, schroefkamertemperatuur en schroefsnelheid op de 
fysicochemische eigenschappen en interacties tussen het geneesmiddel en het polymeer 
werd onderzocht. Bij hot-melt extrusie is de schroefkamer nooit volledig gevuld met 
materiaal, wat een verschil in het achtergrondsignaal in de in-line opgenomen Raman 
spectra veroorzaakte. Hiervoor kon niet gecorrigeerd werden. Daarom werd voor principale 
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componentenanalyse gekozen, om deze bron van variatie in de spectra te scheiden van de 
relevante informatie. Wanneer een formulatie met een hoge geneesmiddelconcentratie 
geëxtrudeerd werd, smolt het geneesmiddel in de eerste kneedzone (tussen segment 2 en 
3). Dit fenomeen vond ook plaats bij formulaties met een lage geneesmiddelconcentratie. 
Daar werd een extra verschil in de spectra waargenomen, onder de vorm van 
piekverschuivingen, ter hoogte van de derde kneedzone, waar het geneesmiddel oploste in 
het polymeer en er een vaste oplossing gevormd werd, dankzij de hoge wrijvingskrachten in 
die derde kneedzone. Dit werd bevestigd door off-line opgenomen FT-IR spectra van stalen 
verzameld in de schroefkamer. Bij een lage geneesmiddelconcentratie had het verhogen van 
de procestemperatuur geen invloed op de fysicochemische eigenschappen van het 
eindproduct of op de locatie in de schroefkamer waar dit eindproduct gevormd werd. Dit 
was ook het geval voor het verdubbelen van de schroefsnelheid. Echter, bij extrusie van een 
fysisch mengsel met een hoog geneesmiddelgehalte, wordt de fysicochemische toestand van 
het eindproduct pas verder in de schroefkamer bereikt wanneer de temperatuur lager wordt 
ingesteld. Wanneer de schroefsnelheid verdubbeld wordt, bevindt het segment waar het 
eindproduct wordt gevormd zich vroeger in de schroefkamer. De uitgevoerde metingen 
doorheen de volledige schroefkamer verstrekken real-time informatie over het gedrag van 
het polymeer-geneesmiddel mengsel in de schroefkamer, wat de optimalisatie van 
procesparameters en procesdesign (schroeven en schroefkamer) toelaat, zodat extrudaten 
met een vooropgestelde en constante kwaliteit kunnen afgeleverd worden. 
 
In Hoofdstuk 7 werd een Raman probe ingebouwd in de matrijs van een dubbele-schroef 
extruder, en elke 20 seconden werd een spectrum opgenomen. Het doel was het opstellen 
van een model om extrudaten te classificeren op basis van hun fysicochemische toestand. 
Het effect van variaties in geneesmiddelconcentratie, veranderingen in procestemperatuur 
en drie verschillende schroefconfiguraties op de fysicochemische eigenschappen van de 
extrudaten werd onderzocht. Een model werd ontwikkeld, gebruik makend van ‘soft 
independent modelling of class analogy’, waardoor het mogelijk was om in-line een 
onderscheid te maken tussen amorfe oplossingen en kristallijne dispersies van het slecht 
oplosbaar geneesmiddel in het polymeer, aan de hand van de opgenomen Raman spectra. 
Off-line analyse met DSC en XRD bleek niet gevoelig genoeg om kleine kristallijne fracties van 
het geneesmiddel te detecteren, die later de uitkristallisatie van het overige amorfe 
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geneesmiddel kunnen induceren. Deze kleine fracties werden wel gedetecteerd met Raman 
spectroscopie, aan de hand van piekvernauwing en het voorkomen van piekverschuivingen. 
De verschillende schroefconfiguraties hadden geen invloed op de fysicochemische 
eigenschappen van de extrudaten. 
 
Naast het opstellen van een classificatiemodel, werd ook nagegaan of de druk in de matrijs 
een invloed heeft op de Raman spectra. De gebruikte geneesmiddelconcentratie, 
procestemperatuur en de manier waarop het fysisch mengsel in de schroefkamer gevoed 
wordt, beïnvloeden de druk in de matrijs, en dit effect wordt teruggevonden in de niet-
gecorrigeerde Raman spectra als een verschil in het achtergrondsignaal. Storingen in de 
voeding kunnen dus geobserveerd en geïdentificeerd worden aan de hand van de Raman 
spectra. 
 
In Hoofdstuk 8 werd het gebruik van nabije-infraroodspectroscopie geëvalueerd om de 
geneesmiddelconcentratie, de fysicochemische eigenschappen van de extrudaten en het 
ontstaan van interacties tijdens extrusie te monitoren. Een NIR probe werd gemonteerd in 
de matrijs, en elke 30 seconden werd een NIR spectrum opgenomen. Een PLS model werd 
ontwikkeld om het geneesmiddelgehalte in-line te bepalen. De voorspelde en echte 
geneesmiddelconcentraties vertoonden een goede correlatie (R² = 0.97), en nieuwe 
metingen resulteerden in een lage predictiefout (RMSEP = 1.54% w/w). De in-line 
opgenomen NIR spectra vertoonden piekverbreding tijdens extrusie, veroorzaakt door de 
aanwezigheid van het geneesmiddel in de amorfe vorm, en het ontstaan van een nieuwe 
piek, die niet teruggevonden werd in de spectra van de fysische mengsels, wees op de 
vorming van waterstofbruggen tussen het polymeer en het geneesmiddel. 
 
Het doel van Hoofdstuk 9 was de evaluatie van ultrasone technieken als proces analytische 
toepassingen om de geneesmiddelconcentratie in-line te bepalen. De transittijd van het 
ultrasone signaal en de piekhoogte werden gemeten in een matrijsadapter, waarin twee 
ultrasone probes ingebouwd waren. Er werd eerst een PLS model voor kwantificatie 
opgesteld, enkel gebaseerd op de gemeten druk in de matrijs en de torsie tijdens extrusie. Er 
werd aangetoond dat het toevoegen van de gemeten transittijd en piekhoogte van het 
ultrasone signaal het voorspellend vermogen van het model verhoogde. 
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De resultaten in deze thesis tonen aan dat de implementatie van zowel Raman als nabije-
infrarood spectroscopie in farmaceutische hot-melt extrusieprocessen toelaat de 
geneesmiddelconcentratie en fysicochemische eigenschappen van extrudaten te 
voorspellen, en de interacties tussen polymeer en geneesmiddel doorheen het volledige 
extrusieproces in kaart te brengen. Dit draagt bij tot de twee objectieven van het toepassen 
van PAT in extrusieprocessen: (i) het proces beter begrijpen aan de hand van visualisatie van 
het gedrag van materialen gedurende het proces en (ii) het meten en analyseren van 
kritische formulatie- en procesparameters om procescontrole mogelijk te maken en de 
kwaliteit van het eindproduct te garanderen. 
 
Alle experimenten uit dit onderzoek werden uitgevoerd op laboschaal-extruders (12 en 16 
mm). Er moet bijgevolg nagegaan worden of de ontwikkelde methodes en gebruikte 
modellen ook van toepassing kunnen zijn op grootschalige toestellen. Het bepalen van de 
geneesmiddelconcentratie en de fysicochemische eigenschappen van de extrudaten laat toe 
de kwaliteit van de extrudaten te definiëren, maar dit zijn niet de enige (kritische) 
kwaliteitseigenschappen die moeten gemeten worden. Naast deze twee karakteristieken is 
het nodig om mogelijke degradatieproducten en -reacties te detecteren, en eventueel om de 
vrijstelling in vitro en in vivo van het geneesmiddel vooraf te bepalen op basis van 
spectroscopische data. De viscositeit van de extrudaten is een eigenschap die van groot 
belang is voor het verder verwerken van de extrudaten, en die kan nagegaan worden door 
het implementeren van on-line reometers in de schroefkamer of na de matrijs. Het gebruik 
van spectroscopische en reologische technieken kan ook bijdragen tot de optimalisatie van 
de gebruikte schroefconfiguratie. De meest energie-efficiënte schroefconfiguratie voor 
extrusie van een bepaalde formulatie kan op deze manier ontwikkeld worden. 
 
Het extrusieproces is slechts 1 stap in een (continue) productielijn. Het voeden van poeders 
of fysische poedermengsels moet voldoende gecontroleerd worden. Daarnaast moet ook de 
impact van de verschillende ‘downstream’ processen op de kwaliteit van de extrudaten 
geëvalueerd worden. Het koelen of opwarmen van de extrudaten, al dan niet gecontroleerd, 
heeft een significant effect op de kristalliniteit, de manier waarop het geneesmiddel 
gedispergeerd is in de matrix en op de viscositeit van het eindproduct. Het bepalen van 
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kritische proces- en formulatie-eigenschappen over de gehele productielijn is noodzakelijk 
om productie volgens het ‘Quality by Design’ principe te garanderen. 
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quality assessment, visualization and understanding of pharmaceutical hot-
melt extrusion” 
Promoter: Prof. Dr. Thomas De Beer, Co-promoter: Prof. Dr. Chris Vervaet 
Laboratory of Pharmaceutical Process Analytical Technology, 
Ghent University, Belgium 
2004 – 2009: Master in Pharmaceutical Care 
   Ghent University, Belgium 
1998 – 2004: Degree Sciences - Mathematics 
   Sint Lodewijkscollege, Brugge, Belgium 
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EXPERIENCE 
 
2012:   Research exchange 
    Brabender® Pharma GmbH 
    Duisburg, Germany 
April – June 2011:  Research exchange 
    School of Engineering, Design and Technology 
    University of Bradford, United Kingdom 
August 2009:  Apotheek Van Nieuwerburgh (Lloyds Pharma), Eeklo, Belgium 
2008 – 2009:  Pharmacist internship 
    Apotheek Martin, Reep 44, 9000 Gent, Belgium 
2008: Master thesis: “The Effect of Moisture on the Mixing Behaviour of 
Granules” 
Promoter: Prof. Dr. Chris Vervaet 
Department of Pharmaceutical Technology, University of Helsinki 
 
PUBLICATIONS IN PEER REVIEWED JOURNALS 
 
 
Validation of an in-line Raman spectroscopic method for continuous API quantification during 
pharmaceutical hot-melt extrusion 
L. Saerens, N. Segher, C. Vervaet, J.P. Remon, T. De Beer 
Accepted for publication in Analytica Chimica Acta (2013) 
 
In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw 
extruder using Raman spectroscopy 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, J. Manz, R. Krüger, S. Krüger, C. Vervaet, J.P. 
Remon, T. De Beer 
Submitted to European Journal of Pharmaceutics and Biopharmaceutics (2013) 
 
Process monitoring and visualization solutions for hot-melt extrusion: A review 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
Journal of Pharmacy and Pharmacology (2013) doi: 10.1111/jphp.12123 
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Visualization and process understanding of material behavior in the extrusion barrel during a 
hot-melt extrusion process using Raman spectroscopy 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
Analytical Chemistry 85 (2013) 5420-5429 
 
Prilling of fatty acids as a continuous process for the development of controlled release 
multiparticulate dosage forms 
A. Vervaeck, L. Saerens, B.G. De Geest, T. De Beer, R. Carleer, P. Adriaensens, J.P. Remon, C. 
Vervaet 
European Journal of Pharmaceutics and Biopharmaceutics (2013)doi:10.1016/j.ejpb.2013.02.003 
 
In-line NIR spectroscopy for the understanding of polymer-drug interaction during 
pharmaceutical hot-melt extrusion 
L. Saerens, L. Dierickx, T. Quinten, P. Adriaensens, R. Carleer, C. Vervaet, J. P. Remon, T. De Beer 
European Journal of Pharmaceutics and Biopharmaceutics 81 (2012) 230-237 
 
Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices 
L. Dierickx, L. Saerens, A. Almeida, T. De Beer, J.P. Remon, C. Vervaet 
European Journal of Pharmaceutics and Biopharmaceutics 81 (2012) 683-689 
 
Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an 
acrylic carrier using injection moulding 
T. Quinten, G.P. Andrews, T. De Beer, L. Saerens, W. Bouquet, D.S. Jones, P. Hornsby, J.P. Remon, 
C. Vervaet 
AAPS PharmSciTech 13 (2012) 1197-1211 
 
Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate 
hot-melt extruded formulations 
A. Almeida, L. Saerens, T. De Beer, J.P. Remon, C. Vervaet 
International Journal of Pharmaceutics 439 (2012) 223-229 
 
Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization 
during a pharmaceutical hot-melt extrusion process 
L. Saerens, L. Dierickx, B. Lenain, C. Vervaet, J.P. Remon, T. De Beer 
European Journal of Pharmaceutics and Biopharmaceutics 77 (2011) 158-163 
 
Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical 
production processes 
T. De Beer, A. Burggraeve, M. Fonteyne, L. Saerens, J.P. Remon, C. Vervaet 
International Journal of Pharmaceutics 417 (2011) 32-47 
 
Detection of counterfeit Viagra® by Raman microspectroscopy imaging and multivariate analysis 
P.-Y. Sacré, E. Deconinck, L. Saerens, T. De Beer, P. Courselle, R. Vancauwenberghe, P. Chiap, J. 
Crommen, J. O. De Beer 
Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 454-461  
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PRESENTATIONS AT CONFERENCES 
 
 
Oral presentations 
 
In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw 
extruder using Raman spectroscopy 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, R. Krüger, S. Krüger, C. Vervaet, J.P. Remon, 
T. De Beer 
7th Annual PSSRC Symposium, Lille (France), 4-6 July 2013 
 
NIR and Raman spectroscopy as PAT tools in pharmaceutical hot-melt extrusion 
L. Saerens, T. De Beer. 
APV Hands-on workshop on Hot Melt Extrusion, Karlsruhe (Germany), 5-6 June 2013 
 
In-line solid state monitoring of Celecoxib/Eudragit EPO systems during hot-melt extrusion by 
Raman spectroscopy 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, R. Krüger, S. Krüger, C. Vervaet, J.P. Remon, 
T. De Beer 
APV Experts’ Workshop on Hot-Melt Extrusion, Ludwigshafen (Germany), 5-6 November 2012. 
 
Spectroscopic hot-melt extrusion in-process monitoring throughout the entire extrusion barrel 
L. Saerens, T. De Beer. 
APS Amorphous IV: Hot-melt extrusion and powder technology in pharmaceutical industry, 
University of Greenwich (United Kingdom), 12-13 June 2012. 
 
Ultrasound and NIR monitoring of a pharmaceutical hot-melt extrusion process 
L. Saerens, E. Brown, A. Kelly, T. Gough, R. Dhumal, P. Apshingekar, A. Paradkar, C. Vervaet, J.P. 
Remon, T. De Beer 
EuPAT 5, Ghent (Belgium), 9-10 May 2012 
 
Visualization and understanding of material behaviour in the extrusion barrel during 
pharmaceutical hot-melt extrusion using Raman spectroscopy 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
16th Forum of Pharmaceutical Sciences, Blankenberge (Belgium), 7-8 May 2012 
 
In-line Raman spectroscopy for the understanding of polymer-drug behavior in the extrusion 
barrel during a pharmaceutical hot-melt extrusion process 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
5th Annual PSSRC Symposium, Helsinki (Finland), 26-27 September 2011 
 
NIR spectroscopy as PAT-tool for in-line monitoring of pharmaceutical hot-melt extrusion 
processes 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
Thermo Scientific User Meeting, Neder-over-heembeek (Belgium), 25 November 2010 
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In-line determination of API content and solid state during pharmaceutical hot-melt extrusion 
processes using Raman spectroscopy 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
IWPCPS 12 Workshop, Lille (France) 21-24 June 2010 
 
NIR spectroscopy as PAT tool for in-line and real-time monitoring of pharmaceutical hot-melt 
extrusion processes 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
Thermo Scientific Summer Meeting, Arnhem (The Netherlands) 16 June 2010 
 
 
Poster presentations 
 
In-line solid state monitoring during pharmaceutical hot-melt extrusion using Raman 
spectroscopy 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, R. Krüger, S. Krüger, C. Vervaet, J.P. Remon, T. 
De Beer 
Knowledge for growth, Ghent (Belgium), 30 May 2013 
 
In-line solid state monitoring during pharmaceutical hot-melt extrusion in a 12mm pharma twin 
screw extruder using Raman spectroscopy 
L. Saerens, D. Ghanam, C. Raemdonck, K. Francois, R. Krüger, S. Schlaefke, C. Vervaet, J.P. 
Remon, T. De Beer 
2012 AAPS annual meeting and exposition, Chicago (USA), 14-18 October 2012 
 
Visualization and understanding of material behaviour in the extrusion barrel during 
pharmaceutical hot-melt extrusion using Raman spectroscopy 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
Scientific Afternoon, Faculty of Pharmaceutical Sciences, Ghent University, Ghent (Belgium), 16 
May 2012 
 
Visualization and understanding of material behaviour in the extrusion barrel during 
pharmaceutical hot-melt extrusion using Raman spectroscopy 
L. Saerens, C. Vervaet, J.P. Remon, T. De Beer 
EuPAT 5, Ghent (Belgium), 9-10 May 2012 
 
Raman spectroscopy for the in-line monitoring of a pharmaceutical hot-melt extrusion process 
L. Saerens, B. Braeckman, C. Vervaet, J.P. Remon, T. De Beer 
8th PBP World Meeting, Istanbul (Turkey), 19-22 March 2012 
 
NIR and Raman spectroscopy as Process Analytical Tools for In-Line and Real-Time Monitoring of 
a Pharmaceutical Hot-Melt Extrusion Process 
L. Saerens, J.P. Remon, C. Vervaet, T. De Beer 
Europact 2011, Glasgow (United Kingdom), 26-29 April 2011 
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Raman spectroscopy as a process analytical tool for in-line and real-time monitoring of a 
pharmaceutical hot-melt extrusion process 
L. Saerens, J.P. Remon, C. Vervaet, T. De Beer 
2010 AAPS annual meeting and exposition / FIP PSWC, New Orleans (USA), 14-18 November 
2010 
 
Raman spectroscopy as a process analytical tool for in-line and real-time monitoring of a 
pharmaceutical hot-melt extrusion process 
L. Saerens, J.P. Remon, C. Vervaet, T. De Beer 
PSWC 2010 Congress for students and postdoctoral fellows, New Orleans (USA), 13-14 November 
2010 
 
Raman spectroscopy as a process analytical tool for in-line and real-time monitoring of a 
pharmaceutical hot-melt extrusion process 
L. Saerens, J.P. Remon, C. Vervaet, T. De Beer 
Drug Analysis, Antwerp (Belgium), 21-24 September 2010 
 
Raman spectroscopy as a process analytical tool for in-line and real-time monitoring of a 
pharmaceutical hot-melt extrusion process 
L. Saerens, J. P. Remon, C. Vervaet, T. De Beer 
Scientific Afternoon, Faculty of Pharmaceutical Sciences, Ghent University, Ghent (Belgium), 12 
May 2010 
 
 
ATTENDED COURSES, CONFERENCES AND WORKSHOPS 
 
 
- Conference: 11th Chemometrics symposium: Advances in Chemometrics, Belgian 
Chemometrics Society, 8 June 2012, Ghent (Belgium) 
- Workshop: Continuous Processing for Tablet Manufacturing, EuPat 5 Pre-conference 
workshop, 8 May 2012, Ghent (Belgium) 
- Course: Introduction to Process Control for Chemists, Pharmacists and Formulation Scientists, 
27-29 June 2011, CPACT, Perceptive Engineering, Daresbury (United Kingdom) 
- Course: Support Vector Machines: Non-linear modeling made easy, 26 April 2011, Glasgow 
(United Kingdom) 
- Course: Hyperspectral Chemical Imaging for Process Analytics, 26 April 2011, Glasgow (United 
Kingdom) 
- Course: Modulated Differential Scanning Calorimetry (MDSC) Training Course, 15 June 2010, 
TA Instruments, Ghent (Belgium) 
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- Course: Differential Scanning Calorimetry (DSC) Training Course, 7 June 2010, TA Instruments, 
Ghent (Belgium) 
- Conference: EuPAT 4 – Taking PAT to the next level, 5-6 May 2010, Kuopio (Finland) 
- Workshop: Pharmaceutical Hot Melt Extrusion, 15 April 2010, Coperion GmbH, Stuttgart 
(Germany) 
- Course: Design of Experiments, January 2010, Ghent (Belgium) 
- Course: Multivariate Data Analysis, January 2010, Ghent (Belgium) 
 
LANGUAGE SKILLS 
 
     Speaking Reading Writing 
Dutch (native language)  very good very good very good 
French    good  good  good 
English    very good very good very good 
German    notions  notions  notions 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
